Document:

<PAGE>

                                  Exhibit 10.1

                   MERGER AGREEMENT AND PLAN OF REORGANIZATION

                                  BY AND AMONG

                            PAINCARE HOLDINGS, INC.,

                      PAINCARE ACQUISITION COMPANY V, INC.,

                    INDUSTRIAL & SPORT REHABILITATION, LTD.,

                        D/B/A ASSOCIATED PHYSICIANS GROUP

                                       AND

                                    JOHN VICK

                         EXECUTION DATE: APRIL 25, 2003.

                                        3

<PAGE>

<TABLE>
<CAPTION>
                                                                                            Page
                                                                                            ----
<S>                                                                                         <C>
1.   DEFINITIONS .......................................................................       1

2.   TRANSACTION .......................................................................       2

     2.1   Transaction .................................................................       2

     2.2   Effect of the Merger ........................................................       2

     2.3   Effective Time; Filing of Certificates of Merger ............................       2

     2.4   Articles of Incorporation ...................................................       2

     2.5   Bylaws ......................................................................       2

     2.6   Directors and Officers ......................................................       2

     2.7   Tax Consequences ............................................................       2

     2.8   Additional Actions ..........................................................       2

     2.9   No Dissenters' Rights .......................................................       3

     2.10  Surrender of Certificates ...................................................       3

           (a)  Company's Shares .......................................................       3

           (b)  Dividends ..............................................................       3

     2.11  Medical Assets ..............................................................       3

     2.12  Conversion of Shares ........................................................       3

     2.13  Shareholder Consent and Release .............................................       4

     2.14  Piggyback Registration ......................................................       4

     2.15  Shareholder's Obligation to Furnish Information .............................       5

     2.16  Suspension of Sales Pending Amendment to Prospectus .........................       5

     2.17  Registration Expenses .......................................................       6

3.   TRANSACTION CONSIDERATION .........................................................       6

     3.1   Merger Consideration ........................................................       6

     3.2   Bridge Deposit ..............................................................       6

     3.3   Closing Date Adjustments ....................................................       7

           (a)  Transaction Related Adjustment .........................................       7

           (b)  Financial Statements ...................................................       7

           (c)  Closing Date Balance Sheet .............................................       7

     3.4   Earnout Payment .............................................................       8

           (a)  General ................................................................       8
</TABLE>

                                        i

<PAGE>

<TABLE>
<CAPTION>
                                                                                            Page
                                                                                            ----
<S>                                                                                         <C>
           (b)  Installment Payment Discount ...........................................       8

           (c)  Installment Payment Premium ............................................       9

           (d)  Manner of Payment ......................................................       8

           (e)  Earnout Cap ............................................................       9

           (f)  Definitions for Purposes of Section 3.4 ................................      10

           (g)  Adjustments to Installment Payments ....................................      10

     3.5   Security and Pledge Agreements ..............................................      10

4.   REPRESENTATIONS AND WARRANTIES OF THE SHAREHOLDER .................................      11

     4.1   Organization, Qualification, and Corporate Power ............................      11

     4.2   Capitalization ..............................................................      11

     4.3   Authorization ...............................................................      11

     4.4   Noncontravention ............................................................      11

     4.5   Broker's Fees ...............................................................      12

     4.6   Title to Assets .............................................................      12

     4.7   No Subsidiaries .............................................................      12

     4.8   Financial Statements ........................................................      12

     4.9   Events Subsequent to Most Recent Year End ...................................      12

           (a)  Sale or Lease of Assets ................................................      13

           (b)  Contracts ..............................................................      13

           (c)  Change in Contracts ....................................................      13

           (d)  Security Interests .....................................................      13

           (e)  Investments ............................................................      13

           (f)  Debts ..................................................................      13

           (g)  Liabilities Unaffected .................................................      13

           (h)  Claims Unaffected ......................................................      13

           (i)  Articles and Bylaws ....................................................      13

           (j)  Changes in Equity ......................................................      13

           (k)  Distribution ...........................................................      13

           (l)  Property Damage ........................................................      13

           (m)  Transactions with Affiliates ...........................................      14
</TABLE>

                                          ii

<PAGE>

<TABLE>
<CAPTION>
                                                                                          Page
                                                                                          ----
<S>                                                                                       <C>
           (n)   Collective Bargaining Agreements ....................................      14

           (o)   Compensation Changes ................................................      14

           (p)   Employee Benefit Plans ..............................................      14

           (q)   Officers; Directors; Employees ......................................      14

           (r)   Charitable or Capital Contributions .................................      14

           (s)   Ordinary Course of Business .........................................      14

           (t)   Accounting Practices ................................................      14

           (u)   Accounts Receivable .................................................      14

           (v)   In General ..........................................................      14

     4.10  Undisclosed Liabilities ...................................................      14

     4.11  Tax Matters ...............................................................      15

           (a)   Tax Returns .........................................................      15

           (b)   Withholding .........................................................      15

           (c)   No Disputes of Claims ...............................................      15

           (d)   No Waivers ..........................................................      15

           (e)   No Special Circumstances ............................................      15

           (f)   Subchapter "S" ......................................................      15

           (g)   Audits of Tax Returns ...............................................      16

           (h)   Period of Assessment ................................................      16

           (i)   Tax Agreements ......................................................      16

           (j)   Inclusions in Taxable Periods .......................................      16

           (k)   Consents ............................................................      16

           (l)   Personal Holding Company ............................................      16

           (m)   Consolidated Tax Returns ............................................      16

     4.12  Real Property .............................................................      16

           (a)   Binding .............................................................      17

           (b)   Continued Validity ..................................................      17

           (c)   No Defaults .........................................................      17

           (d)   Repudiation .........................................................      17

           (e)   No Disputes .........................................................      17
</TABLE>

                                       iii

<PAGE>

<TABLE>
<CAPTION>
                                                                                          Page
                                                                                          ----
<S>                                                                                       <C>
           (f)  Subleases ............................................................      17

           (g)  Encumbrances .........................................................      17

           (h)  Approvals ............................................................      17

           (i)  Utilities ............................................................      17

     4.13  Intellectual Property .....................................................      17

     4.14  Condition of Tangible Assets ..............................................      17

     4.15  Contracts .................................................................      18

           (a)  Personal Property Leases .............................................      18

           (b)  Services .............................................................      18

           (c)  Partnership; Joint Venture ...........................................      18

           (d)  Indebtedness .........................................................      18

           (e)  Confidentiality; Non-Competition .....................................      18

           (f)  Shareholders' Agreements .............................................      18

           (g)  Plans ................................................................      18

           (h)  Employment or Consulting Agreements ..................................      18

           (i)  Advances; Loans ......................................................      18

           (j)  Adverse Effects ......................................................      18

           (k)  Other Agreements .....................................................      18

     4.16  Powers of Attorney ........................................................      19

     4.17  Insurance; Malpractice ....................................................      19

     4.18  Litigation ................................................................      20

     4.19  Health Care Compliance ....................................................      20

     4.20  Fraud and Abuse ...........................................................      20

     4.21  Legal Compliance ..........................................................      21

     4.22  Rates and Reimbursement Policies ..........................................      21

     4.23  Medical Staff .............................................................      22

     4.24  Employees .................................................................      22

     4.25  Employee Benefits .........................................................      22

           (a)  Plans ................................................................      22

           (b)  Compliance ...........................................................      22
</TABLE>

                                       iv

<PAGE>

<TABLE>
<CAPTION>
                                                                                          Page
                                                                                          ----
<S>                                                                                       <C>
           (c)  Reports and Descriptions .............................................      22

           (d)  Contributions ........................................................      22

           (e)  Qualified Plan .......................................................      22

           (f)  Market Value .........................................................      23

           (g)  Copies ...............................................................      23

           (h)  Maintenance of Plans .................................................      23

                (i)    Reportable Events .............................................      23

                (ii)   Prohibited Transactions .......................................      23

     4.26  Physicians and Other Providers ............................................      23

           (a)  Licenses .............................................................      23

           (b)  Controlled Substances ................................................      23

           (c)  Actions ..............................................................      23

                (i)    Malpractice Actions ...........................................      24

                (ii)   Disciplinary Proceedings ......................................      24

                (iii)  Criminal Proceedings ..........................................      24

                (iv)   Investigation .................................................      24

                (v)    Mental Illnesses ..............................................      24

                (vi)   Substance Abuse ...............................................      24

                (vii)  Professional Ethics ...........................................      24

                (viii) Application for Licensure .....................................      24

     4.27  Guaranties ................................................................      24

     4.28  Environment, Health, and Safety ...........................................      24

           (a)  Compliance ...........................................................      24

           (b)  Permits and Licenses .................................................      24

           (c)  Notices ..............................................................      25

           (d)  Hazardous Substances .................................................      25

     4.29  Certain Business Relationships with the Company and its Affiliates ........      25

     4.30  Third-party Payors ........................................................      25

     4.31  Bank Accounts .............................................................      26

     4.32  Tax Status ................................................................      26
</TABLE>

                                        v

<PAGE>

<TABLE>
<CAPTION>
                                                                                  Page
                                                                                  ----
<S>                                                                               <C>
     4.33   Binding Obligation .................................................   26

     4.34   No Corporate Practice or Fee Splitting .............................   26

     4.35   Intentionally Omitted ..............................................   26

     4.36   Securities Representation ..........................................   26

            (a) No Registration of PainCare Shares; Investment Intent ..........   26

            (b) Resale Restrictions ............................................   26

            (c) Ability to Bear Economic Risk ..................................   26

            (d) Accredited Investor ............................................   27

            (e) Residency ......................................................   27

            (f) No Registration ................................................   27

     4.37   HIPAA ..............................................................   27

     4.38   Improper and Other Payments ........................................   27

     4.39   Accounts Receivable ................................................   27

     4.40   Medical Waste ......................................................   28

     4.41   No Untrue or Inaccurate Representation or Warranty .................   28

5.   REPRESENTATIONS AND WARRANTIES OF THE ACQUIRING COMPANIES .................   28

     5.1    Organization of PainCare and Subsidiary ............................   28

     5.2    Authorization of Transaction .......................................   29

     5.3    No Conflict or Violation ...........................................   29

     5.4    Consents and Approvals .............................................   29

     5.5    Disclosure Documents ...............................................   29

     5.6    Capitalization .....................................................   29

     5.7    Litigation .........................................................   30

     5.8    No Undisclosed Liabilities .........................................   30

     5.9    No Brokers .........................................................   30

     5.10   Material Misstatements or Omissions ................................   30

6. CLOSING; TERMINATION ........................................................   30

7. CLOSING DELIVERIES ..........................................................   31

     7.1    Deliveries of the Company and the Shareholder ......................   31
</TABLE>

                                       vi

<PAGE>

<TABLE>
<CAPTION>
                                                                                    Page
                                                                                    ----
<S>                                                                                 <C>
            (a) Consents and Approvals ...........................................   31

            (b) Termination of Agreements ........................................   31

            (c) Company Stock ....................................................   31

            (d) Corporate Authorization ..........................................   31

            (e) Payoffs ..........................................................   31

            (f) Good Standing Certificate ........................................   31

            (g) Secretary's Certificate ..........................................   31

            (h) Other documents ..................................................   31

     7.2    Deliveries of PainCare ...............................................   32

            (a) Transaction Consideration ........................................   32

            (b) Resolutions ......................................................   32

            (c) Security Agreement ...............................................   32

            (d) Counsel's Opinion ................................................   32

8.   CONDITIONS TO THE OBLIGATIONS OF THE PARTIES ................................   32

     8.1    Conditions for the Benefit of PainCare and the Subsidiary ............   32

     8.2    Conditions for the Benefit of the Shareholder ........................   32

9.   COVENANTS ...................................................................   33

     9.1    Operations Pending Closing ...........................................   33

     9.2    Deliveries Pending Closings ..........................................   33

     9.3    Distribution of Sub-Chapter S Income by the Company ..................   33

     9.4    Post-Closing General Covenants .......................................   33

     9.5    Tax Returns ..........................................................   33

     9.6    Transitions ..........................................................   34

     9.7    Litigation Support ...................................................   34

     9.8    Consents .............................................................   34

     9.9    Operational Covenants ................................................   34

     9.10   Capital Adjustments ..................................................   35

10.  SURVIVAL AND INDEMNIFICATION ................................................   36

     10.1   Survival of Representations and Warranties ...........................   36

     10.2   Indemnification Provisions for the Benefit of PainCare
            and Subsidiary .......................................................   36
</TABLE>

                                       vii

<PAGE>

<TABLE>
<CAPTION>
                                                                                      Page
                                                                                      ----
<S>                                                                                   <C>
     10.3   Indemnification Provisions for the Benefit of the Shareholder ...........  36

     10.4   Matters Involving Third Parties .........................................  36

            (a) Notification ........................................................  36

            (b) Defense by Indemnifying Party .......................................  37

            (c) Satisfactory Defense ................................................  37

            (d) Conditions ..........................................................  37

     10.5   Right to Set-Off ........................................................  37

     10.6   Materiality .............................................................  38

     10.7   Limitation ..............................................................  38

11.  RESTRICTIVE COVENANTS; CONFIDENTIALITY .........................................  38

     11.1   Shareholder Restrictive Covenants .......................................  38

            (a) Restricted Period ...................................................  38

            (b) Consideration .......................................................  39

            (c) Third-Party Beneficiaries ...........................................  40

     11.2   Defenses ................................................................  40

     11.3   No Running of Covenant During Breach ....................................  40

     11.4   Blue Pencil Doctrine ....................................................  40

     11.5   Confidentiality, Press Releases, and Public Announcements ...............  40

     11.6   Conduct of Business .....................................................  41

     11.7   No Third-Party Beneficiaries ............................................  43

12.  MISCELLANEOUS ..................................................................  43

     12.1   Entire Agreement ........................................................  38

     12.2   Succession and Assignment ...............................................  38

     12.3   Counterparts ............................................................  38

     12.4   Headings ................................................................  38

     12.5   Notices .................................................................  43

     12.6   Governing Law; Jurisdiction; Attorney's Fees ............................  44

     12.7   Amendments and Waivers ..................................................  44

     12.8   Severability ............................................................  45

     12.9   Expenses ................................................................  45
</TABLE>

                                      viii

<PAGE>

<TABLE>
<CAPTION>
                                                                                  Page
                                                                                  ----
<S>                                                                               <C>
     12.10  Further Assurances. ................................................   45

     12.11  Construction. ......................................................   45

     12.12  Survival. ..........................................................   45

     12.13  Incorporation of Exhibits and Schedules. ...........................   45

     12.14  Submission to Jurisdiction. ........................................   46
</TABLE>

                                       ix

<PAGE>

                   MERGER AGREEMENT AND PLAN OF REORGANIZATION

     THIS MERGER AGREEMENT AND PLAN OF REORGANIZATION (the "Agreement") is made
and entered into as of this 25/th/ day of April, 2003 (the "Execution Date") by
and among PAINCARE HOLDINGS, INC., a Florida corporation ("PainCare"), PAINCARE
ACQUISITION COMPANY V, INC., a Florida corporation ("Subsidiary", and together
with PainCare, the "Acquiring Companies"), INDUSTRIAL & SPORT REHABILITATION,
LTD., an Illinois business corporation, d/b/a ASSOCIATED PHYSICIANS GROUP (the
"Company"), and JOHN VICK, an individual (the "Shareholder"). The Company and
the Shareholder are sometimes referred to herein as the "Sellers." PainCare,
Subsidiary, the Company and the Shareholder are sometimes referred to herein
individually as a "Party" and collectively as the "Parties."

                                    RECITALS

     A. PainCare is in the business of acquiring the non-medical assets of
medical practices and entering into management services agreements with
practices entities associated with the acquired practice;

     B. PainCare desires to enter into this Agreement in order for the
Subsidiary, which is a wholly-owned subsidiary of PainCare, to acquire the
non-medical assets of the Company;

     C. In connection with this acquisition, PainCare desires to have Subsidiary
enter into a management services agreement with the Company, which management
services agreement is the significant inducement for the Subsidiary to acquire
the non-medical assets of the Company;

     D. The Company owns and operates a medical practice (hereinafter sometimes
called the "Business") at 916 Talon Drive, O'Fallon, Illinois 62269 (hereinafter
sometimes called the "Center") and the Shareholder is a licensed medical
provider in the State of Illinois and owns all of the issued and outstanding
shares of the Company stock;

     E. All of the Parties hereto desire to enter into this Agreement to
effectuate the Merger, as hereinafter defined, of the Company with and into
Subsidiary pursuant to the terms and conditions of this Agreement; and

     F. It is the intention of the Parties for the Merger contemplated herein to
qualify as a tax-free reorganization pursuant to Sections 368(a)(1)(A) and
368(a)(2)(D) of the Code.

     NOW, THEREFORE, in consideration of the premises and the actual promises
herein made, and in consideration of the representations, warranties, and
covenants herein

<PAGE>

contained, the receipt and adequacy of which are hereby conclusively
acknowledged, the Parties, intending to become legally bound, hereby agree as
follows:

                              TERMS AND CONDITIONS

1. DEFINITIONS. All capitalized words that are not capitalized for purposes of
grammar and which are not defined in the text of this Agreement are defined
terms with their definitions set forth on Exhibit 1.

2. TRANSACTION.

   2.1 Transaction. Upon the terms and subject to the conditions hereof and in
accordance with the provisions of the Illinois Business Corporation Act (the
"Illinois Act") and the Florida Business Corporation Act (the "Florida Act"),
the Company shall be merged with and into Subsidiary (the "Merger") and the
separate existence of the Company shall thereupon cease, and Subsidiary, as the
surviving corporation (the "Surviving Corporation"), shall continue to exist
under and be governed by the Florida Act (the "Transaction").

   2.2 Effect of the Merger. At and after the Effective Time, as defined in
Section 2.3 below, the effect of the Merger shall, in all respects, be as
provided in the Illinois Act and the Florida Act. From and after the Effective
Time, the Surviving Corporation shall continue to be a Florida corporation.

   2.3 Effective Time; Filing of Certificates of Merger. The Merger shall be
effected by the filing at the time of the Closing or as soon as practicable
thereafter, of the Articles of Merger (the "Articles of Merger"), substantially
in the form of Exhibit 2.3 attached hereto, with the Secretary of the State of
Florida and the Secretary of the State of Illinois in accordance with the
provisions of the Florida Act and the Illinois Act, respectively. The Merger
shall become effective as of 11:59 p.m. on the date of such filing (the
"Effective Time") and the Parties shall take any and all other lawful actions
and do any and all other lawful things necessary to cause the Merger to become
effective.

   2.4 Articles of Incorporation. As of the Effective Time, the articles of
incorporation of Subsidiary, as in effect immediately prior to the Effective
Time, shall be the articles of incorporation of the Surviving Corporation until
thereafter amended in accordance with applicable law.

   2.5 Bylaws. As of the Effective Time, the bylaws of Subsidiary, as in effect
immediately prior to the Effective Time, shall be the bylaws of the Surviving
Corporation until thereafter amended in accordance with its terms and applicable
law.

   2.6 Directors and Officers. As of the Effective Time, the directors and
officers of Subsidiary immediately prior to the Effective Time shall be the
directors and officers of the Surviving Corporation. Each director and officer
of the Surviving

<PAGE>

Corporation shall hold office in accordance with the articles of incorporation
and bylaws of the Surviving Corporation. At the Closing, the Company shall cause
to be delivered to Subsidiary the written resignations of all of the directors
and officers of the Company, which resignations shall be unconditional and
effective as of the Closing Date (as defined in Section 6 below).

   2.7  Tax Consequences. It is intended by the Parties hereto that the Merger
shall constitute a tax-free reorganization within the meaning of Sections
368(a)(1)(A) and 368(a)(2)(D) of the Code.

   2.8  Additional Actions. If, at any time after the Closing, the Surviving
Corporation shall consider or be advised that any further acts are necessary or
desirable: (a) to vest, perfect or confirm, of record or otherwise, in the
Surviving Corporation, title to and possession of any property or right of the
Company acquired or to be acquired by reason of, or as a result of, the Merger;
or (b) otherwise to carry out the purposes of this Agreement, then the
Shareholder shall be deemed to have granted to the Surviving Corporation an
irrevocable power of attorney to execute and deliver all such deeds, assignments
and assurances in law and to do all other acts necessary or proper to vest,
perfect or confirm title to and possession of such property or rights in the
Surviving Corporation and otherwise to carry out the purposes of this Agreement;
and the officers and directors of the Surviving Corporation are fully authorized
in the name of the Shareholder and the Company to take any and all such actions.

   2.9  No Dissenters' Rights. Comprising the sole shareholder of the Company,
the Shareholder's approval and execution of this Agreement constitutes unanimous
approval of the transactions contemplated herein; therefore, neither the
Shareholder, nor any other party, is entitled to dissenters' rights under the
laws of the State of Illinois or the State of Florida.

   2.10 Surrender of Certificates.

        (a) Company's Shares. At the Closing, the Shareholder shall be required
to surrender to Subsidiary the original stock certificate(s) which immediately
prior to the Effective Time represented all of the Company Shares (the
"Certificates") (together with all stock powers duly endorsed to Subsidiary).
Until so surrendered, each Certificate which immediately prior to the Effective
Time represented the Company Shares (other than Company Shares held in the
Company treasury) shall upon and after the Effective Time by virtue of the
Merger be deemed for all purposes to represent and evidence only the right to
receive the Merger Consideration, as hereinafter defined, as provided in this
Agreement. At the Effective Time, the stock transfer books of the Company shall
be closed and no transfer of the Company Shares shall be made at any time
thereafter.

        (b) Dividends. No dividends or other distributions declared or made with
respect to the PainCare Shares with a record date after the Closing will be paid
to

<PAGE>

the holder of any unsurrendered Certificate with respect to the PainCare Shares
represented thereby until the holder of record of such Certificate shall
surrender such Certificate. Subject to applicable law, following surrender of
any such Certificate, there shall be paid to the record holder of the
Certificate representing whole PainCare Shares issued in exchange therefor,
without interest, at the time of such surrender, the amount of dividends or
other distributions with a record date after the Closing payable with respect to
such whole PainCare Shares.

   2.11 Medical Assets. Those assets (the "Medical Assets") of the Company which
require a medical license to own or utilize, such as medical records and any
pharmaceutical supplies, shall not become the possession of Subsidiary pursuant
to the Merger. The Company shall convey all such Medical Assets, which have
nominal value, to Associated Physician Group, LTD, an Illinois professional
corporation (the "New PC") as of the Effective Time for no required
consideration.

   2.12 Conversion of Shares. Each share of capital stock of Subsidiary issued
and outstanding immediately prior to the Closing shall continue to represent one
(1) validly issued, fully paid and non-assessable share of capital stock of the
Surviving Corporation after the Merger. By virtue of the Merger and without any
action on the part of the Shareholder the Company Shares shall be converted into
the Merger Consideration. The PainCare Shares to be received by the Shareholder
as part of the Merger Consideration shall be subject to restrictions of the
sale, transfer or distribution thereof as set forth in Section 4.36.

   2.13 Shareholder Consent and Release. The Shareholder hereby consents to the
Transaction and approves the execution and delivery of this Agreement and the
transactions contemplated hereby. Effective on the Effective Time, the
Shareholder hereby releases the Company from any and all claims he may, could or
will have, whether arising before or after the Effective Time, against the
Company as a result of the Shareholder having served as a stockholder, director,
officer, employee, agent, or in any other capacity of the Company; provided,
however, such release shall not operate to release the Company (or the Surviving
Corporation as successor to the Company) from (i) Shareholder's rights (whether
arising under the Company's By-Laws or by statute) to indemnification, or (ii)
the obligation to make the distributions of pre-Closing Date income as permitted
under this Agreement, or (iii) claims, if any, arising from Shareholder serving
as a guarantor or joint-obligor with respect to those certain obligations of the
Company as identified in Section 2.13 of the Disclosure Schedule.

   2.14 Piggyback Registration.

        (a) If within the three (3) year period commencing on the Execution
Date PainCare proposes for any reason to register the PainCare Shares under the
Securities Act [other than a registration in connection with an exchange offer
(Form S-4) or filed in connection with an employee stock option or other benefit
plan (Form S-8, or any substitute form that may be adopted by the Commission)],
PainCare shall promptly

<PAGE>

give written notice to the Shareholder of its intention to so
register the PainCare Shares and, upon written request by the Shareholder, given
within twenty (20) days after delivery of any such notice by PainCare, to
include in such registration PainCare Shares held by the Shareholder (which
request shall specify the number of PainCare Shares proposed to be included in
such registration), PainCare shall attempt to cause all such PainCare Shares to
be included in such registration on the same terms and conditions as the
securities otherwise being included in such registration; provided however, that
if the managing underwriters advise PainCare that the inclusion of the PainCare
Shares proposed to be included in such registration would interfere with the
successful marketing (including pricing) of the PainCare Shares proposed to be
registered by PainCare, then if such registration is in part an underwritten
primary or secondary registration on behalf of PainCare, PainCare shall include
in such registration the PainCare Shares requested to be included in such
registration, pro rata from among the holders of any and all PainCare shares to
be registered pursuant to such registration according to the number of shares
proposed by each holder to be included. In the event PainCare determines not to
pursue, or to withdraw, a registration as to which it has given notice pursuant
to this section, the Shareholder shall have no further rights hereunder with
respect to such proposed registration. Notwithstanding any other provision of
this Section to the contrary, PainCare shall not be required to include any of
the PainCare Shares in a registration statement relating to an underwritten
offering of PainCare's securities unless the Shareholder accepts the terms of
the underwriting as agreed upon between PainCare and the underwriters selected
by it, including, without limitation, any Underwriter's Cutback and/or Lockup,
and the Shareholder agrees to promptly execute and/or deliver such documents in
connection with such registration as PainCare or the managing underwriter may
reasonably request.

   (b) The Shareholder may exercise his rights under Section 2.14(a) above on an
unlimited number of occasions. PainCare shall pay all Registration Expenses (as
defined below) of any registration effected under this Section, except that in
the event of withdrawal by the Shareholder, the Shareholder shall pay (or
reimburse PainCare for) the amount of registration, filing or listing fees
relating to his PainCare Shares included in the registration and shall pay the
fees of PainCare's counsel associated with such withdrawal, unless such
withdrawal is due to the Shareholder obtaining material adverse information that
was not known by him at the time he requested inclusion of his PainCare Shares
in the registration.

   (c) The Shareholder may not participate in any registration under this
Section which is underwritten unless he agrees to sell such PainCare Shares on
the basis provided in any underwriting agreement (with terms not inconsistent
herewith and customary in underwriting agreements for secondary distributions)
approved by PainCare, provided that the Shareholder shall not be required to
make any representations or warranties to PainCare or the underwriters (other
than representations and warranties regarding such Shareholder and such
Shareholder's intended method of distribution).

<PAGE>

     2.15 Shareholder's Obligation to Furnish Information. PainCare may require
Shareholder to furnish PainCare such information regarding the distribution of
such securities as PainCare may from time to time reasonably request. If the
failure by the Shareholder to furnish such information as expeditiously as
possible would prevent (i) the registration statement relating to such
registration from being declared effective by the Securities Exchange
Commission, or (ii) members of the National Association of Securities Dealers,
Inc. from participating in the distribution of the PainCare Shares proposed to
be registered, PainCare may exclude the Shareholder's PainCare Shares from such
registration.

     2.16 Suspension of Sales Pending Amendment to Prospectus.

          (a) The Shareholder agrees that, upon receipt of any notice from
PainCare of the happening of any event of that requires PainCare not to proceed
with the registration, or if PainCare has decided not to proceed with the
registration for any reason, the Shareholder shall forego the disposition of any
PainCare Shares covered by the registration statement or prospectus until he is
advised in writing by PainCare that the use of the applicable prospectus may be
resumed and, if so directed by PainCare, the Shareholder shall deliver to
PainCare (at PainCare's expense, except as hereinafter provided) all copies,
other than permanent file copies, then in Shareholder's possession of any
prospectus covering such PainCare Shares.

          (b) The Shareholder agrees that he shall, as expeditiously as
possible, notify PainCare at any time when a prospectus relating to a
registration statement covering such Shareholder's PainCare Shares is required
to be delivered under the Securities Act, of the happening of any event which
requires changes to be made in the registration statement or any related
prospectus so that such registration statement or prospectus shall not contain
any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein not
misleading as a result of any information provided by the Shareholder for
inclusion in such prospectus included in such registration statement and, at the
request of PainCare, as expeditiously as possible prepare and furnish to it such
information as may be necessary so that, after incorporation into a supplement
or amendment of such prospectus as thereafter delivered to the purchasers of
such PainCare Shares, the information provided by such Shareholder shall not
include an untrue statement of a material fact or a misstatement of a material
fact required to be stated therein or necessary to make the statements made
therein, in light of the circumstances under which they are made, not misleading
and, in such event the expenses of delivery to PainCare of copies of any
prospectus in the Shareholder's possession shall be at the expense of the
Shareholder.

     2.17 Registration Expenses.

          (A) All expenses incident to PainCare's performance of or compliance
with its obligations under this Section 2, including without limitation all (i)
registration and filing fees, (ii) fees and expenses of compliance with
securities laws, (iii) printing

<PAGE>

expenses, (iv) messenger and delivery expenses, (v) internal expenses, (vi)
reasonable fees and disbursements of its counsel and its independent certified
public accountants (including "comfort" letters), (vii) securities act liability
insurance, (viii) reasonable fees and expenses of any special experts retained
by PainCare in connection with the registration hereunder, and (ix) reasonable
fees and expenses of other persons retained by PainCare (all such expenses being
referred to herein as "Registration Expenses") shall be borne by PainCare.

          (b) Notwithstanding the foregoing, the following costs and expenses
shall be excluded from the term "Registration Expenses": (i) all underwriting
discounts and commissions, (ii) all applicable transfer taxes, (iii) the fees
and disbursements of any counsel retained by the Shareholder, and (iv) except as
provided in Section 2.17(a), all other costs, fees, and expenses incurred by the
Shareholder in connection with the exercise of his registration rights
hereunder.

3.   TRANSACTION CONSIDERATION.

     3.1 Merger Consideration. The aggregate merger consideration (the "Merger
Consideration") shall consist of (i) the Closing Date Consideration (the
"Closing Date Consideration") as hereafter defined, and (ii) the Earnout Payment
as determined under Section 3.4 below. Subject to adjustment as provided in
Section 3.3 below, the Closing Date Consideration that PainCare shall transfer
to the Shareholder shall equal Two Million Seven Hundred Fifty Thousand and
00/100 Dollars ($2,750,000), comprised of: (i) One Million Three Hundred Seventy
Five Thousand and 00/100 Dollars ($1,375,000) (the "Cash Due At Closing") to be
delivered via wire transfer on the Closing Date to a bank account designated by
the Shareholder, plus (ii) One Million Three Hundred Seventy Five Thousand
(1,375,000) PainCare Shares, valued at One Dollar ($1.00) per share and having
an aggregate value of One Million Three Hundred Seventy Five Thousand and 00/100
Dollars ($1,375,000). At least five (5) days prior to the Closing Date, the
Shareholder shall notify PainCare in writing of the bank account to which the
Cash Due At Closing shall be wired.

     3.2 Bridge Deposit. On the Execution Date, PainCare agrees to provide
Shareholder a bridge loan in accordance with the Bridge Deposit Agreement
executed contemporaneously herewith in the amount of Six Hundred Eighty Seven
Thousand Five Hundred and 00/100 Dollars ($687,500) (the "Bridge Deposit"), by
wire transfer. The Bridge Deposit shall be applied (i) to reduce the Cash Due at
Closing as provided in Section 3.3 below or (ii) if the Closing does not occur
on or before August 15, 2003 and either PainCare or the Shareholder then elects
to terminate its obligations under this Agreement, upon which the principal
balance plus accrued interest on the Bridge Deposit shall be immediately payable
to PainCare. As provided in the Bridge Deposit Agreement, any net repayment by
Subsidiary or Shareholder in the event of a termination of this Agreement shall
bear interest on such amount.

<PAGE>

     3.3  Closing Date Adjustments. The Closing Date Consideration shall be
subject to adjustment as follows:

          (a) Transaction Related Adjustments. The Cash Due At Closing shall be
reduced by the amount of the Bridge Deposit. The Cash Due At Closing shall
further be reduced by the amount of any cash payments made by the Company or the
Acquiring Companies (i) in satisfaction of the joint obligation of the Company
and the Shareholder to pay the broker named in Section 4.5 below, (ii) other
expenses paid on behalf of the Shareholder (rather than the Company) in
connection with this Agreement and the transactions contemplated hereby, and
(iii) the cash portion of any bonus or incentive compensation directed by
Shareholder to be paid to employees of the Company at Closing. Similarly, to the
extent that any portion of the obligation of the Company and the Shareholder to
the broker under Section 4.5 below is to be satisfied in shares of PainCare
Shares (or to the extent that any bonus or incentive compensation directed by
Shareholder to be paid to employees of the Company at Closing is to be satisfied
in PainCare Shares), the number of PainCare Shares comprising a portion of the
Closing Date Consideration shall be reduced by the aggregate number of shares so
issued. Shareholder and the Company acknowledge that the obligation of PainCare
to issue shares to others in accordance with the previous sentence is
conditioned upon the availability of exemption(s) from the registration
requirements under the Securities Act and any applicable state securities law
for such transaction(s) and the agreement(s) of the recipients thereof to
restrictions on the transfer, sale or distribution thereof.

          (b) Financial Statements. The Company has prepared financial
statements consisting of (i) a balance sheet, statement of operations and cash
flow statement in accordance with GAAP as of and for the year ended December 31,
2002 (the "GAAP Financial Statements"); and (ii) a balance sheet, statement of
operations and cash flow statement as of and for the quarters ended March 31,
2002 and 2003; (the "Interim Financial Statements") all of which are included in
Section 3.3(b) of the Disclosure Schedule. The GAAP Financial Statements have
been certified by an independent auditor and have been prepared using accounting
principles consistent with the accounting principles utilized by PainCare. The
Interim Financial Statements have been prepared in accordance with the cash
method of accounting. The GAAP Financial Statements and the Interim Financial
Statements (collectively, the "Financial Statements") present fairly the
financial condition of the Company as of such dates and the results of the
operations of the Company for such periods, are correct and complete, and are
consistent with the books and records of the Company (which books and records
are correct and complete).

          (c) Closing Date Balance Sheet. Within forty-five (45) days after the
Closing Date, PainCare or its Affiliate will prepare and deliver to the
Shareholder a balance sheet of the Company as of the close of business on the
Closing Date prepared in accordance with GAAP (the "Closing Date Balance
Sheet"). Within six (6) days after PainCare's delivery of the Closing Date
Balance Sheet to the Shareholder, the Shareholder shall, in a written notice to
PainCare, either accept or describe in reasonable

<PAGE>

detail any proposed adjustments to the Closing Date Balance Sheet and the
reasons therefor, and shall include pertinent calculations. If the Shareholder
fails to deliver notice of acceptance or objection to the Closing Date Balance
Sheet within such six (6) day period, the Shareholder shall be deemed to have
accepted the Closing Date Balance Sheet. Except in the case of a dispute with
respect to the Closing Date Balance Sheet, within seven (7) days after delivery
of the Closing Date Balance Sheet (the "Adjustment Payment Date"), the
Shareholder shall pay the Other Net Equity Adjustment (as defined below) to
PainCare. In the event that PainCare and the Shareholder are not able to agree
on the Closing Date Balance Sheet within thirty (30) days from and after the
receipt by PainCare of any objections raised by the Shareholder, then either
Party shall each have the right to require that such disputed determinations be
submitted to an independent certified public accountant or accounting firm that
PainCare shall select, for computation or verification in accordance with the
provisions of this Agreement, and the Net Equity Adjustment shall be paid by the
Shareholder to PainCare within five (5) days after receipt of the accountant's
computation or verification. The foregoing provisions for certified public
accounting firm review shall be final and binding upon the Parties and there
shall be no right of appeal from such decision. Such accounting firm's fees and
expenses for such disputed determination shall be borne by the Party whose
determination has been modified by such accounting firm's report or by all
Parties in proportion to the relative amount each Party's determination has been
modified. Any payments due under this Section 3.3 shall bear interest at eight
percent (8%) per annum from the Adjustment Payment Date.

          If the final Closing Date Balance Sheet reflects Cash of the Company
that is less than Fifty Thousand Dollars ($50,000) (the "Required Cash"), or Net
Shareholder's Equity (as defined below) of the Company that is less than Two
Hundred Thousand and 00/100 Dollars ($200,000)("Agreed Net Equity"), then the
Cash Due at Closing shall be reduced and the Shareholder shall be required to
immediately return to PainCare dollar for dollar (the "Net Equity Adjustment")
by (i) an Amount equal to the Required Cash less Cash reflected on the Closing
Date Balance Sheet, and (ii) the difference between (x) the Agreed Net Equity;
and (y) the Net Shareholder's Equity set forth in the Closing Date Balance
Sheet. "Net Shareholder's Equity" shall mean the book value of the Company's
tangible assets (less the Required Cash) net of all liabilities of the Company.

     3.4  Earnout Payment.

          (a) General. Subject to the condition that the Surviving Corporation
achieves Formula Period Profits (as defined in Subsection (f) below) of at least
One Million One Hundred Thousand and 00/100 Dollars ($1,100,000) (the "Earnings
Threshold") in each of the three (3) successive twelve (12) month calendar
periods beginning on the first of the first month immediately following the
Closing Date unless the Closing occurs on the first day of a month in which case
the first 12 month period shall begin on the Closing Date, (each such twelve
(12) month calendar period shall be referred to herein as a "Formula Period"),
then PainCare shall pay to the Shareholder a

<PAGE>

total amount of additional consideration of Two Million Seven Hundred Fifty
Thousand and 00/100 Dollars ($2,750,000) for the Formula Periods, payable in
three equal annual installments of Nine Hundred Sixteen Thousand Six Hundred
Sixty Six and 70/100 Dollars ($916,666.70) (the "Intended Installment Payment")
in the form of consideration and subject to adjustment as provided in Section
3.4(d) below.

        (b) Installment Payment Discount. Notwithstanding Section 3.4(a) above,
if the Surviving Corporation fails to achieve the Earnings Threshold in a
Formula Period, the amount of the Intended Installment Payment for such Formula
Period shall be recalculated to equal the product of the Intended Installment
Payment, multiplied by the Installment Payment Discount (as defined below) (the
"Adjusted Installment Payment"). The "Installment Payment Discount" shall equal
(i) the Formula Period Profits (as defined in Subsection (f) below) for such
Formula Period divided by the Earnings Threshold; multiplied by (ii) ninety
percent (90%).

        (c) Installment Payment Premium. Notwithstanding Section 3.4(b), if (i)
the Shareholder receives the Adjusted Installment Payment from PainCare in a
Formula Period rather than the Intended Installment Payment as a result of the
Formula Period Profits equaling less than the Earnings Threshold for such
Formula Period, and (ii) the Subsidiary's Formula Period Profits exceed the
Earnings Threshold in the Formula Period immediately subsequent to the Formula
Period for which the Installment Payment Discount corresponded (or the twelve
(12) month calendar period immediately following the third and final Formula
Period solely with respect to the third and final Formula Period), then PainCare
shall pay to the Shareholder the Installment Payment Premium (as defined below).
The "Installment Payment Premium" shall equal the product of (A) the Formula
Period Profits for the Formula Period in which the Installment Payment Premium
is calculated less the Earnings Threshold, multiplied by (B) Seventy-five
percent (75%). The Installment Payment Premium shall be paid to the Shareholder
in the same percentages, form and time as the Installment Payments (as defined
in Subsection (d) below) are due for the Formula Period for which the
Installment Payment Premium is calculated.

        (d) Manner of Payment. Within thirty (30) days after the end of each
Formula Period, PainCare or its Affiliate shall prepare and deliver to the
Shareholder a financial statement presenting the Formula Period Profits for the
Surviving Corporation for the applicable Formula Period (the "Formula Period
Profits Statement"). Five (5) days after delivery of the Formula Period Profits
Statement, the Shareholder shall in a written notice to PainCare either accept
or describe in reasonable detail any proposed adjustments to the Formula Period
Profits Statement and the reasons therefor, and shall include pertinent
calculations. If the Shareholder fails to deliver notice of acceptance or
objection to the Formula Period Profits Statement within such five (5) day
period, the Shareholder shall be deemed to have accepted the Formula Period
Profits Statement. If the Shareholder accepts or fails to object to the Formula
Period Profits Statement within the five (5) day period set forth above, then
within forty-five (45) days after the end of the Formula Period, PainCare shall
pay to the Shareholder the Intended Installment

<PAGE>

Payment or the Adjusted Installment Payment (each an "Installment Payment", and
collectively, the "Installment Payments") along with any Installment Payment
Premium owed in accordance with Subsection (c) above as follows: (i) fifty
percent (50%) of the Installment Payment shall be made in cash via wire transfer
to a bank account designated by the Shareholder at least five (5) days prior to
the end of the Formula Period; and (ii) fifty percent (50%) of the Installment
Payment shall be made in PainCare Shares priced at One Dollar and 00/100 ($1.00)
per one share of PainCare common stock for all Formula Periods. In the event
PainCare and the Shareholder are not able to agree on the Formula Period Profits
Statement within thirty (30) days from and after the receipt by PainCare of any
objections raised by the Shareholder, PainCare and the Shareholder shall each
have the right to require that such disputed determinations be submitted to an
independent certified public accountant or accounting firm that PainCare shall
select, for computation or verification in accordance with the provisions of
this Agreement, and the Installment Payment shall be paid by PainCare to the
Shareholder within fifteen (15) days after receipt of the accountant's
computation or verification. The foregoing provisions for certified public
accounting firm review shall be final and binding upon the Parties and there
shall be no right of appeal from such decision.

     (e) Earnout Cap. Notwithstanding anything to the contrary in this Section
3, in no event whatsoever shall the aggregate amount of the Installment Payments
paid to the Shareholder from PainCare in cash, in PainCare Shares or any other
form of consideration exceed Two Million Seven Hundred Fifty Thousand and 00/100
Dollars ($2,750,000).

     (f) Definitions for Purposes of Section 3.4. For purposes of Section 3.4 of
this Agreement, "Formula Period Profits" shall mean the Surviving Corporation's
earnings before deductions for interest, taxes, depreciation and amortization
("EBITDA") as calculated utilizing GAAP by PainCare's independent certified
public accountants for the applicable Formula Period where possible, and as
calculated by PainCare for quarterly and less than quarterly data for such
Formula Period. Notwithstanding the foregoing, the calculation of the Formula
Period Profits shall not include any costs or expenses related to: (i) the
corporate overhead of PainCare or other administrative or similar charges that
PainCare might impose upon the Subsidiary, except those charges for services
provided directly to and for the benefit of the Subsidiary; (ii) any
non-recurring charges, losses, profits, gains, or non-cash adjustments not
related to the ongoing operations of the Subsidiary's business, including but
not limited to discontinued operations, extraordinary items, acquisition costs
and goodwill charges incurred in connection with the transactions contemplated
hereby (excluding the write-off of any goodwill with respect to the Surviving
Corporation in accordance with FASA 142), or unusual or infrequent items as such
terms are defined pursuant to generally accepted accounting principles, (iii)
any charge related to grants or exercises of options pursuant to the Independent
Contractor Agreement, or (iv) any charge or expense related to any direct
reduction in payments or distributions due the Shareholder under this Agreement.

<PAGE>

         (g) Adjustments to Installment Payments. The amount of the cash portion
of any Installment Payment due Shareholder hereunder shall be reduced by the
amount of any cash payments made by the Acquiring Companies in satisfaction of
the joint obligation of the Company and the Shareholder to pay the broker named
in Section 4.5 below. Similarly, to the extent that any portion of the
obligation of the Company and the Shareholder to the broker under Section 4.5
below is to be satisfied in shares of PainCare Common Stock, the number of
shares of PainCare Common Stock comprising a portion of any Installment Payment
shall be reduced by the aggregate number of shares so issued. Shareholder and
the Company acknowledge that the obligation of PainCare to issue shares to
others in accordance with the previous sentence is conditioned upon the
availability of exemption(s) from the registration requirements under the
Securities Act and any applicable state securities law for such transaction(s)
and the agreement(s) of the recipients thereof to restrictions on the transfer,
sale or distribution thereof.

     3.5 Security and Pledge Agreements. Payment of the Installment Payments
will be secured by certain assets and all of the issued and outstanding capital
stock of the Surviving Corporation. To that end, the Surviving Corporation will
enter into with the Shareholder a security agreement and pledge agreement in the
form attached hereto as Composite Exhibit 3.5 (hereinafter, collectively the
"Security Agreements").

4.   REPRESENTATIONS AND WARRANTIES OF THE SHAREHOLDER. The Shareholder
represents and warrants to the Acquiring Companies that the statements contained
in this Section 4 are correct and complete as of the date of this Agreement,
except as set forth in the disclosure schedule accompanying this Agreement (the
"Disclosure Schedule"). The Disclosure Schedule will be arranged in paragraphs
corresponding to the numbered paragraphs contained in this Section 4 to the
Agreement.

     4.1 Organization, Qualification, and Corporate Power. The Company is a
corporation duly organized, validly existing, and in good standing under the
laws of the State of Illinois. The Company has full power and authority and all
licenses, permits and authorizations necessary to carry on the businesses in
which it is currently engaged and to own and use the properties owned and used
by it. Section 4.1 of the Disclosure Schedule lists all of the officers and
members of the Board of Directors of the Company, as of the date immediately
preceding the Closing Date. The Company has made available to the Acquiring
Companies correct and complete copies of the minute book, articles of
incorporation and bylaws of the Company, as amended to date. Copies of the
minute book (containing the records of meetings of the stockholders, the board
of directors and any committees of the board of directors), the stock
certificate books and stock record books of the Company are correct and complete
in all material respects and will have been delivered to PainCare prior to or at
the Closing. The Company is not in default under or in violation of any
provision of its articles of incorporation or bylaws.

     4.2 Capitalization. The entire authorized capital stock of the Company
consists of thirty thousand (30,000) shares of common stock, of which two
hundred (200) shares of common stock are issued and outstanding. All of the
issued and outstanding

<PAGE>

Company Shares have been duly authorized, are validly issued, fully paid, and
nonassessable and are held of record by the Shareholder as set forth in Section
4.2 of the Disclosure Schedule. The Shareholder has good title to the Company
Shares free and clear of any and all liens, claims, security interests or other
encumbrances of any Person. There are no outstanding or authorized options,
warrants, purchase rights, subscription rights, redemption rights, conversion
rights, exchange rights, or other contracts or commitments that could require
the Company to issue, sell, or otherwise cause to become outstanding any of its
capital stock. There are no outstanding or authorized stock appreciation,
phantom stock, profit participation, or similar rights with respect to the
Company. There are no stockholders' agreements, voting trusts, proxies, or other
agreements or understandings with respect to the voting of the capital stock of
the Company.

     4.3 Authorization. The Company has full power and authority (including full
corporate power and authority) and the Shareholder has all necessary authority
to execute and deliver this Agreement and to perform its obligations hereunder.
The execution, delivery and performance of this Agreement by the Company has
been duly authorized and approved by its board of directors and no other
corporate proceedings on the part of the Company are necessary to authorize this
Agreement and the transactions contemplated hereby. The Company has given the
Shareholder any and all notice required to be given to the Shareholder under
applicable law. This Agreement constitutes the valid and legally binding
obligation of the Company and the Shareholder, enforceable in accordance with
its terms and conditions.

     4.4 Noncontravention. Except as set forth in Section 4.4 of the Disclosure
Schedule, neither the execution and the delivery of this Agreement by the
Company or the Shareholder, nor the consummation of the transactions
contemplated hereby will: (a) violate any constitution, statute, regulation,
rule, injunction, judgment, order, decree, ruling, or other restriction of any
government, governmental agency or any other third party whatsoever, or court to
which the Company or the Shareholder are subject, or any provision of the
articles of incorporation or bylaws of the Company; or (b) conflict with, result
in a breach of, constitute a default under, result in the acceleration of,
create in any party the right to accelerate, terminate, modify, or cancel, or
require any notice under any agreement, contract, lease, license, instrument or
other arrangement to which the Company or the Shareholder are a party or by
which either the Company or the Shareholder is bound or to which any of the
Company's assets are subject (or result in the imposition of any Security
Interest upon any of its assets). Except as set forth in Section 4.4 of the
Disclosure Schedule, the Shareholder and the Company need not give any notice
to, make any filing with, or obtain any authorization, consent, or approval of
any government or governmental agency or any other third party whatsoever in
order for the Parties to consummate the transactions contemplated by this
Agreement. The Parties agree that Section 4.4 of the Disclosure Schedule shall
be divided into two (2) sections, consisting of: (i) Section 4.4(a) which shall
list all such authorizations, consents and approvals which must be obtained
prior to the Closing, as a condition to Closing; and (ii) Section 4.4(b) which
shall list all such authorizations, consents and approvals which will

<PAGE>

not be obtained prior to Closing which shall be obtained within a reasonable
period of time after Closing.

     4.5 Broker's Fees. The Company and the Shareholder have entered into a
Broker's Agreement dated January __, 2003 with KBL Investments, Inc, ("KBL") for
which the Shareholder agrees to pay any and all Liabilities or obligations to
pay any fees, expenses, or commissions to KBL and any other consultant, broker,
finder, or agent retained by the Company or the Shareholder with respect to the
transactions contemplated by this Agreement.

     4.6 Title to Assets. Section 4.6 of the Disclosure Schedule contains a
complete, true and correct list of all of the assets of the Company. Except as
to assets disposed of in the ordinary course of business subsequent to the date
hereof and as otherwise contemplated by this Agreement, the Company has good and
marketable title to, or a valid leasehold interest in, the properties and assets
used by it, located on its premises, or shown on the Effective Date Balance
Sheet or acquired after the date thereof, free and clear of all Security
Interests. Except for the Medical Assets which are to be transferred to New PC,
the assets set forth in Section 4.6, in conjunction with any assets which the
Company leases, constitute all of the assets used by the Company in connection
with its business as presently conducted and all assets necessary or appropriate
for the continued operation of the Company's business.

     4.7 No Subsidiaries. The Company has no Subsidiaries and does not control,
directly or indirectly, or have any direct or indirect equity participation in
any corporation, partnership, limited liability company, trust or other business
association.

     4.8 Financial Statements. Attached as Section 3.3(b) of the Disclosure
Schedule are true and complete copies of the GAAP Financial Statements and the
Interim Financial Statements. Except as provided in the Interim Financial
Statements, or as fully disclosed in Section 4.8 of the Disclosure Schedule, the
Company does not have any Liabilities or obligations (whether accrued, absolute,
contingent, whether due or to become due or otherwise) which might be or become
a charge against the Company since the date of the Interim Financial Statements.
The Shareholder acknowledges and agrees that PainCare and Subsidiary relied upon
the financial information set forth in the Financial Statements in order to
determine the Transaction Consideration.

     4.9 Events Subsequent to Most Recent Year End. Since December 31, 2002 (the
"Most Recent Year End"), there has not been any material adverse change in the
business, financial condition, operations, results of operations, or future
prospects of the Company. Without limiting the generality of the foregoing,
since the Most Recent Year End:

         (a) Sale or Lease of Assets. The Company has not sold, leased,
transferred, or assigned any of its assets, tangible or intangible, other than
for fair market value in the ordinary course of its business;

<PAGE>

     (b) Contracts. The Company has not entered into any agreement, contract,
lease, or license (or series of related agreements, contracts, leases, and
licenses) outside the ordinary course of business;

     (c) Change in Contracts. No third party (or the Company) has accelerated,
terminated, modified, or canceled any agreement, contract, lease, or license (or
series of related agreements, contracts, leases, and licenses) to which the
Company is a party or by which it is bound and neither the Shareholder nor the
Company has any intent to do any of the foregoing or has received a verbal or
written indication of any third party's intent to do any of the foregoing;

     (d) Security Interests. The Company has not had imposed any Security
Interest upon any of its assets, tangible or intangible;

     (e) Investments. The Company has not made any capital investment in, any
loan to, or any acquisition of the securities or assets of, any other Person (or
series of related capital investments, loans, and acquisitions);

     (f) Debts. The Company has not issued any note, bond, or other debt
security or created, incurred, assumed, or guaranteed any indebtedness for
borrowed money or capitalized lease obligation;

     (g) Liabilities Unaffected. The Company has not delayed or postponed the
payment of accounts payable and other Liabilities or accelerated the collection
of accounts, notes or other receivables;

     (h) Claims Unaffected. The Company has not canceled, compromised, waived,
or released any right or claim (or series of related rights and claims) outside
the ordinary course of its business;

     (i) Articles and Bylaws. There has been no change made or authorized in the
articles of incorporation or bylaws of the Company;

     (j) Changes in Equity. The Company has not issued, sold, or otherwise
disposed of any of its capital stock, or granted any options, warrants, or other
rights to purchase or obtain (including upon conversion, exchange, or exercise)
any of its capital stock;

     (k) Distribution. Except for distributions of subchapter S income as
permitted by Section 9.3 below, the Company has not declared, set aside, or paid
any dividend or made any distribution with respect to its capital stock (whether
in cash or in kind) or redeemed, purchased, or otherwise acquired any of its
capital stock;

     (l) Property Damage. The Company has not experienced any damage,
destruction, or loss (whether or not covered by insurance) to its property or
assets;

<PAGE>

          (m)  Transactions with Affiliates. The Company has not made any loan
to, or entered into any other transaction with, any of its directors, officers
and employees;

          (n)  Collective Bargaining Agreements. The Company has not entered
into any collective bargaining agreement, written or oral, or modified the terms
of any existing such contract or agreement;

          (o)  Compensation Changes. The Company has not granted any increase in
the base compensation of any of its directors, officers, and employees;

          (p)  Employee Benefit Plans. The Company has not adopted, amended,
modified, or terminated any bonus, profit-sharing, incentive, severance, or
other plan, contract, or commitment for the benefit of any of its directors,
officers, and employees (or taken any such action with respect to any other
Employee Benefit Plan);

          (q)  Officers; Directors; Employees. The Company has not made any
change in the employment terms for any of its directors, officers and employees,
other than to terminate such agreements as required herein;

          (r)  Charitable or Capital Contributions. The Company has not made or
pledged to make any charitable or other capital contribution;

          (s)  Ordinary Course of Business. There has not been any other
occurrence, event, incident, action, failure to act, or transaction outside the
ordinary course of business involving the Company;

          (t)  Accounting Practices. Saving the changes associated with the
change to GAAP with respect to the GAAP Financial Statements, there has not been
any change in any method of accounting or accounting principle, estimate or
practice of the Company;

          (u)  Accounts Receivable. The Company has not accelerated the
collection of any Accounts Receivable or any other amounts owed to it; and

          (v)  In General. Neither the Company nor the Shareholder has committed
to do any of the foregoing.

     4.10 Undisclosed Liabilities. The Company has no Liability and there is no
basis for any present or future action, suit, proceeding, hearing,
investigation, complaint, claim, or demand against it giving rise to any
Liability, except for: (a) Liabilities disclosed in the Disclosures Schedule;
(b) contractual obligations incurred in the ordinary course of business; and (d)
Liabilities which have arisen after the Interim Balance Sheet in the ordinary
course of business (none of which results from, arises out of, relates to, is in
the nature of, or was caused by any breach of contract, breach of warranty,
tort, infringement, or violation of law). As of the Closing, other than the
current trade

<PAGE>

accounts payable, leasehold obligations and accrued payroll and benefit
obligations, the Company shall not have any unpaid liabilities, other than those
listed in the Section 4.10 Disclosure Schedule, including, but not limited to,
any bank debt, capital leases or any general or professional liability claims,
or be obliged in any other way to provide funds in respect of, or to guarantee
or assume, any debt, obligation or dividend of any person, except endorsements
in the ordinary course of business in connection with the deposit, in banks or
other financial institutions, of items for collection.

     4.11 Tax Matters.

          (a)  Tax Returns. The Company has filed all Tax Returns it was
required to file. All such Tax Returns were correct and complete in all respects
and were filed on a timely basis. All Taxes owed by the Company (whether or not
shown on any Tax Return) have been paid. The Company currently is not the
beneficiary of any extension of time within which to file any Tax Return. No
claim is currently pending by an authority in a jurisdiction where the Company
is or may be subject to taxation by that jurisdiction. There are no Security
Interests on any of the assets of the Company that arose in connection with any
failure (or alleged failure) to pay any Tax.

          (b)  Withholding. The Company has withheld, and remitted when due, all
Taxes required to have been withheld or paid in connection with amounts paid or
owing to any employee, independent contractor, creditor, stockholder, or other
third party.

          (c)  No Disputes of Claims. No Shareholder or director or officer (or
employee responsible for Tax matters) of the Company expects any authority to
assess any additional Taxes for any period for which Tax Returns have been
filed. There is no dispute or claim concerning any Tax Liability of the Company
either: (a) claimed or raised by any authority in writing; or (b) as to which
any of the Shareholder, directors and officers (and employees responsible for
Tax matters) of the Company has Knowledge based upon personal contact with any
agent of such authority. Section 4.11 of the Disclosure Schedule lists all
federal, state, local, and foreign income Tax Returns filed with respect to the
Company for taxable periods ended on or after December 31, 2002, indicates those
Tax Returns that have been audited, and indicates those Tax Returns that
currently are the subject of audit. The Shareholder has made available to
PainCare correct and complete copies of all federal income Tax Returns,
examination reports, and statements of deficiencies assessed against or agreed
to by any of the Company and its Affiliates since December 31, 2002.

          (d)  No Waivers. The Company has not waived any statute of limitations
in respect of Taxes or agreed to any extension of time with respect to a Tax
assessment or deficiency.

          (e)  No Special Circumstances. The Company has not made any payments,
is not obligated to make any payments, nor is a party to any agreement that

<PAGE>

under certain circumstances could obligate it to make any payments that will not
be deductible under Code Section 280G. The Company has not been a United States
real property holding corporation within the meaning of Code Section 897(c)(2)
during the applicable period specified in Code Section 897(c)(1)(A)(ii). The
Company has disclosed on its federal income Tax Returns all positions taken
therein that could give rise to a substantial understatement of federal income
Tax within the meaning of Code Section 6662.

          (f)  Subchapter "S". The Company has elected, by the unanimous consent
of its shareholders and in compliance with all applicable legal requirements, to
be taxed under Subchapter "S" of the Code and corresponding provisions under any
applicable state and local laws, and such elections are currently in full force
and effect for the Company. No action has been taken by the Company or the
Shareholder that may result in the revocation of any such elections. The Company
has no "Subchapter C earnings and profits," as defined in Code Section 1362(d).
The Company has no "net unrealized built-in gain," as such term is defined in
Code Sections 1374(d)(1) and 1374(d)(8). The Company has no Liability, absolute
or contingent, for the payment of any income Taxes under the Code or under
Subchapter "S" of the Code.

          (g)  Audits of Tax Returns. No Tax Return of the Company is currently
under audit or examination by any taxing authority, and the Company has not
received a written notice stating the intention of any taxing authority to
conduct such an audit or examination. Each deficiency resulting from any audit
or examination relating to Taxes by any taxing authority has been paid, except
for deficiencies being contested in good faith. The revenue agents' reports
related to any prior audits and examinations are attached as part of Section
4.11 of the Disclosure Schedule.

          (h)  Period of Assessment. There is no agreement or other document
extending, or having the effect of extending, the period of assessment or
collection of any Taxes.

          (i)  Tax Agreements. The Company is not a party to or bound by any tax
sharing agreement, tax indemnity obligation or similar agreement with respect to
Taxes, including any advance pricing agreement, closing agreement or other
agreement relating to Taxes with any taxing authority.

          (j)  Inclusions in Taxable Periods. The Company will be required to
include in a taxable period ending after the Closing Date taxable income
attributable to income that accrued in a prior taxable period but was not
recognized in any prior taxable period as a result of the installment method of
accounting, the completed contract method of accounting, the long-term contract
method of accounting, the cash method of accounting or Code Section 481 with
respect to a change in method of accounting occurring before the Closing Date or
comparable provisions of state, local or foreign tax law. As of the Closing
Date, the Shareholder will place funds in a separate bank account

<PAGE>

in the name of the Company in an amount sufficient to pay all such liabilities
and such funds shall be used to pay such liabilities as they become due.

          (k)  Consents. The Company has not filed a consent pursuant to or
agreed to the application of Code Section 341(f).

          (l)  Personal Holding Company. The Company has not, during the five
(5) year period ending on the Closing Date, been a personal holding company
within the meaning of Code Section 541.

          (m)  Consolidated Tax Returns. The Company has never filed or been
included in any combined or consolidated Tax Return with any other person or
been a member of an Affiliated Group filing a consolidated federal income Tax
Return.

     4.12 Real Property. The Company does not own any real property. Section
4.12 of the Disclosure Schedule lists and describes briefly all real property
leased or subleased by the Company. The Shareholder has made available to
PainCare and Subsidiary correct and complete copies of the leases and subleases
listed in Section 4.12 of the Disclosure Schedule (as amended to date). With
respect to each lease and sublease listed in Section 4.12 of the Disclosure
Schedule:

          (a)  Binding. The lease or sublease is legal, valid, binding,
enforceable, and in full force and effect;

          (b)  Continued Validity. The lease or sublease will continue to be
legal, valid, binding, enforceable, and in full force and effect on identical
terms following the consummation of the transactions contemplated hereby;

          (c)  No Defaults. The Company is not in breach or default under the
lease or sublease and no third party is in breach or default under the lease or
sublease, and no event has occurred which, with notice or lapse of time, would
constitute a breach or default or permit termination, modification or
acceleration thereunder;

          (d)  Repudiation. Neither the Company nor any other party to the lease
has repudiated any provision of the lease or sublease;

          (e)  No Disputes. There are no disputes, oral agreements, or
forbearance programs in effect as to the lease or sublease;

          (f)  Subleases. With respect to each sublease, the representations and
warranties set forth in subsections 4.12(a) through 4.12(e) above are to
Shareholder's Knowledge true and correct with respect to the underlying lease;

          (g)  Encumbrances. None of the Company or its Affiliates has assigned,
transferred, conveyed, mortgaged, deeded in trust, or encumbered any interest in
the leasehold or subleasehold;

<PAGE>

          (h)  Approvals. All facilities leased or subleased thereunder have
received all approvals of governmental authorities (including licenses and
permits) required in connection with the operation thereof and have been
operated and maintained in accordance with applicable laws, rules, and
regulations; and

          (i)  Utilities. All facilities leased or subleased thereunder are
supplied with utilities and other services reasonably necessary for the
operation of said facilities.

     4.13 Intellectual Property. The Company owns or has the right to use
pursuant to a valid license, sublicense, agreement, or permission all
Intellectual Property necessary or desirable for the operation of the businesses
of the Company as presently conducted and as presently proposed to be conducted.
No claim or demand of any Person has been made, nor is there any proceeding that
is pending, or to the Shareholder's Knowledge, threatened, which challenges the
rights of the Company with respect to any Intellectual Property or asserts that
the Company is infringing or otherwise in conflict with or is required to pay
any royalty or license fee with respect to any Intellectual Property.

     4.14 Condition of Tangible Assets. Each tangible asset of the Company is
free from defects (patent and latent), has been maintained in accordance with
normal industry practice, is in good operating condition and repair (subject to
normal wear and tear), and is suitable, designed and intended for the purposes
for which it presently is used by the Shareholder and the Company and is not
outdated in comparison with the assets used for similar purposes by similar
businesses.

     4.15 Contracts. Section 4.15 of the Disclosure Schedule lists the following
contracts and other agreements, written or oral, to which the Company was a
party immediately preceding the Closing:

          (a)  Personal Property Leases. Any agreement (or group of related
agreements) for the lease of personal property to or from any Person providing
for lease payments;

          (b)  Services. Any agreement (or group of related agreements) for the
furnishing or receipt of services, the performance of which will extend over a
period of more than one (1) year;

          (c)  Partnership; Joint Venture. Any agreement constituting a
partnership or joint venture;

          (d)  Indebtedness. Any agreement (or group of related agreements)
under which it has created, incurred, assumed, or guaranteed any indebtedness
for borrowed money, or any capitalized lease obligation;

          (e)  Confidentiality; Non-Competition. Any agreement concerning
confidentiality or non-competition;

<PAGE>

          (f)  Shareholders' Agreements. Any agreement by and between the
Shareholder and any Affiliate of the Company;

          (g)  Plans. Any profit sharing, stock option, stock purchase, stock
appreciation, deferred compensation, severance, or other plan or arrangement for
the benefit of its current or former directors, officers, and employees;

          (h)  Employment or Consulting Agreements. Any agreement for the
employment of any individual on a full-time or part-time or the engagement of
any individual as a consultant or independent contractor, or otherwise
compensating an individual for services rendered or to be rendered to the
Company;

          (i)  Advances; Loans. Any agreement under which the Company has
advanced or loaned any amount to any of its directors, officers and employees
outside the ordinary course of business;

          (j)  Adverse Effects. Any agreement under which the consequences of a
default or termination could have a material adverse effect on the business,
financial condition, operations, results of operations or future prospects of
the Company; and

          (k)  Other Agreements. Any other agreement (or group of related
agreements) the performance or rendering of which involves consideration in
excess of Five Thousand and No/100 Dollars ($5,000.00).

The Shareholder has made available to PainCare and Subsidiary a correct and
complete copy of each written agreement listed in Section 4.15 of the Disclosure
Schedule (as amended to date) and a written summary setting forth the terms and
conditions of each oral agreement referred to in Section 4.15 of the Disclosure
Schedule. With respect to each such agreement: (i) the agreement is legal,
valid, binding, enforceable, and in full force and effect; (ii) there shall be
no breach or other violation resulting from the consummation of the transactions
contemplated hereby; (iii) the Company is not in default or breach and no other
party is in breach or default, and no event has occurred which with notice or
lapse of time would constitute a breach or default, or permit termination,
modification, or acceleration, under the agreement; and (iv) neither the Company
nor any other party has repudiated any provision of the agreement. None of the
agreements listed in Section 4.15 of the Disclosure Schedule requires the
consent or approval of any Person, or any compensation or payment to be made to
any such Person by reason of the transactions contemplated by this Agreement, or
the merger of the Company with and into another Person.

     4.16 Powers of Attorney. There are no outstanding powers of attorney
executed on behalf of the Company.

     4.17 Insurance; Malpractice. Section 4.17 of the Disclosure Schedule
contains a list and brief description of all policies or binders of fire,
liability, product

<PAGE>

liability, workers compensation, health and other forms of insurance policies or
binders currently in force insuring against risks to which the Company has been
a party, a named insured or otherwise the beneficiary of coverage at any time
during the five (5) years immediately preceding the Closing Date. Section 4.17
of the Disclosure Schedule contains a description of all current malpractice
liability insurance policies of the Shareholder, the Company and the Company's
professional employees and all predecessor policies in effect. Except as set
forth on Section 4.17 of the Disclosure Schedule: (a) neither the Company, nor
its professional employees, nor the Shareholder has, during the five (5) years
immediately preceding the Closing Date, filed a written application for any
insurance coverage relating to the Company's business or property which has been
denied by an insurance agency or carrier; and (b) the Company, the Company's
professional employees and the Shareholder has been continuously insured for
professional malpractice claims during the same period. Section 4.17 of the
Disclosure Schedule also sets forth a list of all claims for any insured loss in
excess of Five Thousand and 00/100 Dollars ($5,000) per occurrence filed by the
Company, the Company's professional employees or the Shareholder during the five
(5) years immediately preceding the Closing Date, including workers
compensation, general liability, environmental liability and professional
malpractice liability claims. With respect to each insurance policy listed in
Section 4.17 of the Disclosure Schedule: (i) the policy is legal, valid,
binding, enforceable, and in full force and effect; (ii) the policy will
continue to be legal, valid, binding, enforceable, and in full force and effect
on identical terms following the consummation of the transactions contemplated
hereby; (iii) neither the Company, the Shareholder, other health care
professionals nor any other party to the policy is in breach or default
(including with respect to the payment of premiums or the giving of notices),
and no event has occurred which, with notice or the lapse of time, would
constitute such a breach or default, or permit termination, modification, or
acceleration, under the policy; (iv) the Company has not repudiated any
provision thereof and no other party to the policy has repudiated any provision
thereof; (v) there is no claim pending under any of such policies as to which
coverage has been questioned, denied or disputed by the underwriter(s) of such
policies or any notice that a defense will be afforded with reservation of
rights; (vi) the Company has not received: (A) any notice that any issuer of any
such policy has filed for protection under applicable bankruptcy laws or is
otherwise in the process of liquidating or has been liquidated; or (B) any other
indication that such policies are no longer in full force and effect or that the
issuer of any such policy is no longer willing or able to perform its
obligations thereunder; and (vii) neither the Shareholder nor the Company has
received any written notice from or on behalf of any insurance carrier issuing
such policies, that there will hereafter be a cancellation, or an increase in a
deductible or non-renewal of existing policies. The Company has been covered
during the past five (5) years by insurance in scope and amount customary and
reasonable for the business in which it has engaged during the aforementioned
period.

     4.18 Litigation. Except as noted in Section 4.18 of the Disclosure
Schedule, there is no litigation, arbitration, governmental claim, investigation
or proceeding,

<PAGE>

pending or, to Shareholder's Knowledge, threatened, against the Company, or the
Shareholder at law or in equity, before any court, arbitration tribunal or
governmental agency. Each of the Sellers has no knowledge of any facts on which
claims may hereafter be made against the Company that will have a Material
Adverse Effect on the Company. All medical malpractice claims, general liability
incidents and incident reports relating to the Business have been submitted to
Company's insurer. All claims made or, to Shareholder's Knowledge, threatened
against the Company or the Shareholder in excess of the deductible are covered
under the Shareholder's or Company's current insurance policies. Section 4.18 of
the Disclosure Schedule provides a complete list of all general liability
incidents, incident reports and malpractice claims relating to the Business or
the Center that have for the five (5) year period prior to the date hereof.

     4.19 Health Care Compliance. The Company is participating or otherwise
authorized to receive reimbursement from Medicare and Medicaid and is a party to
other third-party payor agreements set forth in Section 4.19 of the Disclosure
Schedule. All necessary certifications and contracts required for participation
in such programs are in full force and effect and have not been amended or
otherwise modified, rescinded, revoked or assigned, and no condition exists or
event has occurred which in itself or with the giving of notice or the lapse of
time or both would result in the suspension, revocation, impairment, forfeiture
or non-renewal of any such third-party payor program. The Company is in
compliance in all material respects with the requirements of all such
third-party payors applicable thereto. None of the Company, its physician
employees, the Shareholder, or immediate family members of the Shareholder or
other physician employees, have any financial relationship (whether investment
interest, compensation interest, or otherwise) with any entity to which any of
the foregoing refer patients, except for such financial relationships that
qualify for exceptions to state and federal laws restricting physician referrals
to entities in which they have a financial interest.

     4.20 Fraud and Abuse. The Company, the Shareholder, and all persons and
entities providing professional services for the Company have not engaged in any
activities which are prohibited under 42 U.S.C. (S) 1320a-7b, or the regulations
promulgated thereunder pursuant to such statutes, or related state or local
statutes or regulations, or which are prohibited by rules of professional
conduct, including the following: (a) knowingly and willfully making or causing
to be made a false statement or representation of a material fact in any
application for any benefit or payment; (b) knowingly and willfully making or
causing to be made any false statement or representation of a material fact for
use in determining rights to any benefit or payment; (c) failing to disclose
Knowledge by a claimant of the occurrence of any event affecting the initial or
continued right to any benefit or payment on its own behalf or on behalf of
another, with intent to fraudulently secure such benefit or payment; and (d)
knowingly and willfully soliciting or receiving any remuneration (including any
kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in
cash or in kind or offering to pay or receive such remuneration: (A) in return
for referring an individual to a person for the furnishing or arranging for the
furnishing of any item or service for which payment may be made in whole or in
part by Medicare or Medicaid; or (B) in return for purchasing,

<PAGE>

leasing, or ordering or arranging for or recommending purchasing, leasing, or
ordering any good, facility, service or item for which payment may be made in
whole or in part by Medicare or Medicaid. The Company has at all times complied
with the requirements of Illinois Statutes which prohibit physicians who have an
ownership, investment or beneficial interest in certain health care facilities
from referring patients to such facilities for the provisions of designated and
other health services, and has at all times complied with the Illinois Statutes.
Furthermore, the Company has filed all reports required to be filed by the State
of Illinois and federal law regarding compensation arrangements and financial
relationships between a physician and an entity to which the physician refers
patients.

     4.21 Legal Compliance. The Company and its predecessors and Affiliates have
complied with all applicable Laws (including rules, regulations, codes,
injunctions, judgments, orders, decrees, and rulings of federal, state, local,
and foreign governments (and all agencies thereof)), and no action, suit,
proceeding, hearing, complaint, claim, demand, notice or investigation has been
filed or commenced, or to the Knowledge of the Shareholder and the Company,
threatened against the Company alleging any failure so to comply. The Company
and all physicians and other health care professionals engaged or employed by
the Company (or associated with the Company as a result of being engaged or
employed by New PC) have all permits and licenses required by applicable Law,
have made all required regulatory filings and are not in violation of any such
permit or license. The Company is lawfully operated in accordance with the
requirements of all applicable Laws and has in full force and effect all
authorizations and permits necessary to operate a medical practice saving those
that have been assigned or transferred to the New PC in accordance with this
Agreement. There are no outstanding notices of deficiencies relating to the
Company issued by any governmental authority or third-party payor requiring
conformity or compliance with any applicable law or condition for participation
with such governmental authority or third-party condition for participation with
such governmental authority or third-party payor. The Company has not received
notice and the Company and Shareholder has no knowledge or reason to believe
that, such necessary authorizations may be revoked or not renewed in the
ordinary course of business.

     4.22 Rates and Reimbursement Policies. The jurisdiction in which the
Company is located does not currently impose any restrictions or limitations on
rates which may be charged to private pay patients receiving services provided
by the Company except for restrictions promulgated by Illinois law and
regulation on charging of excessive fees and limitations on charges for and
profits from the sale of medications, goods and devices and free samples. The
Company does not have any rate appeal currently pending before any governmental
authority or any administrator of any third-party payor program. The Company and
the Shareholder have no Knowledge of any applicable Law, which affects rates or
reimbursement procedures which has been enacted, promulgated or issued within
the eighteen (18) months preceding the date of this Agreement or any such legal
requirement proposed or currently pending in the State of Illinois which could
have a Material Adverse Effect on the Company, its business or operations, or
may result in the imposition of additional Medicaid, Medicare, charity, free

<PAGE>

care, welfare, or other discounted or government assisted patients at the
Company or require the Company to obtain any necessary authorization which the
Company does not currently possess. Neither the Company nor the Shareholder have
Knowledge of any impending proposed reduction in reimbursement from third party
or other payors nor Knowledge of any threatened termination of payor contracts.

     4.23 Medical Staff. Except as set forth on Section 4.23 of the Disclosure
Schedule, the Shareholder has no Knowledge of a physician who is providing
services on behalf of the Company or New PC who plans, or has threatened to
terminate his or her employment or other relationship with the Company. None of
the physicians providing services on behalf of the Company currently has plans
to retire from the practice of medicine in the next three (3) years.

     4.24 Employees. Except as set forth on Section 4.24 of the Disclosure
Schedule: (a) there is no unfair labor practice charge or complaint pending or
threatened relating to the business of the Company; and (b) payment in full to
all of the employees of the Company of all wages, salaries, commissions,
bonuses, benefits, and other compensation lawfully due and owing to such
employees or otherwise arising under any policy, practice, agreement, plan,
program, statute, or other law as of the Closing Date has been made.

     4.25 Employee Benefits.

          (a)  Plans. Section 4.25 of the Disclosure Schedule lists each
Employee Benefit or health and welfare plan that the Company maintains or to
which the Company contributes.

          (b)  Compliance. Each such Employee Benefit Plan (and each related
trust, insurance contract, or fund) complies in form and in operation in all
material respects with its terms and with the applicable requirements of ERISA,
the Code and other applicable laws.

          (c)  Reports and Descriptions. All required reports and descriptions
(including Form 5500 Annual Reports, Summary Annual Reports, PBGC-1's, and
Summary Plan Descriptions) have been filed or distributed appropriately with
respect to each such Employee Benefit Plan. The requirements of Part 6 of
Subtitle B of Title I of ERISA and of Code Section 4980B have been met with
respect to each such Employee Benefit Plan which is an Employee Welfare Benefit
Plan.

          (d)  Contributions. All contributions (including all employer
contributions and employee salary reduction contributions) which are due have
been paid to each such Employee Benefit Plan which is an Employee Pension
Benefit Plan and all contributions for any pay period ending on or before the
Closing Date which are not yet due have been paid to each such Employee Pension
Benefit Plan or accrued in accordance with the past custom and practice of the
Company. All premiums or other

<PAGE>

payments due for all periods ending on or before the Closing Date have been paid
with respect to each such Employee Benefit Plan which is an Employee Welfare
Benefit Plan.

          (e)  Qualified Plan. Each such Employee Benefit Plan which is an
Employee Pension Benefit Plan and is intended to meet the requirements of a
"qualified plan" under Code Section 401(a) meets such requirements and has
received, within the last two (2) years, a favorable determination letter from
the IRS.

          (f)  Market Value. The market value of assets under each such Employee
Benefit Plan which is an Employee Pension Benefit Plan (other than any
Multiemployer Plan) equals or exceeds the present value of all vested and
nonvested Liabilities thereunder determined in accordance with PBGC methods,
factors, and assumptions applicable to an Employee Pension Benefit Plan
terminating on the date for determination.

          (g)  Copies. The Shareholder has delivered to PainCare and Subsidiary
correct and complete copies of the plan documents and summary plan descriptions,
the most recent determination letter received from the IRS, the most recent Form
5500 Annual Report, and all related trust agreements, insurance contracts, and
other funding agreements which implement each such Employee Benefit Plan.

          (h)  Maintenance of Plans. With respect to each Employee Benefit Plan
that the Company maintains, ever has maintained, or to which it contributes,
ever has contributed, or ever has been required to contribute:

               (i) Reportable Events. No such Employee Benefit Plan which is an
Employee Pension Benefit Plan has been completely or partially terminated or
been the subject of a Reportable Event as to which notices would be required to
be filed with the PBGC. No proceeding by the PBGC to terminate any such Employee
Pension Benefit Plan has been instituted or threatened; and

               (ii)  Prohibited Transactions. There have been no Prohibited
Transactions with respect to any such Employee Benefit Plan. No Fiduciary has
any Liability for breach of fiduciary duty or any other failure to act or comply
in connection with the administration or investment of the assets of any such
Employee Benefit Plan. No action, suit, proceeding, hearing, or investigation
with respect to the administration or the investment of the assets of any such
Employee Benefit Plan (other than any Multiemployer Plan), other than routine
claims for benefits, is pending or threatened. The Shareholder and the Company
have no Knowledge of any basis for any such action, suit, proceeding, hearing,
or investigation.

     4.26 Physicians and Other Providers. During the five (5) years preceding
the Closing Date, each physician, and other health care provider who is or was
employed by, or who renders or has rendered services on behalf of, the Company
or New PC:

<PAGE>

          (a)  Licenses. Has been duly licensed and registered, and in good
standing by the State of Illinois to engage in the practice of medicine, and
said license and registration have not been suspended, revoked or restricted in
any manner;

          (b)  Controlled Substances. Has current controlled substances
registrations issued by the State of Illinois and the U.S. Drug Enforcement
Administration, which registrations have not been surrendered, suspended,
revoked or restricted in any manner;

          (c)  Actions. Except as set forth on Section 4.26 of the Disclosure
Schedule, has not been a party or subject to:

               (i)    Malpractice Actions. Any malpractice suit, claim (whether
or not filed in court), settlement, settlement allocation, judgment, verdict or
decree;

               (ii)   Disciplinary Proceedings. Any disciplinary, peer review or
professional review investigation, proceeding or action instituted by any
licensure board, hospital, medical school, physical therapy school, health care
facility or entity, professional society or association, third party payor, peer
review or professional review committee or body, or governmental agency;

               (iii)  Criminal Proceedings. Any criminal complaint, indictment
or criminal proceedings;

               (iv)   Investigation. Any investigation or proceedings, whether
administrative, civil or criminal, relating to an allegation of filing false
health care claims, violating anti-kickback or fee-splitting laws, or engaging
in other billing improprieties;

               (v)    Mental Illnesses. Any organic or mental illness or
condition that impairs or may impair such physician's ability to practice;

               (vi)   Substance Abuse. Any dependency on, habitual use or
episodic abuse of alcohol or controlled substances, or any participation in any
alcohol or controlled substance detoxification, treatment, recovery,
rehabilitation, counseling, screening or monitoring program;

               (vii)  Professional Ethics. Any allegation, or any investigation
or proceeding based on any allegation of violating professional ethics or
standards, or engaging in illegal, immoral or other misconduct (of any nature or
degree), relating to his or her practice; or

               (viii) Application for Licensure. Any denial or withdrawal of an
application in any state for licensure as a physician or physical therapist, for
medical staff privileges at any hospital or other health care entity, for board
certification or

<PAGE>

recertification, for participation in any third party payment program, for state
or federal controlled substances registration, or for malpractice insurance.

     4.27 Guaranties. Saving the guaranties listed in Section 4.27 of the
Disclosure Schedule, the Company is not a guarantor or otherwise liable for any
Liability or obligation (including indebtedness) of any other Person.

     4.28 Environment, Health, and Safety.

          (a)  Compliance. Each of the Company and its predecessors and
Affiliates has complied and is in material compliance with all Environmental,
Health, and Safety Requirements.

          (b)  Permits and Licenses. Without limiting the generality of the
foregoing, each of the Company and its Affiliates has obtained and complied in
all material respects with, and is in compliance in all material respects with,
all permits, licenses and other authorizations that are required pursuant to
Environmental, Health, and Safety Requirements for the occupation of its
facilities and the operation of its business; a list of all such permits,
licenses and other authorizations is set forth on Section 4.28 of the Disclosure
Schedule.

          (c)  Notices. None of the Company nor its predecessors or Affiliates
has received any written or oral notice, report or other information regarding
any actual or alleged violation of Environmental, Health, and Safety
Requirements, or any Liabilities or potential Liabilities (whether accrued,
absolute, contingent, unliquidated or otherwise), including any investigatory,
remedial or corrective obligations, relating to any of them or its facilities
arising under Environmental, Health, and Safety Requirements.

          (d)  Hazardous Substances. None of the Company or its predecessors or
Affiliates has treated, stored, disposed of, arranged for or permitted the
disposal of, transported, handled, or released any substance, including without
limitation any hazardous substance, or owned or operated any property or
facility (and no such property or facility is contaminated by any such
substance) in a manner that has given or would give rise to liabilities,
including any Liability for response costs, corrective action costs, personal
injury, property damage, natural resources damages or attorney fees, pursuant to
the Comprehensive Environmental Response, Compensation and Liability Act of
1980, as amended, the Solid Waste Disposal Act, as amended or any other
Environmental, Health, and Safety Requirements.

          (e)  The Company has not received any communication (written or oral),
whether from a governmental authority, citizens' group, employee or otherwise,
that alleges that the Business or the Company is not in full compliance with
Environmental Laws, or that the Company is otherwise subject to liability under
Environmental Laws, and to the Shareholder's Knowledge, there are no
circumstances that may prevent or interfere with such full compliance in the
future. There is no

<PAGE>

Environmental Claim (as defined below) pending or, to the Shareholder's
Knowledge, threatened against the Company, the Business or the Center.

          (f)  The Shareholder has no Knowledge of any actions, activities,
circumstances, conditions, events or incidents, including, but not limited to,
the release, emission, discharge, presence or disposal of any Hazardous
Substances that could form the basis of any Environmental Claim against the
Company, the Business or the Center, or Sellers in connection with the Business
or the Center.

     4.29 Certain Business Relationships with the Company and its Affiliates.
Except as contemplated hereby with respect to New PC, neither the Shareholder
nor any of his Affiliates have been involved in any business arrangement or
relationship with the Company and its Affiliates within the past twelve (12)
months, and none of the Shareholder and his Affiliates owns any asset, tangible
or intangible, which is material to the business of any of the Company and its
Affiliates.

     4.30 Third-party Payors. Section 4.30 of the Disclosure Schedule sets forth
an accurate, correct and complete list of the Company's third-party payors.
Neither the Company nor the Shareholder has received any notice nor has any
Knowledge that any third-party payor intends to terminate or materially reduce
its business with, or reimbursement to, the Company. The Company has no reason
to believe that any third-party payor will cease to do business with the Company
after, or as a result of, the consummation of any transactions contemplated
hereby. The Company does not know of any fact, condition or event which would
adversely affect its relationship with any third-party payor.

     4.31 Bank Accounts. Section 4.31 of the Disclosure Schedule sets forth all
of the bank and security accounts and all safe deposit boxes maintained by the
Company and all lines of credit owned or used by the Company, and the names of
all persons with authority to withdraw funds from, or execute drafts or checks
on, each such account.

     4.32 Tax Status. The Shareholder is not a "nonresident alien individual" or
"foreign corporation" for purposes of Code Section 897(a)(1).

     4.33 Binding Obligation. This Agreement constitutes the valid and legally
binding obligation of the Shareholder, enforceable in accordance with its terms
and conditions.

     4.34 No Corporate Practice or Fee Splitting. The Shareholder does not have
any Knowledge that the actions, transactions or relationships arising from, and
contemplated by, the Transaction violate any law, rule or regulation relating to
the corporate practice of medicine or fee splitting. The Shareholder accordingly
agrees that he will not and will not cause any other Party, in an attempt to
void or nullify this Agreement or any document related to the Transaction or any
relationship involving PainCare or Subsidiary to sue, claim, aver, allege or
assert that any such document or any

<PAGE>

such relationship violates any law, rule or regulation relating to the corporate
practice of medicine or fee splitting.

     4.35 Intentionally Omitted.

     4.36 Securities Representation.

          (a)  No Registration of PainCare Shares; Investment Intent. The
Shareholder acknowledges that the PainCare Shares to be delivered pursuant to
this Agreement have not been and will not be registered under the Securities Act
and may not be resold without compliance with the Securities Act. The PainCare
Shares to be acquired by the Shareholder pursuant to this Agreement are being
acquired solely for his own account, for investment purposes only and with no
present intention of distributing, selling or otherwise disposing of them in
connection with a distribution other than in compliance with the Securities Act.

          (b)  Resale Restrictions. The Shareholder covenants, warrants and
represents that none of the PainCare Shares issued to Shareholder will be
offered, sold, assigned, pledged, hypothecated, transferred or otherwise
disposed of except after full compliance with all of the applicable provisions
of the Securities Act and the rules of regulations of the Commission and
applicable state securities laws, and the applicable provisions of any PainCare
Stockholders' Agreement and this Agreement. All certificates evidencing PainCare
Shares shall bear the legends contained in the PainCare Stockholders' Agreement.

          (c)  Ability to Bear Economic Risk. The Shareholder covenants,
warrants and represents that he is able to bear the economic risk of an
investment in PainCare Shares acquired pursuant to this Agreement and can afford
to sustain a total loss of such investment and has such Knowledge and experience
in financial and business matters that he is capable of evaluating the merits
and risks of the proposed investment and therefore has the capacity to protect
his own interests in connection with the acquisition of the PainCare Shares. The
Shareholder, and the Shareholder's purchaser representative, if any, have
received copies of PainCare's most recent 10-K, 10-Q AND 8-K filings and have
had an adequate opportunity to ask questions and receive answers from the
officers of PainCare concerning any and all matters relating to the background
and experience of the officers and directors of PainCare, the plans for the
operations of the business of PainCare, and any plans for additional
acquisitions and the like. The Shareholder, and the Shareholder's purchaser
representative, if any, have asked any and all questions in the nature described
in the preceding sentence and all questions have been answered to such
individual's satisfaction.

          (d)  Accredited Investor. The Shareholder covenants, represents and
warrants that he is an: (a) individual with a net worth (either individually or
jointly with his respective spouse) in excess of One Million and No/100 Dollars
($1,000,000.00); or (b) individual who had an income in excess of Two Hundred
Thousand and No/100

<PAGE>

Dollars ($200,000.00) in each of 2001 and 2002, or had a joint income with his
spouse in excess of Three Hundred Thousand and No/100 Dollars ($300,000.00) in
each of 2001 and 2002, and has a reasonable expectation of reaching the same
income level in 2003.

          (e) Residency. The Shareholder covenants, warrants and represents that
he is a resident of the State of Illinois, and received this Agreement and first
learned of the transactions contemplated hereby in the State of Illinois. He
executed and will execute all documents contemplated hereby in the State of
Illinois, and intends that the laws of the State of Illinois govern this
transaction.

          (f) No Registration. The Shareholder understands, agrees and
acknowledges that the PainCare Shares have not been registered under the
Illinois Securities Act or the Securities Act in reliance upon exemption
provisions contained therein which PainCare believes are available.

     4.37 HIPAA. Schedule 4.37 lists and describes all plans and other efforts
of the Shareholder with respect to the practice locations to comply with the
Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), including
the final regulations promulgated thereunder, whether such plans and efforts
have been put in place or are in process. Schedule 4.37 includes but is not
limited in any manner whatsoever to any privacy compliance plan of Sellers in
place or in development, and any plans, analyses or budgets relating to
information systems including but not limited to necessary purchases, upgrades
or modifications to effect HIPAA compliance.

     4.38 Improper and Other Payments. (a) Neither the Company, any director,
officer, employee thereof, nor any agent or representative of the Company nor
any person acting on behalf of any of them, has made, paid or received any
unlawful bribes, kickbacks or other similar payments to or from any person or
authority, (b) no contributions have been made, directly or indirectly, by the
Company to a domestic or foreign political party or candidate; and (c) the
internal accounting controls of the Company are believed by the Company's
management to be adequate to detect any of the foregoing under current
circumstances.

     4.39 Accounts Receivable. Schedule 4.39 sets forth a list, accurate,
correct and complete in all respects, of all outstanding accounts and notes
receivable of the Company as of the last day of the month immediately preceding
the Execution Date (which will be updated as of the Closing to the last day of
the month immediately preceding the Closing Date). All outstanding accounts and
notes receivable reflected on Schedule 4.39 are due and valid claims against
account debtors for services rendered in accordance with the usual business
practices and historical collection experience of the Company and to the best of
Shareholder's knowledge are subject to no counterclaims, and have been
outstanding for the periods indicated in the aging analysis at Schedule 4.39.
The Shareholder know of no reason why such accounts receivable would not be
collectible by the Company according to approximately the same ratios as
accounts receivable have been historically collectible by the Company. All
outstanding accounts

<PAGE>

and notes receivable included on Schedule 4.39 arose in the ordinary course of
business. The Company has not incurred any liabilities to customers for
discounts, returns, promotional allowances or otherwise, except as provided in
the Financial Statements

     4.40 Medical Waste. With respect to the generation, transportation,
treatment, storage, and disposal, or other handling of Medical Waste, the
Company, with respect to the business, has complied with all Medical Waste Laws
(as hereinafter defined).

          "Medical Waste" includes, but is not limited to, (a) pathological
waste, (b) blood, (c) sharps, (d) wastes from surgery or autopsy, (e) dialysis
waste, including contaminated disposable equipment and supplies, (f) cultures
and stocks of infectious agents and associated biological agents, (g)
contaminated animals, (h) isolation wastes, (i) contaminated equipment, (j)
laboratory waste, and (k) various other biological waste and discarded materials
contaminated with or exposed to blood, excretion, or secretions from human
beings or animals. "Medical Waste" also includes any substance, pollutant,
material, or contaminant listed or regulated under the Medical Waste Tracking
Act of 1988, 42 U.S.C. (S)(S)6992, et seq. ("MWTA").

          "Medical Waste Law" means the following, including regulations
promulgated and orders issued thereunder, all as may be amended from time to
time: the MWTA; the U.S. Public Vessel Medical Waste Anti-Dumping Act of 1988,
33 USCA (S)(S)2501 et seq.; the Marine Protection, Research, and Sanctuaries Act
of 1972, 33 USCA (S)(S)1401 et seq.; the Occupational Safety and Health Act, 29
USCA (S)(S)651 et seq.; the United States Department of Health and Human
Services, National Institute for Occupational Self-Safety and Health Infectious
Waste Disposal Guidelines, Publication No. 88-119; and any other federal, state,
regional, county, municipal, or other local laws, regulations, and ordinances
insofar as they purport to regulate Medical Waste, or impose requirements
relating to Medical Waste.

     4.41 No Untrue or Inaccurate Representation or Warranty. No representation
or warranty by Sellers contains or will contain any untrue statement of fact, or
omits or will omit to state a fact necessary to make the statements and
information contained in this Section 4 not misleading.

5.   REPRESENTATIONS AND WARRANTIES OF THE ACQUIRING COMPANIES. The Acquiring
Companies represent and warrant to the Shareholder that the statements contained
in this Section 5 are correct and complete as of the Closing Date.

     5.1 Organization of PainCare and Subsidiary. PainCare is a corporation duly
organized, validly existing, and in good standing under the laws of the State of
Florida. Subsidiary is a corporation duly organized, validly existing and in
good standing under the laws of the State of Florida.

<PAGE>

     5.2 Authorization of Transaction. PainCare and Subsidiary have full power
and authority (including full corporate power and authority) to execute and
deliver this Agreement and to perform its obligations hereunder. This Agreement
constitutes the valid and legally binding obligation of PainCare, enforceable in
accordance with its terms and conditions. The execution and delivery of this
Agreement has been approved and authorized by the Board of Directors of
PainCare.

     5.3 No Conflict or Violation. Neither the execution and delivery of this
Agreement nor the consummation of the transactions contemplated hereby will
result in (a) a violation of or a conflict with any provision of the Certificate
or Articles of Incorporation or bylaws of the PainCare or Subsidiary, (b) a
breach of, or a default under, any term or provision of any contract, agreement,
indebtedness, lease, commitment, license, franchise, permit, authorization or
concession to which the PainCare or Subsidiary is a party, which breach or
default could reasonably be expected to have a Company material adverse effect
on the business or financial condition of the PainCare or Subsidiary or its
ability to consummate the transactions contemplated hereby or (c) a violation by
the PainCare or Subsidiary of any statute, rule, regulation, ordinance, code,
order, judgment, writ, injunction, decree or award, which violation could
reasonably be expected to have a material adverse effect on the business or
financial condition of the PainCare or Subsidiary, or their ability to
consummate the transactions contemplated hereby.

     5.4 Consents and Approvals. Except as set forth on Disclosure Schedule 5.4,
no notice to, declaration, filing or registration with, or authorization,
consent or approval of, or permit from, any domestic or foreign governmental or
regulatory body or authority, or any other person or entity, is required to be
made or obtained by the PainCare or Subsidiary in connection with the execution,
delivery and performance of this Agreement and the consummation of the
transactions contemplated hereby.

     5.5 Disclosure Documents. PainCare has delivered or Stockholder has had the
opportunity to obtain and review PainCare's Form 10-KSB for the year ending
December 31, 2002, Form S-4/A filed with the SEC on July 11, 2002, Form 10-QSB
for the period ending September 30, 2002, Form 14A (Definitive Proxy) filed with
the SEC on September 17, 2002 and current Forms 8-K (the "PainCare Disclosure
Documents"). The PainCare Disclosure Documents are true and correct in all
material respects and do not contain any untrue statement of a material fact or
omit to state any material fact necessary in order to make the statements
therein, in light of the circumstances under which such statements were made,
not misleading. To the knowledge of PainCare nothing has occurred after the date
of the documents contained in the Disclosure Documents that would individually
or in the aggregate have a material adverse effect on PainCare.

     5.6 Capitalization. The authorized capital stock of PainCare consists of
75,000,000 shares of Common Stock, $.0001 par value per share, which as of March
31, 2002, approximately 18,813,961 shares are issued and outstanding, 10,000,000
shares of "blank check" preferred none of which have been issued or are
outstanding. All of the

<PAGE>

PainCare Shares are, and all shares of PainCare Shares to be issued pursuant to
this Agreement will be, validly issued, fully paid and non-assessable.
Disclosure Schedule 5.6(a) hereto sets forth a listing of all options, warrants
and outstanding PainCare securities which are convertible (with or without the
payment of consideration) into shares of the Common Stock of PainCare, including
all contingently issuable shares of such Common Stock issuable pursuant to
agreements outstanding as of March 31, 2003. Disclosure Schedule 5.6(b) also
sets forth the terms of any financing proposed to be raised by PainCare in
connection with the transactions contemplated by this Agreement.

     5.7 Litigation. Except as set forth in Disclosure Schedule 5.7, there is no
charge, complaint, action, order, writ, injunction, judgment or decree
outstanding or claim, suit, litigation, proceeding, labor dispute, arbitrable
action or investigation (collectively, "Actions") pending or, to the knowledge
of the PainCare, threatened against, relating to or affecting (i) the PainCare
or its assets or the operation of the business of the PainCare as currently
operated and as proposed to be operated, (ii) any Employee Plan of PainCare or
any trust or other funding instrument, fiduciary or administrator thereof or
(iii) the transactions contemplated by this Agreement, before or by any federal,
state, municipal or other governmental department, commission, board, bureau,
agency or instrumentality, domestic or foreign, any of which is reasonably
expected to result in a loss not covered by insurance in excess of $100,000 or
reasonably expected to have a material adverse effect on PainCare. To the
knowledge of the PainCare, the PainCare is not in default with respect to any
judgment, order, writ, injunction or decree of any court or governmental agency,
and there are no unsatisfied judgments against the PainCare or the business of
the PainCare. Except as set forth in Disclosure Schedule 5.7, each Action
pending or, to the knowledge of the PainCare, threatened (whether or not
disclosed in Disclosure Schedule 5.7), is covered by insurance of reputable and
solvent insurance companies.

     5.8 No Undisclosed Liabilities. Except as set forth in Disclosure Schedule
5.8, to the knowledge of PainCare, PainCare has no liabilities or obligations
(absolute, accrued, contingent or otherwise) except (i) liabilities that are
reflected and reserved against on PainCare's audited balance sheet dated
December 31, 2002 (the "PainCare Balance Sheet Date") that have not been paid or
discharged since the date thereof and (ii) liabilities incurred by PainCare
since the PainCare Balance Sheet Date in the ordinary course of business
consistent with past practice (none of which relates to any breach of contract,
breach of warranty, tort, infringement or violation of law or arose out of any
complaint, action, suit or proceeding except those which individually or in the
aggregate could not have a material adverse effect on PainCare).

     5.9 No Brokers. There is no obligation on the part of PainCare to pay any
finder's fee, brokerage commission or similar payment in connection with the
transactions contemplated hereby other than Dr. Mark Lee (KBL Investments) for
which it will be responsible.

<PAGE>

     5.10 Material Misstatements Or Omissions. To the knowledge of PainCare, no
representations or warranties by PainCare in this Agreement, nor any document,
exhibit, statement, certificate or schedule furnished or to be furnished to the
Shareholder pursuant hereto, or in connection with the transactions contemplated
hereby, contains or will contain any untrue statement of a material fact, or
omits or will omit to state any material fact necessary to make the statements
or facts contained therein not misleading.

6.   CLOSING; TERMINATION. The closing of the Transaction (the "Closing") shall
take place at the offices of PainCare, or via remote location as coordinated by
the Parties' respective counsel commencing at 10:00 a.m. Eastern Daylight Time
on the later of (i) the third business date following the date on which the New
PC obtains its Medicare provider number and the Company effectively assigns all
Medical Assets and managed care contracts to the New PC, (ii) the date upon
which all other conditions to the Parties obligations have been met or waived,
or such other date or time as the Parties may mutually agree (the "Closing
Date"). In the event that the Closing has not occurred on or before July 31,
2003, this Agreement may be terminated by either Party provided such Party has,
as of the date of such election to terminate, fulfilled all conditions to the
obligations of the other Party. In the event that Closing does not occur by
August 15, 2003, this Agreement shall terminate unless the Parties otherwise
agree in writing.

7.   CLOSING DELIVERIES.

     7.1  Deliveries of the Company and the Shareholder. At or prior to the
Closing, the Company and the Shareholder shall deliver to the Acquiring
Companies the following:

          (a) Consents and Approvals. Copies of all authorizations, consents,
and approvals of governments, governmental agencies and third parties referred
to in Section 4.4(a) of the Disclosure Schedule;

          (b) Termination of Agreements. Copies of documents effectuating the
termination of any and all written employment and independent contractor
agreements, compensation agreements, buy-sell agreements and other similar
agreements entered into by the Company and which are in effect immediately
preceding the Closing, which terminations shall each include a complete release
of the Company from all known or unknown obligations or liabilities;

          (c) Company Stock. The Certificates and stock powers, duly endorsed,
transferring the Company Stock to Subsidiary and the officer and director
resignations required in Section 4.6;

          (d) Corporate Authorization. A certified copy of resolution(s) of the
Shareholder and board of directors of the Company which authorizes the
Transaction in accordance with: (a) applicable law; (b) the Company's articles
of incorporation and bylaws; and (c) all other requirements for proper corporate
authorization;

<PAGE>

          (e) Payoffs. Payoff letters from those creditors listed in Section
7.1(e) of the Disclosure Schedules;

          (f) Good Standing Certificate. A certificate issued by the appropriate
state governmental authority no more than ten (10) days prior to the Closing
Date evidencing the good standing of the Company;

          (g) Secretary's Certificate. A certificate of the secretary of the
Company certifying that the minute books, articles of incorporation and bylaws
of the Company, attached as exhibits to such certificate, are true, correct, and
complete; and

          (h) Other documents. Such other instruments or documents as may be
necessary or appropriate to carry out the Transactions.

     7.2 Deliveries of PainCare. At the Closing, PainCare shall deliver to the
Shareholder the following:

          (a) Transaction Consideration. The Transaction Consideration;

          (b) Resolutions. A certified copy of the resolution of the board of
directors of PainCare, and the sole shareholder and members of the board of
directors of Subsidiary, authorizing the Transaction;

          (c) Security Agreements. A duly executed signature page to the
Security Agreements;

          (d) Counsel's Opinion. An opinion from PainCare's legal counsel in the
form attached hereto as Schedule 7.2(d); and

          (e) Other documents. Such other instruments or documents as may be
necessary or appropriate to carry out the Transactions.

8.   CONDITIONS TO THE OBLIGATIONS OF THE PARTIES. The obligations of the
Parties to Close are subject to the satisfaction of the following respective
conditions unless waived by the Party for whose benefit the condition applies.

     8.1 Conditions for the Benefit of PainCare and the Subsidiary. (a) The
representations and warranties of the Shareholder and the Company in this
Agreement and all information contained in any exhibit, certificate, schedule or
attachment hereto or in any writing delivered by, or on behalf of the
Shareholder or the Company shall be true and correct when made and shall be true
and correct in all material respects on the Closing Date as though then made,
except as expressly provided for herein, and (b) both the Shareholder and the
Company shall have performed and complied with all agreements, covenants and
conditions and shall have made all deliveries required by this Agreement to be
performed, delivered and complied with by them prior to the Closing Date; and
(c) New PC shall have received a Medicare provider number to obtain payment

<PAGE>

or reimbursement for its services, and (d) the Company shall have assigned to
the New PC any and all Medical Assets and payor contracts of the Company, and
such payors have provided written consent to such assignment or otherwise were
properly notified of such assignment pursuant to the terms of such payor
contracts.

     8.2 Conditions for the Benefit of the Shareholder. (a) The representations
and warranties of PainCare in this Agreement and all information contained in
any exhibit, certificate, schedule or attachment hereto or in any writing
delivered by, or on behalf of PainCare or the Subsidiary shall be true and
correct when made and shall be true and correct in all material respects on the
Closing Date as though then made, except as expressly provided for herein, and
(b) both the Shareholder and the Company shall have performed and complied with
all agreements, covenants and conditions and shall have made all deliveries
required by this Agreement to be performed, delivered and complied with by them
prior to the Closing Date; and (c) New PC shall have received a Medicare
provider number to obtain payment and reimbursement for its services.

9. COVENANTS. The Parties covenant and agree as follows with respect to the
period following the Execution Date:

     9.1 Operations Pending Closing. Simultaneously with the execution of this
Agreement, the Company, New PC and the Subsidiary are executing and delivering
the Management Services Agreement and the Shareholder and the Subsidiary are
executing and delivering the Independent Contractor Agreement. Pending the
Effective Date, the Shareholder shall be designated by the Subsidiary as the
Medical Group Administrator under the Management Services Agreement.

     9.2 Deliveries Pending Closing. PainCare will promptly deliver and make
available to Shareholder copies of any filings made by it under the Securities
Act or the Securities Exchange Act, including the exhibits thereto and any
correspondence with the Securities Exchange Commission or its staff.

     9.3 Distributions of Sub-Chapter S Income by the Company. Not later than
the Closing Date, one hundred percent (100%) of the taxable income (as
determined by using the cash method of accounting) allocated to Shareholder for
the period beginning on January 1, 2003 and ending on the Execution Date shall
have been distributed to the Shareholder subject to the requirement that
Shareholder shall insure that as of the Closing Date that the Company will have
a minimum cash balance of Fifty Thousand Dollars ($50,000). The Shareholder
shall not be entitled to any additional distributions or payments with respect
to taxable income of the Company (i) for the period ending December 31, 2002;
(ii) for the period beginning on the Execution Date and ending on the Closing
Date; or (iii) after the Closing Date for any reasons whatsoever, other than as
specifically set forth in this Agreement.

     9.4 Post-Closing General Covenant. In the event that at any time after the
Closing any further action is necessary to carry out the purposes of this
Agreement, each

<PAGE>

of the Parties will take such further action (including the execution and
delivery of such further instruments and documents) as any other Party may
reasonably request, all at the sole cost and expense of the requesting Party;
provided, however, that the costs and expenses associated with the taking of any
action necessary to execute or deliver to PainCare any stock powers and such
other instruments of transfer as may be necessary to transfer ownership of the
Company's Shares by the Shareholder shall be borne by the Shareholder.

     9.5 Tax Returns. The Shareholder shall be responsible for preparing and
filing all income or franchise Tax Returns of the Company relating to periods of
time prior to the Closing Date. PainCare and the Subsidiary will provide to the
Shareholder access to all books and records of the Company necessary to the
preparation of such Tax Returns and the Subsidiary, as the successor to the
Company will execute such Tax Returns. The Shareholder will take no positions on
the Tax Returns of the Company that relate to the tax period prior to the
Closing Date that could adversely affect the Company or PainCare after the
Closing. The Shareholder will provide PainCare with an opportunity to review and
comment on such Tax Returns (including any amended returns). PainCare will be
responsible for preparing and filing all income and franchise Tax Returns of the
Company relating to periods after the Closing. The income of the Company will be
apportioned to the period up to the Closing Date and the period from and after
the Closing Date in accordance with the provisions of Code Section 1362(e)(6)(D)
by closing the books of the Company as of the close of business on the last
calendar day immediately preceding the Closing Date, with recognition that the
Company files on that basis of a cash rather than accrual method. The Acquiring
Companies shall be solely responsible for any taxes due arising from conversion
to the accrual method.

     9.6 Transition. Neither the Shareholder nor the Company will take any
action that is designed, intended or likely to have the effect of discouraging
any lessor, licensor, customer, supplier or other business associate of the
Company from maintaining the same business relationships with the Company after
the Closing as he, she or it maintained with the Company prior to the Closing.

     9.7 Litigation Support. In the event and for so long as any Party actively
is contesting or defending against any action, suit, proceeding, hearing,
investigation, charge, complaint, claim or demand in connection with: (a) any
transaction contemplated under this Agreement; or (b) any fact, situation,
circumstances, status, condition, activity, practice, occurrence, event,
incident, action, failure to act, or transaction on or prior to the Closing Date
involving the Company, each of the Parties will cooperate with the contesting or
defending Party and its or his counsel in the contest or defense, at the sole
cost and expense of the contesting or defending Party except to the extent that
the contesting or defending party is entitled to indemnification therefor under
this Agreement.

     9.8 Consents. The Shareholder hereby covenants and agrees that, after the
Execution Date, he will use his best efforts to obtain all authorizations,
consents, and

<PAGE>

approvals set forth in Section 4.4(b) of the Disclosure Schedule. If such
consent, approval or agreement is not obtained, or if an attempted assignment
thereof would affect the rights of the parties thereunder so that such parties
would not in fact receive all such rights, the Parties will cooperate in any
arrangement designed to provide for the Parties to receive the benefits under
any such contract, including enforcement for the benefit of PainCare and
Subsidiary of any and all rights of the Shareholder against a third party
thereto arising out of the breach or cancellation by such third party or
otherwise.

         9.9 Operational Covenants. Without the prior written consent of
Shareholder, which shall not be unreasonably withheld, PainCare shall not, prior
to the conclusion of the third Formula Period:

             (a) reorganize the Surviving Corporation, whether by integrating or
consolidating the business of the Surviving Corporation with other operating
units of PainCare or its subsidiaries or affiliates, except in the case that at
the time of such integration or consolidation such transaction could not
reasonably be expected to have a material adverse effect on the Formula Period
Profits;

             (b) effect any reassignment, reprioritization, reallocation,
restructuring, or reduction of the Surviving Corporation's human or other
resources, their research and development initiatives, or their marketing
programs, except in a manner that at the time of such event could not reasonably
be expected to have a material adverse effect on the Formula Period Profits or
that are reasonably necessary in light of the Surviving Corporation's results of
operation;

             (c) amend the articles of incorporation or bylaws of the Surviving
Corporation in any manner that at the time of such amendment could reasonably be
expected to have a material adverse effect on the Formula Period Profits;

             (d) cause the Surviving Corporation to become a party to or
terminate any agreement which at the time such agreement is entered into or
terminated could reasonably be expected to have a material adverse effect on the
Formula Period Profits or that is reasonably necessary in light of the Surviving
Corporation's results of operation;

             (e) cause the Surviving Corporation to undertake actions outside
the ordinary course of its business which at the time of such undertaking could
reasonably be expected to have a material adverse effect on the Formula Period
Profits;

             (f) sell a material portion of the Surviving Corporation or its
assets, merge the Surviving Corporation with any other entity, sell a
controlling interest in the Surviving Corporation, or make any fundamental
change in the business of the Surviving Corporation unless such action(s) at the
time of such undertaking could not reasonably be expected to have a material
adverse effect on the Formula Period Profits or that is reasonably necessary in
light of the Surviving Corporation's results of operation;

<PAGE>

          The parties hereby acknowledge and agree that the foregoing covenants
in this Section 9.9 shall become null and void and of no further force or effect
if the Formula Period Profits of the Surviving Corporation in each of any two
(2) consecutive calendar quarters are less than $175,000, or if the Formula
Period Profits of the Surviving Corporation in one (1) calendar quarter is less
than $80,000.

     9.10 Capital Adjustments. In the event of a stock dividend,
recapitalization, or merger in which PainCare is the surviving corporation,
split-up, combination or exchange of shares or the like which results in a
change in the number or kind of shares of common stock which is outstanding
immediately prior to such event, the rights of the Shareholder to receive
PainCare Shares in respect of this Agreement and the price thereof, shall be
appropriately adjusted in the same manner as the number and kind of shares a
shareholder of PainCare who owned the same number and kind of shares immediately
prior to such event. Such adjustments shall be made in good faith by the Board
of Directors of PainCare, whose determination shall be conclusive and binding on
all parties, subject to manifest error.

          In case of any consolidation or merger of PainCare with or into
another party or parties or the conveyance of all or substantially all of the
assets of PainCare to another party or parties or a share exchange transaction
involving more than 50% of the issued and outstanding common stock of PainCare,
the PainCare Shares and right to receive PainCare Shares shall thereafter be
convertible into the number of shares of stock, options or other securities or
property to which a shareholder of the PainCare who owned the same number and
kind of shares prior to such event would have been entitled upon such
consolidation, merger, conveyance, conversion or exchange; and, in any such
case, appropriate adjustment shall be made in the application of the provisions
herein set forth with respect to the rights and interest thereafter of the
Shareholder' rights to receive PainCare Shares, to the end that the provisions
set forth herein shall thereafter be applicable, as nearly as reasonably
possible, in relation to any shares of stock or other property thereafter
deliverable upon the Shareholder's entitlement to same.

10.  SURVIVAL AND INDEMNIFICATION.

     10.1 Survival of Representations and Warranties. All of the
representations, warranties, covenants, and agreements including but not limited
to the restrictive covenants and the indemnification provisions contained in
this Agreement are material and have been relied upon by the Parties hereto and
shall survive the Closing for their applicable statute of limitations. The
representations and warranties contained herein shall not be affected by any
investigation, verification or examination by any Party or by anyone on behalf
of such Party.

     10.2 Indemnification Provisions for the Benefit of PainCare and Subsidiary.
In the event of: (a) a misrepresentation (or in the event any third party
alleges facts that, if true, would mean a misrepresentation) of any of the
Shareholder's representations and/or warranties contained in this Agreement; (b)
a breach (or in the

<PAGE>

event any third party alleges facts that, if true, would mean a breach) of any
of the Shareholder's covenants contained in this Agreement, or; (c) any
Liability of the Company of any nature whatsoever accrued or existing as of the
Closing Date or related to actions of the Company which occurred prior to the
Closing Date, which is not reflected on the Financial Statements, the Closing
Date Balance Sheet, or Section 10.2 of the Disclosure Schedule then the
Shareholder agrees to indemnify PainCare and Subsidiary from and against any
Adverse Consequences PainCare and Subsidiary may suffer through and after the
date of the claim for indemnification resulting from, arising out of, relating
to, in the nature of, or caused by the misrepresentation or breach (or alleged
breach) or non-disclosed Liability. No provision of this Agreement, including
but not in any way limited to, any "Knowledge" qualifiers or materiality
standards in the representations and warranties of the Shareholder, shall have
any effect on the Shareholder's obligation to provide indemnity of any Liability
arising prior to the Closing Date which was required but omitted from the
Disclosure Schedule unless such Liability was incurred on behalf of the Company
by Subsidiary under the Management Agreement..

     10.3  Indemnification Provisions for the Benefit of the Shareholder. In the
event of a misrepresentation or breach (or in the event any third party alleges
facts that, if true, would mean a misrepresentation or breach) of any of
PainCare's or Subsidiary's representations, warranties, and covenants contained
in this Agreement, then PainCare and Subsidiary agree to indemnify the
Shareholder from and against any Adverse Consequences the Shareholder may suffer
through and after the date of the claim for indemnification resulting from,
arising out of, relating to, in the nature of, or caused by the breach (or the
alleged breach).

     10.4  Matters Involving Third Parties.

           (a) Notification. If any third party shall notify any Party (the
"Indemnified Party") with respect to any matter (a "Third Party Claim") which
may give rise to a claim for indemnification against the other Party (the
"Indemnifying Party") pursuant to this Section 10, then the Indemnified Party
shall promptly notify the Indemnifying Party thereof in writing; provided,
however, that no delay on the part of the Indemnified Party in notifying the
Indemnifying Party shall relieve the Indemnifying Party from any obligation
hereunder unless the Indemnifying Party thereby is prejudiced and then only to
the extent that the Indemnifying Party is actually prejudiced.

           (b) Defense by Indemnifying Party. The Indemnifying Party shall have
the right to defend the Indemnified Party against the Third Party Claim with
counsel of its choice satisfactory to the Indemnified Party so long as: (i) the
Indemnifying Party notifies the Indemnified Party in writing within ten (10)
business days after the Indemnified Party has given notice of the Third Party
Claim that the Indemnifying Party will indemnify the Indemnified Party from and
against any Adverse Consequences the Indemnified Party may suffer resulting
from, arising out of, relating to, in the nature of, or caused by the Third
Party Claim; (ii) the Indemnifying Party provides the Indemnified

<PAGE>

Party with evidence reasonably acceptable to the Indemnified Party that the
Indemnifying Party will have the financial resources to defend against the Third
Party Claim and fulfill the Indemnifying Party's indemnification obligations
hereunder; (iii) the Third Party Claim involves only money damages and does not
seek an injunction or other equitable relief; (iv) settlement of, or an adverse
judgment with respect to, the Third Party Claim is not, in the good faith
judgment of the Indemnified Party, likely to establish a precedential custom or
practice adverse to the continuing business interests of the Indemnified Party;
and (e) the Indemnifying Party conducts the defense of the Third Party Claim
actively and diligently.

           (c) Satisfactory Defense. So long as the Indemnifying Party is
conducting the defense of the Third Party Claim in accordance with Section
10.4(b) above: (i) the Indemnified Party may retain separate co-counsel at its
sole cost and expense and participate in the defense of the Third Party Claim;
(ii) the Indemnified Party will not consent to the entry of any judgment or
enter into any settlement with respect to the Third Party Claim without the
prior written consent of the Indemnifying Party (not to be withheld or delayed
unreasonably); and (iii) the Indemnifying Party will not consent to the entry of
any judgment or enter into any settlement with respect to the Third Party Claim
without the prior written consent of the Indemnified Party (not to be withheld
or delayed unreasonably) and any such settlement must include a complete release
of the Indemnified Party.

           (d) Conditions. In the event any of the conditions in Section 10.4(b)
above is or becomes unsatisfied, however: (i) the Indemnified Party may defend
against, and consent to the entry of any judgment or enter into any settlement
with respect to, the Third Party Claim in any manner it reasonably may deem
appropriate (and the Indemnified Party need not consult with, or obtain any
consent from, the Indemnifying Party in connection therewith); (ii) the
Indemnifying Party will reimburse the Indemnified Party promptly and
periodically for the costs of defending against the Third Party Claim (including
reasonable attorneys' fees and expenses); and (iii) the Indemnifying Party will
remain responsible for any Adverse Consequences the Indemnified Party may suffer
resulting from, arising out of, relating to, in the nature of, or caused by the
Third Party Claim to the fullest extent provided in this Section 10.

     10.5  Right to Set-Off. If any such cost, loss, damage, expense, liability,
claim, or obligation occurs or is incurred by PainCare or Subsidiary, PainCare
or Subsidiary shall have the right, after written notice to the Shareholder and
subject to a final decision by a court of requisite jurisdiction, at PainCare's
or Subsidiary's option and in addition to any other actions permitted by law, to
offset the amount of any such cost, loss, damage, expense, liability, obligation
or claim against amounts due from PainCare or Subsidiary to the Shareholder,
including the right to offset any post-closing payment due from PainCare or
Subsidiary to the Shareholder under this Agreement or any other agreement.

     10.6  Materiality. Notwithstanding any provision in this Agreement to the
contrary, the indemnifying Party's obligation to indemnify the Indemnified Party
in

<PAGE>

connection with a breach of any representation, warranty, covenant or other
agreement included in this Agreement, and the amount of damages to be
indemnified, shall be determined without regard to any "material", "materiality"
(or correlative meanings") or "Material Adverse Effect" qualifications,
provisions or exceptions set forth in such representation, warranty, covenant or
other agreement, each of which shall be deemed to be given for the purposes of
this Section 10 as though there were no such qualifications, provisions or
exceptions.

     10.7  Limitation. The indemnification provisions set forth in this Section
10 shall be limited to all claims in excess of Twenty Five Thousand and 00/100
Dollars ($25,000) (the "Threshold"). Once a claim exceeds the Threshold, if a
Party is entitled to indemnification under this Section 10, such party shall
recover all appropriate funds from the first dollar of damages. Further, the
indemnitors shall not be liable for any liabilities resulting from claims that
are covered by any insurance policy or other indemnity or contribution agreement
unless, and only to the extent that, the full limit of such insurance policy,
indemnity or contribution agreement has been exceeded. The Party entitled to
indemnification shall have a duty to mitigate its damages. Notwithstanding the
foregoing, a Party's obligation to indemnify under this Article 10 shall be
limited to an amount equal to $2,750,000 plus the amount of any Earnout
Installment Payments paid or due pursuant to Section 3.4 of this Agreement prior
to any reduction of such Installment Payments permitted under Section 3.4(g);
provided however that such cap shall not be applicable to Sections 4.2, 4.10,
4.11, 4.19, 4.20, 4.22, 4.25, 4.27, 4.36 and 4.37.

11.  RESTRICTIVE COVENANTS; CONFIDENTIALITY.

     11.1 Shareholder Restrictive Covenants.

           (a) Restricted Period. Except with respect to the specific carve-outs
set forth in Schedule 11.1 attached hereto, the Shareholder hereby agrees that
during the time period commencing as of the Execution Date and continuing for a
period of two (2) years thereafter (the "Restricted Period"), neither the
Shareholder nor any of his Affiliates, shall, other than on behalf of PainCare
or Subsidiary, directly or indirectly, for himself, or on behalf of any other
corporation, person, firm, partnership, association, or any other entity
whatsoever (whether as an individual, agent, servant, employee, employer,
officer, director, shareholder, investor, principal, consultant or in any other
capacity whatsoever) take any action or undertake any matter set forth in
11.1(a)(i)-(ii) below; provided, however, that the Restricted Period shall
terminate upon the earlier to occur of (i) any bankruptcy, liquidation or
assignment for the benefit of creditors applicable to either PainCare or
Subsidiary, or (ii) upon a default by PainCare or Subsidiary in any covenant or
term of this Agreement to be performed after the Closing or any covenant or term
of the Management Services Agreement if Shareholder shall have given written
notice of such default to PainCare and such default shall not have been cured
within 30 business days after the giving of such notice and provided further,
however, that the prohibitions contained in clauses (i) and (ii) above shall not
prohibit Shareholder from continuing active participation in his separate
businesses conducted

<PAGE>

under the names "AC Diagnostics" and "Integrated Concepts" so long as (x) any
consulting and related activities associated with such businesses to not relate
to the business practice areas of the Company involving pain management,
physical medicine and rehabilitation, physical therapy and chiropractic
medicine, (y) does not interfere with Shareholder's obligations under this
Agreement and his Independent Contractor's Agreement of even date herewith, and
(z) Shareholder is not in breach of this Agreement or such Independent
Contractor's Agreement.

               (i)   Establish, operate or provide physician services at any
medical office, hospital, clinic or out-patient and/or ambulatory treatment or
diagnostic facility or become employed by, or serve as a health care consultant
or medical director to any health care provider providing services similar to
those provided by PainCare or Subsidiary, or engage or participate in or finance
any business which engages in direct competition with the business being
conducted by PainCare or the Surviving Corporation at such time, anywhere within
a fifty (50) mile radius of any office of the Company or the New PC;

               (ii)  Solicit or engage in the solicitation of, or serve or
accept any business from patients, insurance companies, managed care plans,
employers or other customers of the business conducted by PainCare or the
Surviving Corporation for services competitive with those of PainCare or
Subsidiary, PainCare's and Subsidiary's successors and assigns, or PainCare's
and Subsidiary's Affiliates;

               (iii) Request, induce or advise any patients, insurance
companies, managed care plans, suppliers, vendors, employers or other customers
of the business conducted by PainCare or Subsidiary, or PainCare's or
Subsidiary's Affiliates to withdraw, curtail or cancel their business or other
relationships with PainCare or Subsidiary, or assist, induce, help or join any
other person or entity in doing any of the above activities; or

               (iv)  Induce or attempt to influence any employee of the Company,
the New PC, PainCare or Subsidiary, to terminate his or her employment with the
Company, the New PC, PainCare or Subsidiary, or to hire, recruit or solicit any
such employee, whether or not so induced or influenced.

           (b) Consideration. PainCare, Subsidiary and the Shareholder has
carefully considered the nature and extent of the restrictions imposed by this
Section 11.1 and the rights and remedies conferred upon PainCare and Subsidiary
hereunder and hereby expressly acknowledge and agree that: (i) the restricted
territory, period, and activities are reasonable and are necessary and fully
required to protect the legitimate business interests of PainCare and
Subsidiary; (ii) any violation of the terms of these restrictive covenants would
have a substantial detrimental effect on PainCare's and Subsidiary's businesses;
(iii) the restrictive covenants do not stifle the Shareholder's inherent skill
and experience; and (iv) would not operate as a bar to any of the Shareholder's
means of support. Because of the difficulty of measuring economic losses

<PAGE>

to PainCare and the Surviving Corporation as a result of the breach of the
foregoing covenants, and because of the immediate and irreparable damage that
would be caused to PainCare and the Surviving Corporation for which it would
have no other adequate remedy, the Shareholder agrees that, in the event of a
breach by him of the foregoing covenants, the covenants set forth in this
Section 11.1 may be enforced by PainCare and the Surviving Corporation by
injunctions and restraining orders, in addition to all other available legal
remedies.

          (c) Third-Party Beneficiaries. All successors and assigns of PainCare,
Subsidiary, all Affiliates of PainCare and Subsidiary, and all successors and
assigns of such Affiliates are third-party beneficiaries of the restrictive
covenants contained in this Section 11.1 and the provisions of this Section 11.1
are intended for the benefit of, and may be enforced by, PainCare's and
Subsidiary's successors and assigns and PainCare's and Subsidiary's Affiliates
and such Affiliates' successors and assigns.

     11.2 Defenses. The existence of any claim or cause of action by the
Shareholder against PainCare or Subsidiary, whether predicated upon this
Agreement or otherwise, shall not constitute a defense to the enforcement by
PainCare, Subsidiary, or any of PainCare's or Subsidiary's successors and
assigns or Affiliates and such Affiliates' successors and assigns, but shall be
litigated separately. The provisions of this Section 11 shall survive the
termination of this Agreement.

     11.3 No Running of Covenant During Breach. The covenants set forth in this
Section 11 shall apply for the applicable periods as set forth above. If the
Shareholder violates such covenants, and PainCare, the Surviving Corporation or
any of their successors and assigns or Affiliates bring a legal action for
injunctive or other relief, such party bringing the action shall not, as a
result of the time involved in obtaining the relief, be deprived of the benefit
of the full period of the covenant period, unless a court of competent
jurisdiction holds that the covenant is not enforceable in whole or in part.
Accordingly, for any time period that the Shareholder is in violation of the
covenant, such time period shall not be included in calculating the applicable
time period of the covenant.

     11.4 Blue Pencil Doctrine. The covenants set forth in this Section 11 are
severable and separate, and the unenforceability of any specific covenant shall
not affect the provisions of any other covenant. Moreover, in the event any
court of competent jurisdiction shall determine that the scope, time or
territorial restrictions set forth are unreasonable, then it is the intention of
the parties that such restrictions be enforced to the fullest extent which the
court deems reasonable, and the Agreement shall thereby be reformed.

     11.5 Confidentiality, Press Releases, and Public Announcements.

<PAGE>

     (a)  No Party shall issue any press release or make any public announcement
relating to the subject matter of this Agreement without the prior written
approval of the other Parties.

          (b) The Parties covenant and agree that from and after the Execution
Date, neither of the Parties nor their Affiliates (to the extent any such
Affiliate has received Confidential Information as defined below or Trade
Secrets, as defined below) shall disclose, divulge, furnish or make accessible
to anyone any Confidential Information or Trade Secrets, or in any way use any
Confidential Information or Trade Secrets in the conduct of any business;
provided, however, that nothing in this Section 11.5 will prohibit the
disclosure of any Confidential Information or Trade Secrets which is required to
be disclosed by a Party or any of its or his Affiliates in connection with any
court action or any proceeding before any authority. Notwithstanding the
foregoing, in the case of a disclosure contemplated by this Section 11.5, no
disclosure shall be made until the disclosing Party shall give notice to the
non-disclosing Party of the intention to disclose such Confidential Information
or Trade Secrets so that the non-disclosing Party may contest the need for
disclosure, and the disclosing Party will cooperate (and will cause its or his
Affiliates and their respective representatives to cooperate) with the
non-disclosing in connection with any such proceeding. Notwithstanding any
provision of this Agreement which may be to the contrary, the foregoing
provisions restricting the use of Confidential Information and Trade Secrets
shall survive the Closing for the time period equal to five (5) years from the
Execution Date. For the purpose of this Agreement, the term "Confidential
Information" shall mean all records, files, reports, protocols, policies,
manuals, databases, processes, procedures, computer systems, materials and other
documents pertaining to the operations of a Party and the term "Trade Secrets"
shall mean information, including a formula, pattern, compilation, program,
device, method, technique, or process that: (i) derives independent economic
value, actual or potential, from not being generally known to, and not being
readily ascertainable by proper means by, other persons who can obtain economic
value from its disclosure or use; and (ii) is the subject of efforts that are
reasonable under the circumstances to maintain its secrecy.

     11.6 Conduct of Business. From the date hereof through the Closing, the
Shareholder shall, except as contemplated by this Agreement, or as consented to
by PainCare in writing, cause the Company to be operated in the ordinary course
and in accordance with past practice and will not take any action inconsistent
with this Agreement or with the consummation of the Closing. Without limiting
the generality of the foregoing, the Company shall not, and, with respect to the
Company, the Shareholder shall not, except as specifically contemplated by this
Agreement, as set forth in Section 11.6 of the Disclosure Schedule, or as
consented to by PainCare in writing:

          (a) change or amend the organizational documents of the Company;

<PAGE>

          (b) enter into, extend, materially modify, terminate or renew any
lease or any contract, except modifications, extensions or renewals of contracts
in the ordinary course of business or as contemplated by this Agreement;

          (c) sell, assign, transfer, convey, lease, mortgage, pledge or
otherwise dispose of or encumber any of the assets or any interests therein of
the Company except in the ordinary course of business and, without limiting the
generality of the foregoing, the Company will maintain, dispose of, and sell
inventory consistent with past practices;

          (d) incur any liability for indebtedness for borrowed money, guarantee
the obligations of others, indemnify or agree to indemnify others or, except in
the ordinary course of business, incur any other liability;

          (e) take any action with respect to the grant of any bonus, severance
or termination pay (otherwise than pursuant to policies or agreements of the
Company in effect on the date hereof that are described in the Disclosure
Schedule) or with respect to any increase of benefits payable under its
severance or termination pay policies or agreements in effect on the date hereof
or increase in any manner the compensation or fringe benefits of any employee of
the Company or pay, any benefit not required by any existing Employee Plan or
policy;

          (f) make any change in the key management structure of the Company,
including, without limitation, the hiring of additional officers or the
termination of existing officers;

          (g) adopt, enter into or amend any Employee Plan, agreement
(including, without limitation, any collective bargaining or employment
agreement), trust, fund or other arrangement for the benefit or welfare of any
employee, except for any such amendment as may be required to comply with
applicable regulations;

          (h) fail to maintain all Employee Plans in accordance with applicable
Regulations;

          (i) acquire by merger or consolidation with, or merge or consolidate
with, or purchase substantially all of the assets of, or otherwise acquire any
material assets or business of, any corporation, partnership, association or
other business organization or division thereof or acquire any subsidiary;

          (j) willingly allow or permit to be done any act by which any of the
insurance policies of the Company or Shareholder may be suspended, impaired or
canceled;

          (k) enter into, renew, modify or revise any agreement or transaction
relating to the Company with any of its or their Affiliates except as
contemplated by this Agreement;

<PAGE>

          (l) fail to maintain the assets of the Company in substantially their
current state of repair, excepting normal wear and tear, or fail to replace
(consistent with the Company's past practice) inoperable, worn-out or obsolete
or destroyed assets;

          (m) make any loans or advances relating to the Company to any
partnership, firm, individual, or corporation, except for expenses incurred in
the ordinary course of business consistent with past practice;

          (n) fail to comply in all material respects with all laws and
regulations applicable to the Company;

          (o) intentionally do any other act which would cause any
representation or warranty of the Company or the Shareholder in this Agreement
to be or become untrue, or any covenant in this Agreement to be breached, in any
material respect;

          (p) fail to use reasonable efforts consistent with past business
practice to (i) maintain the Company so that the services of its officers,
employees, consultants and agents will remain available to it on and after the
Closing Date, (ii) maintain existing relationships with suppliers, patients,
customers and others having business dealings with the Company and (iii)
otherwise preserve the goodwill of the business of the Company so that such
relationships and goodwill will be preserved on and after the Closing Date;

          (q) enter into any agreement, or otherwise become obligated, to do any
action prohibited hereunder;

          (r) except as provided herein, declare, set aside for payment, or pay
any dividend or distribution in respect of any capital stock of the Company,
redeem, purchase or otherwise acquire any of the Company's equity securities; or
otherwise transfer any of the assets of the Company to or on behalf of any
Shareholder of the Company or any Affiliate of the Company, including, without
limitation, any payment of principal of or interest on any debt owed to any of
the foregoing or any payment of a bonus, fee or other payment to any of the
foregoing as an employee of the Company; or

          (t) fail to comply with all applicable filing, payment, withholding,
collection and record retention obligations under all applicable federal, state,
local or foreign Tax laws.

     11.7 No Third-Party Beneficiaries. Other than with respect to the
restrictive covenants set forth in Section 11, this Agreement shall not confer
any rights or remedies upon any Person other than the Parties and their
respective successors and permitted assigns.

12.  MISCELLANEOUS.

<PAGE>

     12.1 Entire Agreement. This Agreement (including the documents referred to
herein) constitutes the entire agreement between the Parties and supersedes any
prior understandings, agreements, or representations by or between the Parties,
written or oral, to the extent they related in any way to the subject matter
hereof.

     12.2 Succession and Assignment. This Agreement shall be binding upon and
inure to the benefit of the Parties named herein and their respective
successors, assigns, distributees, heirs, and grantors of any revocable trusts
of a Party hereto. No Party may assign either this Agreement or any of its or
his rights, interests, or obligations hereunder without the prior written
approval of the other Parties; provided, however, PainCare and Subsidiary, may,
without the prior consent of the other Party, assign this Agreement to their
Affiliates.

     12.3 Counterparts. This Agreement may be executed in one or more
counterparts, each of which shall be deemed an original but all of which
together will constitute one and the same instrument.

     12.4 Headings. The section headings contained in this Agreement are
inserted for convenience only and shall not affect in any way the meaning or
interpretation of this Agreement.

     12.5 Notices. All notices, requests, demands, claims, and other
communications hereunder will be in writing. Any notice, request, demand, claim,
or other communication hereunder shall be deemed duly given: (a) upon receipt if
it is sent by facsimile, (b) the next business day if sent by reputable
overnight courier, or (c) five (5) days after mailing if by certified mail
return receipt requested, postage prepaid, and addressed or otherwise sent to
the intended recipient as set forth below:

          If to PainCare
          or Subsidiary:                    PainCare Holdings, Inc.
                                            37 North Orange Avenue
                                            Suite 500
                                            Orlando, Florida  32801
                                            Attention: President

          If to the Shareholder:            John Vick
                                            916 Talon Drive
                                            O'Fallon, Illinois 62269

          If to the Company:                Associated Physicians Group
                                            916 Talon Drive
                                            O'Fallon, Illinois 62269

          With a copy in each case to:      Greensfelder, Hemker & Gale, P.C.

<PAGE>

                         2000 Equitable Building
                         10 South Broadway
                         St. Louis, Missouri  63102
                         Attention: Charles E. H. Luedde

     Any Party may send any notice, request, demand, claim, or other
communication hereunder to the intended recipient at the address or facsimile
number set forth above using any other means (including personal delivery,
messenger service, ordinary mail, or electronic mail), but no such notice,
request, demand, claim, or other communication shall be deemed to have been duly
given unless and until it actually is received by the intended recipient. Any
party may change the address or facsimile number to which notices, requests,
demands, claims, and other communications hereunder are to be delivered by
giving the other Party notice in the manner herein set forth.

     12.6 Governing Law; Jurisdiction; Attorney's Fees. This Agreement, and all
proceedings hereunder, shall be governed by and construed in accordance with the
domestic laws of the State of Illinois without giving effect to any choice or
conflict of law provision or rule (either of the State of Illinois or any other
jurisdiction) that would cause the application of the laws of any jurisdiction
other than the State of Illinois. In the event of any suit under this Agreement
or otherwise between the parties hereto, the prevailing Party shall be entitled
to all reasonable attorney's fees and costs, including allocated costs of
in-house counsel, to be included in any judgment recovered. In addition, the
prevailing Party shall be entitled to recover reasonable attorney's fees and
costs, including allocated costs of in-house counsel, incurred in enforcing any
judgment arising from a suit under this Agreement. This post-judgment attorney's
fees and costs provision shall be severable from the other provisions of this
Agreement and shall survive any judgment on such suit and is not to be deemed
merged into the judgment.

     12.7 Amendments and Waivers. No amendment of any provision of this
Agreement shall be valid unless the same shall be in writing and signed by the
Parties. No waiver by any Party of any default, misrepresentation, or breach of
warranty or covenant hereunder, whether intentional or not, shall be deemed to
extend to any prior or subsequent default, misrepresentation, or breach of
warranty or covenant hereunder or affect in any way any rights arising by virtue
of any prior or subsequent such occurrence and all waivers must be in writing,
signed by the waiving Party, to be effective.

     12.8 Severability. Any term or provision of this Agreement that is invalid
or unenforceable in any situation in any jurisdiction shall not affect the
validity or enforceability of the remaining terms and provisions hereof or the
validity or enforceability of the offending term or provision in any other
situation or in any other jurisdiction.

     12.9 Expenses. Except as set forth herein, Shareholder shall bear and be
responsible and shall pay for all costs and expenses (including, but not limited
to, legal and accounting fees and expenses) incurred by Shareholder, the Company
and the New

<PAGE>

P.C. in connection with this Agreement and the transactions contemplated hereby.
Notwithstanding the foregoing, PainCare will reimburse the Shareholder up to
$20,000 with respect to legal fees incurred by the Shareholder (or the Company
and the New P.C. which he shall be responsible for pursuit to this section) and
the Company shall be solely responsible for the cost of the GAAP Financial
Statements prepared in connection with this Agreement and the transactions
contemplated hereby

     12.10 Further Assurances. Each Party shall, at the reasonable request of
any other Party hereto, execute and deliver to such other Party all such further
instruments, assignments, assurances and other documents, and take such actions
as such other Party may reasonably request in connection with the carrying out
the terms and provisions of this Agreement.

     12.11 Construction. Any reference to any federal, state, local, or foreign
statute or law shall be deemed also to refer to all rules and regulations
promulgated thereunder, unless the context requires otherwise. The word
"including" shall mean including without limitation. Nothing in the Disclosure
Schedule shall be deemed adequate to disclose an exception to a representation
or warranty made herein, unless the Disclosure Schedule identifies the exception
with reasonable particularity. The Parties intend that each representation,
warranty, and covenant contained herein shall have independent significance. If
any Party has breached any representation, warranty, or covenant contained
herein in any respect, the fact that there exists another representation,
warranty, or covenant relating to the same subject matter (regardless of the
relative levels of specificity) which the Party has not breached shall not
detract from nor mitigate the fact that the Party is in breach of the first
representation, warranty, or covenant.

     12.12 Survival. All of the representations, warranties, covenants and
agreements including but not limited to Articles VI and VII made by the Parties
in this Agreement or pursuant hereto in any certificate, instrument or document
shall survive the consummation of the transactions described herein shall
survive for all applicable statute of limitations, and may be fully and
completely relied upon by Sellers and the Acquiring Companies, as the case may
be, notwithstanding any investigation heretofore or hereafter made by any of
them or on behalf of any of them, and shall not be deemed merged into any
instruments or agreements delivered at Closing or thereafter.

     12.13 Incorporation of Exhibits and Schedules. The exhibits and schedules
(including the Disclosure Schedule) identified in this Agreement and the
recitals first set forth above are incorporated herein by reference and made a
part hereof.

     12.14 Submission to Jurisdiction. With respect to any legal proceeding
brought by PainCare which arises out of or relates to this Agreement or the
transactions contemplated hereby, exclusive jurisdiction and venue with respect
to such matter shall lie in any state or federal court within St. Clair County,
IL. With respect to any legal proceeding brought by the Shareholder or the
Company which arises out of or relates to this Agreement or the transactions
contemplated hereby, exclusive jurisdiction and venue

<PAGE>

with respect to such matter shall lie in any state or federal court within
Orange County, FL. Each party to this Agreement hereby irrevocably waives, to
the fullest extent permitted by law, any objections which it may now or
hereafter have to the laying of the venue of any such proceeding brought in such
a court and any claim that any such proceeding brought in such a court has been
brought in an inconvenient forum.

                        [SIGNATURES APPEAR ON NEXT PAGE]

<PAGE>

     IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of
the date first above written.

                                           PAINCARE:

                                           PAINCARE HOLDINGS, INC., a Florida
                                           corporation

                                           By: /s/ Mark Szporka
                                              ------------------------------
                                           Print: Mark Szporka
                                                 ---------------------------
                                           Its: CFO
                                               -----------------------------

                                           ACQUISITION:

                                           PAINCARE ACQUISITION COMPANY V, INC.,
                                           a Florida corporation

                                           By: /s/ Mark Szporka
                                              ----------------------------------
                                           Print: Mark Szporka
                                                 -------------------------------
                                           Its: CFO
                                                --------------------------------

                                           COMPANY:

                                           INDUSTRIAL & SPORT REHABILITATION,
                                           LTD., an Illinois corporation, d/b/a
                                           ASSOCIATED PHYSICIANS GROUP

                                           By: /s/ John Vick
                                              ----------------------------------
                                           Print: John Vick
                                                  ------------------------------
                                           Its: President
                                                --------------------------------

                                           SHAREHOLDER:

                                           /s/ John Vick
                                               ---------------------------------
                                           John Vick<Page>

                                                                    EXHIBIT 4.15

                           [AMENDED FORM OF INDENTURE]

                           --------------------------

                                GRUPO TMM, S.A.,
                                    as Issuer

                           TMM HOLDINGS, S.A. DE C.V.,
                                  as Guarantor

                                       and

                              THE BANK OF NEW YORK,
                                   as Trustee

                                    INDENTURE

                             Dated as of May___, 2003

                            12% Senior Notes Due 2004

                           --------------------------

<Page>

                                Table of Contents

<Table>
<Caption>
                                                                                                      Page
                                                                                                      ----
<S>                                                                                                     <C>
ARTICLE ONE DEFINITIONS AND OTHER PROVISIONS  OF GENERAL APPLICATION.....................................1

   SECTION 1.01  Definitions.............................................................................1
   SECTION 1.02  Compliance Certificates and Opinions...................................................16
   SECTION 1.03  Form of Documents Delivered to Trustee.................................................17
   SECTION 1.04  Notices, Etc., to Trustee and Company..................................................18
   SECTION 1.05  Notice to Holders; Waiver..............................................................18
   SECTION 1.06  Conflict With Trust Indenture Act......................................................19
   SECTION 1.07  Effect of Headings and Table of Contents...............................................19
   SECTION 1.08  Successors and Assigns.................................................................19
   SECTION 1.09  Separability Clause....................................................................19
   SECTION 1.10  Benefits of Indenture..................................................................19
   SECTION 1.11  Governing Law..........................................................................19
   SECTION 1.12  Legal Holidays.........................................................................19
   SECTION 1.13  Appointment of Agent for Service.......................................................20
   SECTION 1.14  Counterpart Originals..................................................................20

ARTICLE TWO NOTE FORMS..................................................................................20

   SECTION 2.01  Forms Generally........................................................................20
   SECTION 2.02  Form of Face of Note...................................................................20
   SECTION 2.03  Form of Reverse of Note................................................................22
   SECTION 2.04  Form of Guarantee......................................................................28
   SECTION 2.05  Form of Trustee's Certificate of Authentication........................................30

ARTICLE THREE THE NOTES.................................................................................30

   SECTION 3.01  Title and Terms........................................................................30
   SECTION 3.02  Denominations; Payment Currency........................................................30
   SECTION 3.03  Execution, Authentication, Delivery and Dating.........................................30
   SECTION 3.04  Temporary Notes........................................................................31
   SECTION 3.05  Registration; Registration of Transfer and Exchange....................................31
   SECTION 3.06  Mutilated, Destroyed, Lost and Stolen Notes............................................32
   SECTION 3.07  Payment of Interest; Interest Rights Preserved.........................................33
   SECTION 3.08  Persons Deemed Owners..................................................................34
   SECTION 3.09  Cancellation...........................................................................34
   SECTION 3.10  Computation of Interest................................................................35

ARTICLE FOUR REDEMPTION OF NOTES........................................................................35

   SECTION 4.01  Right of Redemption....................................................................35
   SECTION 4.02  Applicability of Article...............................................................35
</Table>

<Page>

<Table>
<S>                                                                                                     <C>
   SECTION 4.03  Election to Redeem; Notice to Trustee..................................................35
   SECTION 4.04  Selection by Trustee of Notes to Be Redeemed...........................................36
   SECTION 4.05  Notice of Redemption...................................................................36
   SECTION 4.06  Deposit of Redemption Price............................................................37
   SECTION 4.07  Notes Payable on Redemption Date.......................................................37
   SECTION 4.08  Notes Redeemed in Part.................................................................37
   SECTION 4.09  Optional Redemption Due to Changes in Tax Treatment....................................37

ARTICLE FIVE COVENANTS..................................................................................38

   SECTION 5.01  Payments of Principal, Premium, if any, and Interest...................................38
   SECTION 5.02  Maintenance of Office or Agency........................................................38
   SECTION 5.03  Money for Note Payments to be Held in Trust............................................38
   SECTION 5.04  Existence..............................................................................40
   SECTION 5.05  Maintenance of Properties; Insurance...................................................40
   SECTION 5.06  Payment of Taxes.......................................................................40
   SECTION 5.07  Annual Officers' Certificate to Trustee................................................40
   SECTION 5.08  Reports to be Furnished to Holders.....................................................41
   SECTION 5.09  Further Assurances.....................................................................42
   SECTION 5.10  Company to Furnish Trustee Information as to Names and Addresses of Holders............42
   SECTION 5.11  Waiver of Stay, Extension or Usury Laws................................................42
   SECTION 5.12  Limitation on Restricted Payments......................................................42
   SECTION 5.13  Limitation on Transactions With Affiliates.............................................44
   SECTION 5.14  Limitation on Indebtedness.............................................................44
   SECTION 5.15  Limitation on Dividend and Other Payment Restrictions Affecting Restricted
                 Subsidiaries...........................................................................46
   SECTION 5.16  Change of Control or Receipt of VAT Proceeds...........................................47
   SECTION 5.17  Limitation on Liens....................................................................49
   SECTION 5.18  Restriction on Asset Dispositions......................................................50
   SECTION 5.19  Limitation on Sale and Leaseback Transactions..........................................53
   SECTION 5.20  Limitation on Issuance of Subordinated Indebtedness....................................53
   SECTION 5.21  Limitation on Investments..............................................................53
   SECTION 5.22  [intentionally omitted]................................................................54
   SECTION 5.23  Limitation on Business Activities......................................................55
   SECTION 5.24  Additional Covenants Applicable to the Guarantor and TMM Multimodal....................55
   SECTION 5.25  Payments for Consent...................................................................56
   SECTION 5.26  Covenant Suspension....................................................................56

ARTICLE SIX REMEDIES....................................................................................57

   SECTION 6.01  Events of Default......................................................................57
   SECTION 6.02  Acceleration of Maturity; Rescission and Annulment.....................................59
   SECTION 6.03  Collection of Indebtedness by Trustee; Trustee May Prove Debt..........................59
   SECTION 6.04  Trustee May File Proofs of Claim.......................................................60
   SECTION 6.05  Trustee May Enforce Claims Without Possession of Notes.................................61
</Table>

                                       ii
<Page>

<Table>
<S>                                                                                                     <C>
   SECTION 6.06  Application of Money or Property Collected.............................................61
   SECTION 6.07  Limitation on Suits....................................................................62
   SECTION 6.08  Restoration of Rights and Remedies.....................................................62
   SECTION 6.09  Rights and Remedies Cumulative.........................................................62
   SECTION 6.10  Delay or Omission Not Waiver...........................................................63
   SECTION 6.11  Control by Holders.....................................................................63
   SECTION 6.12  Waiver of Past Defaults................................................................63

ARTICLE SEVEN CONCERNING THE TRUSTEE....................................................................64

   SECTION 7.01  Duties of Trustee......................................................................64
   SECTION 7.02  Certain Rights of Trustee..............................................................65
   SECTION 7.03  Trustee Not Responsible for Recitals, Etc..............................................66
   SECTION 7.04  Trustee and Others May Hold Notes......................................................66
   SECTION 7.05  Moneys Held by Trustee or Paying Agent.................................................67
   SECTION 7.06  Compensation of Trustee and Its Lien...................................................67
   SECTION 7.07  Right of Trustee to Rely on Certificate of Certain Officers............................68
   SECTION 7.08  Persons Eligible for Appointment as Trustee............................................68
   SECTION 7.09  Resignation and Removal of Trustee; Appointment of Successor...........................68
   SECTION 7.10  Acceptance of Appointment by Successor Trustee.........................................69
   SECTION 7.11  Merger, Conversion or Consolidation of Trustee.........................................70
   SECTION 7.12  Authenticating Agents..................................................................70
   SECTION 7.13  Reports by Trustee.....................................................................72
   SECTION 7.14  Trustee Risk...........................................................................72

ARTICLE EIGHT CONCERNING THE HOLDERS....................................................................72

   SECTION 8.01  Evidence of Action Taken by Holders....................................................72
   SECTION 8.02  Proof of Execution of Instruments and of Holding of Notes..............................73
   SECTION 8.03  Right of Revocation of Action Taken....................................................74

ARTICLE NINE HOLDERS' MEETINGS..........................................................................74

   SECTION 9.01  Purposes for Which Holders' Meetings May Be Called.....................................74
   SECTION 9.02  Call of Meetings by Trustee............................................................74
   SECTION 9.03  Company and Holders May Call Meeting...................................................75
   SECTION 9.04  Persons Entitled to Vote at Meeting....................................................75
   SECTION 9.05  Determination of Voting Rights; Conduct and Adjournment of Meeting.....................75
   SECTION 9.06  Counting Votes and Recording Action of Meeting.........................................76

ARTICLE TEN SUPPLEMENTAL INDENTURES.....................................................................76

   SECTION 10.01  Supplemental Indentures without Consent of Holders....................................76
   SECTION 10.02  Supplemental Indentures with Consent of Holders.......................................77
   SECTION 10.03  Execution of Supplemental Indentures..................................................78
   SECTION 10.04  Effect of Supplemental Indentures.....................................................78
   SECTION 10.05  Conformity With Trust Indenture Act...................................................78
</Table>

                                       iii
<Page>

<Table>
<S>                                                                                                     <C>
   SECTION 10.06  Reference in Notes to Supplemental Indentures.........................................78

ARTICLE ELEVEN SUCCESSOR CORPORATION....................................................................78

   SECTION 11.01  When Company May Merge, Etc...........................................................78
   SECTION 11.02  Successor Corporation.................................................................79

ARTICLE TWELVE SATISFACTION AND DISCHARGE OF INDENTURE; UNCLAIMED MONEYS................................80

   SECTION 12.01  Termination of Company's Obligations..................................................80
   SECTION 12.02  Application of Trust Money............................................................82
   SECTION 12.03  Repayment to Company..................................................................82
   SECTION 12.04  Reinstatement.........................................................................82

ARTICLE THIRTEEN IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS........................83

   SECTION 13.01  Personal Immunity from Liability of Incorporators, Stockholders, Etc..................83

ARTICLE FOURTEEN GUARANTEE..............................................................................83

   SECTION 14.01  Guarantee.............................................................................83
   SECTION 14.02  Execution and Delivery of Guarantee...................................................85
   SECTION 14.03  When the Guarantor and TMM Multimodal May Merge, Etc..................................85
   SECTION 14.04  Application of Certain Terms and Provisions to the Guarantor..........................85
</Table>

                                       iv
<Page>

CROSS-REFERENCE TABLE*

<Table>
<Caption>
                                                                      Indenture
TIA Section                                                           Section
--------------------------------------------------------------------  ---------
<S>                                                                   <C>
310(a)(1)                                                             7.08
  (a)(2)                                                              7.08
  (a)(3)                                                              N.A.
  (a)(4)                                                              N.A.
  (a)(5)                                                              7.08
  (b)                                                                 N.A.
  (c)                                                                 N.A.
311(a)                                                                N.A.
  (b)                                                                 N.A.
  (c)                                                                 N.A.
312(a)                                                                5.10
  (b)                                                                 N.A.
  (c)                                                                 N.A.
313(a)                                                                7.13
  (b)                                                                 N.A.
  (c)                                                                 7.13
  (d)                                                                 5.08
314(a)                                                                N.A.
  (b)                                                                 N.A.
  (c)                                                                 1.02
  (d)                                                                 N.A.
  (e)                                                                 1.02
  (f)                                                                 N.A.
315(a)                                                                7.01, 7.02, 7.07
  (b)                                                                 N.A.
  (c)                                                                 7.01(a)
  (d)                                                                 7.01(c)
  (e)                                                                 N.A.
316(a)                                                                6.02, 6.11, 6.12
  (b)                                                                 N.A.
  (c)                                                                 8.02
317(a)                                                                6.04, 6.05
  (b)                                                                 7.05
318(a)                                                                1.06
  (b)                                                                 N.A.
  (c)                                                                 N.A.
</Table>

----------
  N.A. means not applicable
  *This Cross-Reference table shall not, for any purpose, be deemed to be part
   of the Indenture

                                        v
<Page>

          INDENTURE, dated as of May __, 2003, by and between GRUPO TMM,
S.A., a corporation duly organized and existing under the laws of the United
Mexican States (herein called the "Company"), having its principal business
office at Avenida de la Cuspide, No. 4755, Colonia Parques del Pedregal, 14010
Mexico, D.F., TMM HOLDINGS, S.A. DE C.V., a corporation duly organized and
existing under the laws of the United Mexican States (herein called the
"Guarantor"), having its principal business office at Avenida de la Cuspide, No.
4755, Colonia Parques del Pedregal, 14010 Mexico and THE BANK OF NEW YORK, a New
York banking corporation, as Trustee (herein called the "Trustee"), having its
principal trust office at 101 Barclay Street, New York, New York 10286,
Attention: Corporate Trust Administration.

          Each party agrees as follows for the benefit of each other and for the
equal and ratable benefit of the Holders of the Company's 12% Senior Notes due
2004 (the "Notes"):

                                   ARTICLE ONE

             DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION

          SECTION 1.01 DEFINITIONS. For all purposes of this Indenture, except
as otherwise expressly provided or unless the context otherwise requires:

          (1)     the terms defined in this Article have the meanings assigned
to them in this Article and include the plural as well as the singular;

          (2)     all other terms used herein which are defined in the Trust
Indenture Act of 1939, as amended, either directly or by reference therein, have
the meanings assigned to them therein;

          (3)     all accounting terms not otherwise defined herein have the
meanings assigned to them in accordance with IAS (as hereinafter defined); and

          (4)     the words "herein," "hereof" and "hereunder" and other words
of similar import refer to this Indenture as a whole and not to any particular
Article, Section or other subdivision.

          "ACQUIRED INDEBTEDNESS" means Indebtedness of a Person existing at the
time such Person becomes a Restricted Subsidiary or assumed in connection with
the acquisition of assets from such Person and not incurred in connection with,
or in contemplation of, such Person becoming a Restricted Subsidiary or such
acquisition.

          "ADDITIONAL LIENS" shall have the meaning assigned to such term in
Section 5.17.

          "AFFILIATE" of any specified Person means any other Person directly or
indirectly controlling or controlled by or under direct or indirect common
control with such specified Person. For the purposes of this definition,
"control" when used with

<Page>

respect to any specified Person means the power to direct the management and
policies of such Person, directly or indirectly, whether through the ownership
of voting securities, by contract or otherwise; and the terms "controlling" and
"controlled" have meanings correlative to the foregoing.

          "AFFILIATE TRANSACTION" shall have the meaning assigned to such term
in Section 5.13.

          "ASSET DISPOSITION" means any sale, lease, conveyance, transfer or
other disposition (or series of related sales, leases, conveyances, transfers or
dispositions) of any Capital Stock of a Restricted Subsidiary of the Company
(whether or not upon issuance), property or other assets (each referred to for
the purposes of this definition as a "disposition") by the Company or any of its
Restricted Subsidiaries, whether for cash or other consideration, other than (i)
a disposition by a Wholly Owned Subsidiary of the Company to the Company or
another Wholly Owned Subsidiary of the Company, (ii) a disposition by the
Company to a Wholly Owned Subsidiary of the Company, (iii) the disposition in
any single transaction or series of transactions of any assets or Capital Stock
or other ownership interest by the Company or its Restricted Subsidiaries if the
gross proceeds thereof (exclusive of indemnities) do not exceed $10 million
(such proceeds, to the extent not in cash, to be determined in good faith by the
Board of Directors) in any 12-month period, (iv) an exchange of assets, PROVIDED
the assets received are to be used in the lines of business engaged in by the
Company or any of its Restricted Subsidiaries on the Initial Issuance Date or
reasonably related extensions of such lines of business, (v) a Qualifying
Disposition or a disposition that is governed by Article Eleven, (vi) a
disposition of assets in one or a series of related transactions which are no
longer used or, in the reasonable opinion of the Company (which, in the case of
each disposition for gross proceeds in excess of $2 million will be evidenced by
a Board Resolution as set forth in an Officers' Certificate delivered to the
Trustee) useful in the business of the Company or any Restricted Subsidiary or
(vii) a disposition pursuant to a Qualifying PEMEX Securitization Transaction.

          "ASSOCIATE" has the meaning assigned to such term in Rule 12b-2 of the
rules and regulations of the Commission promulgated under the Exchange Act.

          "ATTRIBUTABLE DEBT" means, with respect to a sale and leaseback
transaction, as at the time of determination, the greater of (a) the fair market
value of the property subject to such sale and leaseback transaction (as set
forth in a Board Resolution) and (b) the present value (discounted at the
interest rate borne by the Notes, compounded annually) of the total obligations
of the lessee for rental payments during the remaining term of the lease
included in such sale and leaseback transaction (including any period for which
such lease has been extended).

          "AUTHENTICATING AGENT" means any agent of the Trustee which at any
time shall be appointed and acting pursuant to the provisions of Section 7.12.

          "AVERAGE LIFE" means as of the date of determination, with respect to
any debt security, the quotient obtained by dividing (i) the sum of the products
of the number

                                        2
<Page>

of years from the date of determination to the dates of each successive
scheduled principal payment of such debt security multiplied by the amount of
such principal payment by (ii) the sum of all such principal payments.

          "BANKRUPTCY LAW" shall have the meaning assigned to such term in
Section 6.01(8).

          "BENEFITED PARTY" shall have the meaning assigned to such term in
Section 14.01.

          "BOARD OF DIRECTORS" means the Board of Directors of any Person, or
any duly authorized committee of such Board or any officers of such Person duly
authorized so to act by such Board, provided that if the transaction giving rise
to the need for action by the Board of Directors of such Person, together with
any related transactions, involve aggregate value or consideration in excess of
$10 million, "Board of Directors" means the entire Board of Directors of such
Person and not a committee of such Person or an officer of such Board; provided,
further, that any action required to be taken by the Board of Directors of the
Company or any of its Restricted Subsidiaries with respect to the sale or sale
and leaseback of any individual vessel may be taken by the Executive Committee
of such Board of Directors.

          "BOARD RESOLUTION" means a copy of a resolution or resolutions
certified by the Secretary or an Assistant Secretary of any Person to have been
duly adopted by the Board of Directors, or by the Executive Committee of the
Board of Directors or any other committee of such Person to the extent that such
other committee has been authorized by the Board of Directors to adopt a "Board
Resolution" for purposes hereof, and to be in full force and effect on the date
of such certification, or a certificate executed by officers of such Person to
the extent that such officers have been authorized to act for purposes hereof
setting forth the action taken by such officers and stating that the officers
are duly authorized to take such action, in each case as filed with the
corporate records of such Person.

          "BUSINESS DAY" means each Monday, Tuesday, Wednesday, Thursday and
Friday which is not a day on which banking institutions in New York, New York
are authorized or obligated by or pursuant to law, regulation or executive order
to close.

          "CAPITAL STOCK" of any Person means any and all shares, interests,
participations or other equivalents (however designated) of such Person's
capital stock and warrants, options and similar rights to acquire such capital
stock (other than debt securities convertible into or exchangeable for such
capital stock).

          "CAPITALIZED LEASE OBLIGATION" of any Person means any obligation of
such Person to pay rent or other amounts under a lease of (or other agreement
conveying the right to use) real or personal property that is required to be
classified and accounted for as a capital lease obligation on a balance sheet of
such Person under IAS and, for purposes of this Indenture, the amount of such
obligation at any date shall be the capitalized amount thereof at such date,
determined in accordance with IAS. For

                                        3
<Page>

purposes of this definition, with respect to the Company, "Person" shall mean
the Company or any Restricted Subsidiary, as the case may be.

          "CASH EQUIVALENTS" means (i) any evidence of indebtedness, maturing
not more than one year after the date of purchase, issued or fully guaranteed or
insured by the United Mexican States, the United States of America, or an
instrumentality or agency thereof, (ii) any certificate of deposit, Eurodollar
time deposit, overnight bank deposit or bankers acceptance maturing not more
than one year after the date of purchase, issued by, or time deposit of, a
commercial banking institution which has combined capital and surplus and
undivided profits of not less than $100,000,000, (iii) commercial paper,
maturing not more than 180 days after the date of purchase, issued by a
corporation (other than an Affiliate of the Company) organized and existing
under the laws of the United Mexican States or the United States of America or
any State thereof or the District of Columbia which is rated, at the time as of
which any investment therein is made, "P-1" (or higher) by Moody's or "Al" (or
higher) by Standard & Poor's, (iv) money market funds and (v) deposits with
financial institutions available for withdrawal on demand.

          "CHANGE OF CONTROL" shall have the meaning assigned to such term in
Section 5.16.

          "CHANGE OF CONTROL REPURCHASE DATE" shall have the meaning assigned
to such term in Section 5.16.

          "COMMISSION" means the Securities and Exchange Commission, as from
time to time constituted, created under the Exchange Act or, if at any time
after the execution of this instrument such Commission is not existing and
performing the duties now assigned to it under the Trust Indenture Act, then the
body performing such duties at such time.

          "COMPANY" means the Person named as the "Company" in the first
paragraph of this Indenture and its successors and assigns.

          "COMPANY REQUEST" or "COMPANY ORDER" means a written request or order
signed in the name of the Company by its Chief Executive Officer, its Director
General, its Chief Operating Officer, or its Chief Financial Officer, and by its
Director of Administration, its Treasurer or any other duly authorized officer,
and delivered to the Trustee.

          "CONSOLIDATED AMORTIZATION EXPENSE" of any Person means, for any
period, the amortization expense of such Person and its Subsidiaries, determined
on a consolidated basis for such period in accordance with IAS. In applying this
definition to the Company, "Person" shall mean the Company, and "Subsidiaries"
shall mean Restricted Subsidiaries.

          "CONSOLIDATED CASH FLOW AVAILABLE FOR INTEREST EXPENSE" of any Person
means, for any period, the sum (without duplication) of the amounts for such
period of (i) Consolidated Net Income, (ii) Consolidated Interest Expense, (iii)
Consolidated Income Tax Expense, (iv) Consolidated Depreciation Expense, (v)
Consolidated Amortization Expense and (vi) other non-cash items reducing
Consolidated Net Income, all as determined on a consolidated basis for such
Person and its

                                        4
<Page>

Subsidiaries for such period in accordance with IAS. For purposes of this
definition, with respect to the Company, "Person" shall mean the Company, and
"Subsidiaries" shall mean Restricted Subsidiaries.

          "CONSOLIDATED DEBT SERVICE COVERAGE RATIO" of any Person means the
ratio of (i) the aggregate amount of Consolidated Cash Flow Available for
Interest Expense of such Person for the four full fiscal quarters for which
financial information in respect thereof is available immediately prior to the
date of the transaction giving rise to the need to calculate the Consolidated
Debt Service Coverage Ratio (the "TRANSACTION DATE") to (ii) the aggregate
Consolidated Interest Expense of such Person for the fiscal quarter in which the
Transaction Date occurs and to be accrued during the three fiscal quarters
immediately subsequent to such fiscal quarter (based upon the pro forma amount
of Indebtedness of such Person and its consolidated Subsidiaries expected by
such Person to be outstanding on the Transaction Date); provided that in making
the calculation of Consolidated Interest Expense for purposes of this clause
(ii), interest on any Indebtedness (whether existing or being incurred) bearing
a floating interest rate shall be computed as if the rate in effect on the date
of computation had been the applicable rate for the entire period unless such
Person is a party to an Interest Swap Obligation which has the effect of
reducing the rate below the rate on the date of computation, in which case such
lower rate shall be used. For purposes of the first sentence of this definition,
"Consolidated Cash Flow Available for Interest Expense" and "Consolidated
Interest Expense" shall be calculated after giving effect on a pro forma basis
for the period of such calculation to (i) the incurrence of any Indebtedness of
such Person or any Subsidiary of such Person during the period commencing on the
first day of the four full fiscal quarters immediately preceding the Transaction
Date for which financial information in respect thereof is available to and
including the Transaction Date (the "REFERENCE PERIOD"), (ii) the repayment of
any Indebtedness of such Person or a Subsidiary of such Person during the
Reference Period with the proceeds of any Indebtedness referred to in the
immediately preceding clause (i) or the proceeds from the sale or other
disposition of assets referred to in clause (iv) below, (iii) the acquisition by
such Person or any Subsidiary of such Person during the Reference Period of any
other Person which, as a result of such acquisition, becomes a Subsidiary of
such Person or the acquisition of assets during the Reference Period from any
Person which constitutes all or substantially all of an operating unit or
business of such Person and (iv) any sale or other disposition of assets or
properties outside the ordinary course of business by such Person occurring
during the Reference Period, as if such incurrence, repayment, acquisition, sale
or disposition occurred on the first day of the Reference Period. In addition,
for purposes of this definition, (x) the Consolidated Debt Service Coverage
Ratio of the Company shall be calculated on a pro forma basis without giving
effect to assets or liabilities or results of operations of Grupo Servia prior
to the effective date of the Merger; (y) with respect to the Company, "Person"
shall mean the Company; and (z) "Subsidiary" shall mean a Subsidiary other than
Grupo TFM and its consolidated subsidiaries.

          "CONSOLIDATED DEPRECIATION EXPENSE" of any Person means, for any
period, the depreciation and depletion expense of such Person and its
Subsidiaries, determined on a consolidated basis for such period in accordance
with IAS. For purposes

                                        5
<Page>

of this definition, with respect to the Company, "Person" shall mean the
Company, and "Subsidiaries" shall mean Restricted Subsidiaries.

          "CONSOLIDATED INCOME TAX EXPENSE" of any Person means, for any period,
the aggregate of the income tax expense of such Person and its Subsidiaries,
determined on a consolidated basis for such period in accordance with IAS. For
purposes of this definition, with respect to the Company, "Person" shall mean
the Company, and "Subsidiaries" shall mean Restricted Subsidiaries.

          "CONSOLIDATED INTEREST EXPENSE" of any Person means, for any period,
the aggregate of (a) the interest expense of such Person and its Subsidiaries
(including, without limitation, amortization of the issuance cost of any
Indebtedness other than the Notes, original issue cost of any Indebtedness other
than the Notes, original issue discount on any Indebtedness, the interest
portion of any deferred payment obligation in accordance with the effective
interest method of accounting, all commissions, discounts and other fees and
charges owed with respect to letters of credit and bankers' acceptance
financings and the net cost associated with Interest Swap Obligations to the
extent attributed to such period), and (b) the interest expense of such Person
and its Subsidiaries with respect to guaranteed Indebtedness (to the extent not
included in clause (a) above), all as determined on a consolidated basis for
such period in accordance with IAS. In applying this definition to the Company,
"Person" shall mean the Company, and "Subsidiaries" shall mean Restricted
Subsidiaries.

          "CONSOLIDATED NET INCOME" of a Person means, for any period, the
aggregate of the net income or loss of such Person and its Subsidiaries for such
period, determined on a consolidated basis in accordance with IAS, provided that
(i) the net income (or loss) of any person which is not a Subsidiary of such
Person or which is accounted for by the equity method of accounting, shall be
included only to the extent of the amount of cash dividends or distributions
paid by such person or its consolidated subsidiaries to such Person in such
period, (ii) the net income (or loss) of any Subsidiary that is subject to any
restriction or limitation on the payment of dividends and other distributions
(including loans or advances) by operation of the terms of its charter or by
agreement, instrument, judgment, decree, order or governmental regulation
applicable to the Subsidiary shall be excluded to the extent of such restriction
or limitation in such period, (iii) the net income (or loss) of any person
acquired in a pooling of interests transaction for any period prior to the date
of such acquisition shall be excluded, (iv) any cash gains or losses
attributable to dispositions of capital assets shall be included, including
provisions for any such dispositions, and any non-cash extraordinary items shall
be excluded, and (v) the net income (or loss) from discontinued operations shall
be excluded. For purposes of calculating "Consolidated Net Income" of the
Company for any period, each reference in the foregoing definition to a
"Subsidiary" or "Subsidiaries" shall be deemed a reference to a Subsidiary other
than Grupo TFM and its consolidated subsidiaries.

          "CONSOLIDATED NET WORTH" means, with respect to any Person, as at any
date of determination, consolidated stockholders' equity of such Person and its
Subsidiaries determined on a consolidated basis in accordance with IAS, but
excluding

                                        6
<Page>

(to the extent not already excluded from such stockholders' equity) any amounts
attributable to Disqualified Stock of such Person. For purposes of this
definition, with respect to the Company, "Person" shall mean the Company, and
"Subsidiaries" shall mean Restricted Subsidiaries.

          "CONSOLIDATION" means, with respect to any Person, the consolidation
of the accounts of such Person and each of its Subsidiaries if and to the extent
that the accounts of such Person and each of its Subsidiaries would normally be
consolidated, all in accordance with IAS. The term "consolidated" shall have a
similar meaning.

          "CORPORATE TRUST OFFICE" means the principal office of the Trustee at
which at any particular time its corporate trust business shall be principally
administered, which office as of the date of execution of this Indenture is 111
Wall Street, 14th Floor, Zone 3, New York, New York 10005, Attention: Corporate
Agency and Trust.

          "CPO TRUSTEE" means the Trustee with respect to the Company's
outstanding certificados de participacion ordinarios (CPOs).

          "CURRENCY AGREEMENT" means any foreign exchange contract, currency
swap agreement or other similar agreement or arrangement.

          "DEFAULT" means any event which is, or after notice or passage of time
would be, an Event of Default.

          "DEFAULTED INTEREST" shall have the meaning specified in Section 3.07.

          "DISQUALIFIED STOCK" of any Person means any Capital Stock of such
Person that, by its terms (or by the terms of any security into which it is
convertible or for which it is exercisable, redeemable or exchangeable),
matures, or is mandatorily redeemable, pursuant to a sinking fund obligation or
otherwise, or is redeemable at the option of the holder thereof, in whole or in
part, on or prior to the stated final maturity of the Notes, except to the
extent that such Capital Stock is solely redeemable with, or solely exchangeable
for any Capital Stock of such Person that is not Disqualified Stock.

          "EVENT OF DEFAULT" shall have the meaning assigned to such term in
Section 6.01.

          "EXCESS PROCEEDS" shall have the meaning assigned to such term in
Section 5.18(b).

          "EXCHANGE ACT" means the Securities Exchange Act of 1934, as amended.

          "EXISTING LIENS" shall have the meaning assigned to such term in
Section 5.17.

          "GROUP" shall have the meaning assigned to such term in Section 5.16.

                                        7
<Page>

          "GRUPO SERVIA" means Grupo Servia, S.A. de C.V., a corporation
organized under the laws of the United Mexican States.

          "GRUPO TFM" means Grupo Transportacion Ferroviaria Mexicana, S.A. de
C.V., a corporation organized under the laws of the United Mexican States.

          "GUARANTEE" means, as applied to any Indebtedness, (i) a guarantee
(other than by endorsement of negotiating instruments for collection in the
ordinary course of business), direct or indirect, in any manner, of any part or
all of such Indebtedness or (ii) an agreement, direct or indirect, contingent or
otherwise, providing assurance of the payment or performance (or payment of
damages in the event of non-performance) of any part or all of such
Indebtedness, including, without limiting the foregoing, the payment of amounts
drawn down by letters of credit. Notwithstanding anything herein to the
contrary, a guarantee shall not include any agreement solely because such
agreement creates a Lien on the assets of any Person or any agreement providing
for indemnification. The amount of a guarantee shall be deemed to be the maximum
amount of the Indebtedness guaranteed for which the guarantor could be held
liable under such guarantee. When used with respect to the Notes, a "Guarantee"
means the guarantee by the Guarantor of all or any part of the Notes, in
accordance with Article Fourteen.

          "GUARANTEE OBLIGATIONS" shall have the meaning assigned to such term
in Section 14.01.

          "GUARANTOR" means the Person named as the "Guarantor" in the first
paragraph of this Indenture and its successors and assigns.

          "HOLDER" means a Person in whose name a Note is registered in the Note
Register.

          "IAS" means accounting principles issued by the International
Accounting Standards Committee as in effect from time to time; provided that
with respect to the obligations of the Company under Articles Five and Eleven,
"IAS" means accounting principles issued by the International Accounting
Standards Committee as in effect on the date of this Indenture, in each case, as
consistently applied by the Company.

          "INCURRENCE" shall have the meaning assigned to such term in Section
5.14(a).

          "INDEBTEDNESS" with respect to any Person means (without duplication)
any liability, whether or not contingent, (i) in respect of borrowed money
(whether or not the recourse of the lender is to the whole of the assets of such
Person or only to a portion thereof) or evidenced by bonds, notes, debentures or
similar instruments, or (ii) representing the balance deferred and unpaid of the
purchase price of any property, conditional sales obligations and obligations
under any title retention agreement (but excluding trade account payables and
other accrued current liabilities arising in the ordinary course of business),
and shall also include (without duplication) (a) any Capitalized Lease
Obligations, (b) the maximum fixed repurchase price of any Disqualified Stock of
such Person, (c) obligations of others secured by a Lien to which

                                        8
<Page>

any property or asset, including leasehold interests under Capitalized Lease
Obligations and any other tangible or intangible property rights, owned or held
by such Person is subject, whether or not the obligation secured thereby shall
have been assumed (provided that, if the obligations have not been assumed, such
obligations shall be deemed to be in an amount equal to the fair market value of
the property or properties to which the Lien relates, as determined in good
faith by the Board of Directors of such Person and as evidenced by a Board
Resolution), (d) reimbursement obligations in respect of letters of credit
(other than letters of credit issued for the benefit of trade creditors in the
ordinary course of business of such Person in connection with obtaining goods,
materials or services) and (e) guarantees with respect to the foregoing items
(regardless of whether the foregoing items would appear as a liability on a
balance sheet of such Person prepared on a consolidated basis in accordance with
IAS); provided that, for the purpose of computing the amount of Indebtedness of
such Person outstanding at any time, such items shall be excluded to the extent
that they would be eliminated as intercompany items for purposes of such
Person's consolidated financial statements. For purposes of the preceding
sentence, the "maximum fixed repurchase price" of any Disqualified Stock which
does not have a fixed repurchase price shall be calculated in accordance with
the terms of such Disqualified Stock as if such Disqualified Stock were
purchased on any date on which Indebtedness shall be required to be determined
pursuant to this Indenture, and if such price is based upon, or measured by, the
fair market value of such Disqualified Stock (or any equity security for which
it may be exchanged or converted), such fair market value shall be determined in
good faith by the Board of Directors of such Person and evidenced by a Board
Resolution. Notwithstanding anything in this definition to the contrary,
"Indebtedness" shall not include (i) customer advance payments and customer
deposits received by the Company or any Restricted Subsidiary in the ordinary
course of business or (ii) revenue and costs of voyages in process. For purposes
of this definition, with respect to the Company, "Person" shall mean the
Company, and "Subsidiary" shall mean a Restricted Subsidiary. For the avoidance
of doubt, the obligations of the Company and its Restricted Subsidiaries under
the agreements entered into in connection with the Receivables Securitization
Facility shall not be considered to be "Indebtedness" for purposes of this
Indenture.

          "INDENTURE" means this instrument as originally executed or as it may
from time to time be supplemented or amended by one or more indentures
supplemental hereto entered into pursuant to the applicable provisions hereof.

          "INITIAL ISSUANCE DATE" means __________, 1993.

          "INTEREST PAYMENT DATE" means the Stated Maturity of the Notes.

          "INTEREST RATE AGREEMENT" means any interest rate protection
agreement, interest rate future agreement, interest rate option agreement,
interest rate swap agreement, interest rate cap agreement, interest rate collar
agreement, interest rate hedge agreement, option or future contract or other
similar agreement or arrangement.

                                        9
<Page>

          "INTEREST SWAP OBLIGATIONS" means, with respect to any Person, the
obligations of such Person pursuant to any arrangement with any other Person
whereby, directly or indirectly, such Person is entitled to receive from time to
time periodic payments calculated by applying either a floating or a fixed rate
of interest on a stated notional amount in exchange for periodic payments made
by such Person calculated by applying a fixed or a floating rate of interest on
the same notional amount and shall also include, without limitation, interest
rate exchange, collar, cap, ceiling rate or similar agreements providing
interest rate protection.

          "INVESTMENT" means any direct or indirect advance, loan or other
extension of credit or capital contribution to (by means of any transfer of cash
or other property (other than Capital Stock of the Company which is not
Disqualified Stock) to others or any payment for property or services for the
account or use of others), or any purchase or acquisition of Capital Stock,
bonds, notes, debentures or other securities issued by any other Person.

          "INVESTMENT GRADE RATING" means a rating equal to or higher than BBB-
(or the equivalent at the time) from Standard & Poor's and Baa3 (or the
equivalent at the time) by Moody's.

          "LIEN" means any lien, mortgage, pledge, assignment (including any
assignment of rights to receive payments of money), security interest, charge or
encumbrance of any kind (including any conditional sale or other title retention
agreement or any lease in the nature thereof), and any agreement to give a lien,
mortgage, pledge, assignment (including any assignment of rights to receive
payments of money), security interest, charge or other encumbrance of any kind.
For the avoidance of doubt, the arrangements entered into by the Company and its
Restricted Subsidiaries under the [Amended and Restated Option Agreement], dated
as of October [  ], 2002, or any other similar arrangements that are hereafter
entered into relating to the same or other assets of the Company or its
Restricted Subsidiaries, in each case with respect to the Receivables
Securitization Facility shall not be considered to be a "Lien" for purposes of
this Indenture.

          "MAJOR ASSET SALE" means the TFM Sale, the Port Sale and any other
Asset Disposition where the assets disposed of consist of (i) any Capital Stock
of a Restricted Subsidiary, (ii) any securities received in any Qualified
Disposition, or (iii) all or any substantial portion of the assets of any
Restricted Subsidiary. For purposes of this definition of Major Asset Sale, the
provision of clauses (iii) and (v) of the definition of Asset Disposition shall
not apply.

          "MANAGEMENT AGREEMENT" means the professional services agreement
between the Company and Grupo Servia dated as of January 1, 1991, as amended by
a Convenio Modificatorio, dated as of January 1, 1996, and by a Convenio de
Adhesion, dated February 1, 1999, and as further amended by a Convenio
Suplementario, dated December 21, 2000.

          "MATURITY", when used with respect to any Note, means the date on
which the principal (or a portion thereof) of such Note becomes due and payable
as therein or herein provided, whether at Stated Maturity or by declaration of
acceleration, call for redemption or otherwise.

          "MEASUREMENT DATE" shall have the meaning assigned to such term in
Section 5.22(c).

                                       10
<Page>

          "MERGER" means the merger on December 27, 2001 of Transportacion
Maritima Mexicana, S.A. de C.V. with and into Grupo Servia, S.A. de C.V., and
the change of the name of the surviving entity to Grupo TMM, S.A. de C.V.

          "MOODY'S" means Moody's Investors Service, Inc. or any successor
thereto.

          "NET CASH PROCEEDS" means cash payments in U.S. dollars or a currency
freely convertible into U.S. dollars received by the Company or any of its
Restricted Subsidiaries (including any cash payments received by way of deferred
payment of principal pursuant to a note or installment receivable or otherwise
or amounts eliminated from any reserve referred to in clause (v) below, but only
as and when received or eliminated) from any Asset Disposition (after repayment
of any Indebtedness due by reason of such Asset Disposition) made by the Company
or such Restricted Subsidiaries after the Initial Issuance Date, in each case
net of the amount of (i) brokers' and advisors' fees and commissions payable in
connection with such Asset Disposition, (ii) all foreign, Federal, state and
local taxes payable as a direct consequence of such Asset Disposition, including
in connection with the payment of a dividend, or the making of a distribution,
by a Restricted Subsidiary of the Company of such cash payments to the Company
or any Restricted Subsidiary of the Company (including, without limitation,
taxes withheld in connection with repatriation of such proceeds), net of any tax
benefits derived in respect of such dividend or distribution, (iii) the fees and
expenses attributable to such Asset Disposition to the extent not included in
clause (i), except to the extent payable to any Affiliate of the Company, (iv)
any amount required to be paid to any Person (other than the Company or any of
its Restricted Subsidiaries) owning a beneficial interest in the property or
assets sold, and (v) deduction of appropriate amounts to be provided by the
Company or its Restricted Subsidiaries as a reserve, in accordance with IAS,
against any liabilities retained by the Company or any Restricted Subsidiary of
the Company associated with such assets after such Asset Disposition, including,
without limitation, any indemnification or purchase price adjustment associated
with such Asset Disposition. For purposes of the foregoing, Net Cash Proceeds
shall be deemed to include awards of compensation for any asset or property or
group thereof taken by condemnation or eminent domain and insurance proceeds for
the loss of or damage to any asset or property if such awards or proceeds equal
or exceed $500,000 (per occurrence) and within 180 days after the receipt
thereof such asset or property has not been replaced or repair or construction
has not commenced, provided that if, at any time such repair or construction is
abandoned or otherwise discontinued prior to completion or is not diligently
pursued, such remaining awards or proceeds, as the case may be, shall constitute
Net Cash proceeds at such time.

          "NET CASH PROCEEDS OFFER" shall have the meaning assigned to such term
in Section 5.18(b).

          "NET CASH PROCEEDS OFFER AMOUNT" shall have the meaning assigned to
such term in Section 5.18(b).

                                       11
<Page>

          "NET CASH PROCEEDS PURCHASE DATE" shall have the meaning assigned to
such term in Section 5.18(b).

          "NOTE REGISTER" and "NOTE REGISTRAR" shall have the respective
meanings specified in Section 3.05.

          "NOTES" shall have the meaning assigned to such term in the recitals
above.

          "OFFER" shall have the meaning assigned to such term in Section 5.16.

          "OFFICERS' CERTIFICATE" means a certificate signed by the Chairman of
the Board of Directors, a Vice Chairman of the Board of Directors, the
President, or any Vice President, and the Treasurer, the Secretary or any
Assistant Treasurer or Assistant Secretary, of the Company, and delivered to the
Trustee. Each such Officers' Certificate shall comply with Section 1.02.

          "OPINION OF COUNSEL" means a written opinion of counsel, who may be
counsel for or an employee of the Company, which is acceptable in form and
substance to the Trustee. Each Opinion of Counsel shall comply with Section
1.02.

          "OUTSTANDING", when used with reference to Notes means, as of the date
of determination, all Notes authenticated and delivered by the Trustee under
this Indenture, except

          (a)     Notes theretofore canceled by the Trustee or delivered to the
Trustee for cancellation;

          (b)     Notes or portions thereof for the payment or redemption of
which moneys shall have been deposited in trust with the Trustee, provided that
if such Notes are to be redeemed, notice of such redemption shall have been
given pursuant to this Indenture, or provision satisfactory to the Trustee has
been made; and

          (c)     Notes in lieu of or in substitution for which other Notes
shall have been authenticated and delivered pursuant to Section 3.06;

PROVIDED, HOWEVER, that in determining whether the Holders of the requisite
principal amount of the Outstanding Notes have given any request, demand,
authorization, direction, notice, consent or waiver hereunder, Notes owned by
the Company or any other obligor upon the Notes or any Affiliate of the Company
or of such other obligor shall be disregarded and deemed not to be Outstanding,
except that, in determining whether the Trustee shall be protected in relying
upon any such request, demand, authorization, direction, notice, consent or
waiver, only Notes which the Trustee knows to be so owned shall be so
disregarded. Notes so owned which have been pledged in good faith may be
regarded as Outstanding if the pledgee establishes to the satisfaction of the
Trustee the pledgee's right so to act with respect to such Notes and that the
pledgee is not the Company or any other obligor upon the Notes or any Affiliate
of the Company or of such other obligor.

                                       12
<Page>

          "PAYING AGENT" means any Person authorized by the Company to pay the
principal of, premium, if any, and interest on the Notes on behalf of the
Company.

          "PERSON" or "PERSON" means any individual, corporation, partnership,
joint venture, trust, unincorporated organization or a government or any agency
or political subdivision thereof.

          "PLACE OF PAYMENT" means the principal office of the Trustee and such
other place or places where the principal of, premium, if any, and interest on
the Notes are payable.

          "PORT SALE" means a transaction through which the Company sells its
interest in its ports and terminals division to an affiliate of Stevedoring
Services of America, Inc. ("SSA").

          "PREDECESSOR NOTE" of any particular Note means every previous Note
evidencing all or a portion of the same debt as that evidenced by such
particular Note; and, for the purposes of this definition, any Note
authenticated and delivered under Section 3.06 in exchange for or in lieu of a
mutilated, destroyed, lost or stolen Note shall be deemed to evidence the same
debt as the mutilated, destroyed, lost or stolen Note.

          "PURCHASE MONEY LIENS" shall have the meaning assigned to such term in
Section 5.17.

          "QUALIFYING DISPOSITION" means any (i) sale, conveyance, transfer or
other disposition (or series of related sales, conveyances, transfers or other
dispositions) of the Capital Stock of TMM Multimodal or Grupo TFM (or any
successor of either of them) or (ii) any merger or consolidation with or of TMM
Multimodal or Grupo TFM (or any successor of either of them) where:

          (1)     the Company and the Guarantor receive an opinion from an
independent investment banking firm of national standing in Mexico and the
United States to the effect that the consideration to be received in connection
with such transaction is fair, from a financial point of view, to TMM Multimodal
or the Guarantor, as the case may be;

          (2)     the consideration to be received in connection with the
transaction will be cash, securities or a combination thereof;

          (3)     any securities received in such transaction are issued by an
entity that is eligible to register securities on Form F-3 or Form S-3 under the
Securities Act and such securities so received are either (x) freely
transferable under the Securities Act or (y) entitled to the benefits of a
registration rights agreement pursuant to which the issuer of such securities is
required to effect a registration under the Securities Act of the shares
received in such transaction not later than six months after the closing of the
transaction (subject to customary blackout, hold-back and other similar
provisions);

          (4)     if equity securities of any entity constitute a portion of the
consideration received in connection with the transaction and following the
transaction the Company directly and indirectly owns a majority of the voting
interests or economic interests in such entity, such entity shall expressly
assume, by written agreement executed

                                       13
<Page>

and delivered to the Trustee in form satisfactory to the Trustee, TMM
Multimodal's agreement to be bound by the terms of this Indenture applicable to
it; and

          (5)     the party to which such shares of Capital Stock are sold,
conveyed, transferred or otherwise disposed of or with or into which such TMM
Multimodal or Grupo TFM (or any successor of either of them) is merged is not an
Affiliate of the Company.

          For purposes of determining whether any series of related
transactions shall be considered a Qualifying Disposition, all of such
related transactions shall be viewed as a single integrated transaction and
any intermediate steps in such transaction shall not be considered
individually. The TFM Sale shall be a Qualifying Disposition.

          "QUALIFYING PEMEX SECURITIZATION TRANSACTION" means a transaction in
which:

          (1)     certain assets of the Company or a Restricted Subsidiary used
or intended to be used in connection with services to be rendered to or
contracts with Petroleos Mexicanos are transferred at fair market value to an
entity formed for the sole purpose of participating in the Qualifying PEMEX
Securitization Transaction;

          (2)     the Company receives an opinion as to the fairness of such
transaction to the Company from a financial point of view issued by an
investment banking firm of national standing in the United States and Mexico;
and

          (3)     such entity incurs Indebtedness secured by such assets that is
not guaranteed by, do not have recourse to, and does not constitute Indebtedness
of, the Company or any of its Restricted Subsidiaries.

          "RECEIVABLES SECURITIZATION FACILITY" means the receivables
securitization facility established pursuant to the Amended and Restated Master
Trust Agreement, dated as of October 25, 2002, and the documents related
thereto, in each case as in effect from time to time, and any replacement,
refinancing or extension thereof.

          "REDEMPTION DATE", when used with respect to any Note to be redeemed,
in whole or in part, means the date fixed for such redemption by or pursuant to
this Indenture.

          "REDEMPTION PRICE", when used with respect to any Note to be redeemed,
means the price (exclusive of accrued interest and Additional Amounts, if any)
at which it is to be redeemed pursuant to this Indenture.

          "REFINANCING INDEBTEDNESS" shall have the meaning assigned to such
term in Section 5.14(b)(vii).

          "REPURCHASE DATE" shall have the meaning assigned to such term in
Section 5.16.

                                       14
<Page>

          "REQUIRED RATING AGENCIES" means Standard & Poor's and Moody's.

          "RESPONSIBLE OFFICER", when used with respect to the Trustee, means
any officer within the Corporate Trust Office (or any successor office) of the
Trustee, including, without limitation, any Vice President, any Assistant Vice
President, any Senior Trust Officer, any Trust Officer or any other officer of
the Trustee customarily performing functions similar to those performed by any
of the above designated officers, who shall, in any case, be responsible for the
administration of this document or have familiarity with it, and also means,
with respect to particular corporate trust matters, any other officer to whom
such matter is referred because of his knowledge of and familiarity with the
particular subject.

          "RESTRICTED PAYMENTS" shall have the meaning assigned to such term in
Section 5.12(a).

          "RESTRICTED SUBSIDIARY" means any consolidated Subsidiary of the
Company other than Grupo TFM and its consolidated subsidiaries and other than
any Subsidiary formed for the sole purpose of, and whose only operations consist
of, participating in a Qualifying PEMEX Securitization Transaction.

          "REVERSION DATE" means any date on which either of the following
occur: (i) one or both Rating Agencies withdraws or downgrades its rating of the
Notes such that the Notes no longer have Investment Grade Ratings from the
Required Rating Agencies, or (ii) an Event of Default occurs and is continuing.

          "SECURITIES ACT" means the Securities Act of 1933, as amended from
time to time.

          "STANDARD & POOR'S" means Standard & Poor's, a division of McGraw-Hill
Inc., or any successor thereto.

          "STATED MATURITY", when used with respect to any Note or any
installment of interest thereon, means the date specified in such Note as the
fixed date on which the principal of such Note or such installment of interest
is due and payable.

          "SUBSIDIARY" means any corporation of which the Company directly or
indirectly owns or controls stock which under ordinary circumstances (not
dependent upon the happening of a contingency) has voting power to elect a
majority of the board of directors of such corporation.

                                       15
<Page>

          "SURVIVING ENTITY" shall have the meaning assigned to such term in
Section 11.01 (1).

          "SUSPENSION DATE" means any date on which the Notes have received
Investment Grade Ratings from the Required Rating Agencies.

          "SUSPENSION PERIOD" means the period of time beginning on any
Suspension Date and ending on the next succeeding Reversion Date.

          "TFM" means TFM, S.A. de C.V., a corporation organized under the laws
of the United Mexican States.

          "TFM SALE" means a transaction through which the Company sells its
entire interest in Grupo TFM to Kansas City Southern ("KCS").

          "TMM MULTIMODAL" means TMM Multimodal, S.A. de C.V., a corporation
organized under the laws of the United Mexican States.

          "TRANSFER" shall have the meaning assigned to such term in Section
11.01.

          "TRIGGERING EVENT" shall have the meaning assigned to such term in
Section 5.22(c).

          "TRUSTEE" means the Person named as the "Trustee" in the first
paragraph of this instrument until a successor Trustee shall have become such
pursuant to the applicable provisions of this Indenture, and thereafter
"Trustee" shall mean such successor Trustee.

          "TRUST INDENTURE ACT" means the Trust Indenture Act of 1939, as
amended, and as in force at the date this Indenture was executed, except as
provided in Section 10.05.

          "U.S. GOVERNMENT OBLIGATIONS" shall have the meaning assigned to such
term in Section 12.01.

          "VAT EVENT" shall have the meaning assigned to such term in Section
5.16.

          "VAT PROCEEDS" means any proceeds received by TFM from the Mexican
government pursuant to the October 11, 2002 judgment by the Mexican Magistrates
Court in favor of TFM related to a dispute over a value added tax certificate.

          "VAT REPURCHASE DATE" shall have the meaning assigned to such term
in Section 5.16.

          "WHOLLY OWNED SUBSIDIARY" of any Person shall mean any Subsidiary of
such Person of which all of the shares of Capital Stock (except directors'
qualifying shares) are at the time directly or indirectly owned by such Person
or by one or more Wholly Owned Subsidiaries of such Person or by such Person and
one or more of its Wholly Owned Subsidiaries.

          SECTION 1.02 COMPLIANCE CERTIFICATES AND OPINIONS. Upon any
application or request by the Company to the Trustee to take any action under
any provision of this Indenture, the Company shall furnish to the Trustee an
Officers' Certificate stating that all conditions precedent, if any, provided
for in this Indenture relating to the proposed action have been complied with
and an Opinion of Counsel stating that in the opinion of such counsel all such
conditions precedent, if any, have been

                                       16
<Page>

complied with, except that in the case of any such application or request as to
which the furnishing of such documents is specifically required by any provision
of this Indenture relating to such particular application or request, no
additional certificate or opinion need be furnished.

          Every certificate or opinion with respect to compliance with a
condition or covenant provided for in this Indenture shall include:

          (1)     a statement that each individual signing such certificate or
opinion has read such covenant or condition and the definitions herein relating
thereto;

          (2)     a brief statement as to the nature and scope of the
examination or investigation upon which the statements or opinions contained in
such certificate or opinion are based;

          (3)     a statement that, in the opinion of each such individual, he
has made such examination or investigation as is necessary to enable him to
express an informed opinion as to whether or not such covenant or condition has
been complied with; and

          (4)     a statement as to whether, in the opinion of each such
individual, such condition or covenant has been complied with.

          SECTION 1.03 FORM OF DOCUMENTS DELIVERED TO TRUSTEE. In any case where
several matters are required to be certified by, or covered by an opinion of,
any specified Person, it is not necessary that all such matters be certified by,
or covered by the opinion of, only one such Person, or that they be so certified
or covered by only one document, but one such Person may certify or give an
opinion with respect to some matters and one or more other such Persons as to
other matters, and any such Person may certify or give an opinion as to such
matters in one or several documents.

          Any certificate, statement or opinion of an officer of the Company may
be based, insofar as it relates to legal matters, upon a certificate or opinion
of or representations by counsel, unless such officer knows, or in the exercise
of reasonable care should know, that the certificate or opinion or
representation with respect to the matters upon which such officer's certificate
statement or opinion is based are erroneous. Any certificate, statement or
Opinion of Counsel may be based, insofar as it relates to factual matters, upon
a certificate, statement or opinion of or representations by an officer or
officers of the Company stating that the information with respect to such
factual matters is in the possession of the Company, unless such counsel knows,
or in the exercise of reasonable care should know, that the certificate,
statement or opinion or representation with respect to such matters are
erroneous.

          Where any Person is required to make, give or execute two or more
applications, requests, consents, certificates, statements, opinions or other
instruments under this Indenture, they may, but need not, be consolidated and
form one instrument.

                                       17
<Page>

          SECTION 1.04 NOTICES, ETC., TO TRUSTEE AND COMPANY. Any request,
demand, authorization, direction, notice, consent, waiver or act of Holders or
other document provided or permitted by this Indenture to be made upon, given or
furnished to, or filed with,

          (1)     the Trustee by any Holder or by the Company shall be made,
given, furnished or filed in writing to or with the Trustee at the principal
office of the Trustee located at 101 Barclay Street, New York, New York 10286,
Attention: Corporate Trust Administration, telephone number (212) _______
facsimile number (212) _____________, and unless otherwise herein expressly
provided, any such document shall be deemed to be sufficiently made, given,
furnished or filed upon its receipt by a Responsible Officer of the Trustee,
provided that if receipt of any facsimile transmission is not confirmed in
writing or by facsimile by the Trustee, a copy of such transmission shall be
delivered by hand or mailed, first class, postage prepaid, to the Trustee, or

          (2)     the Company by the Trustee or by any Holder shall be
sufficient for every purpose hereunder (unless otherwise herein expressly
provided) if in writing and mailed, first-class postage prepaid, or sent by
facsimile transmission to the Company addressed to it at Avenida de la Cuspide,
No. 4755, Colonia Parques del Pedregal, 14010 Mexico, D.F., Attention: Jacinto
Marina, telephone number (011) ______________, facsimile number (011)
________________, at the office maintained by the Company pursuant to Section
5.02 hereof or at any other address previously furnished in writing to the
Trustee by the Company, provided that if receipt of such facsimile transmission
is not confirmed in writing or by facsimile by the Company, a copy of such
transmission shall be delivered by hand or mailed, first class, postage prepaid,
to the Company.

          SECTION 1.05 NOTICE TO HOLDERS; WAIVER.

          (a)     Where this Indenture provides for notice to Holders of Notes
of any event, such notice shall be sufficiently given (unless otherwise herein
expressly provided) if in writing and mailed, first-class postage prepaid, to
each Holder of a Note affected by such event at the address of such Holder as it
appears in the Note Register, not later than the latest date and not earlier
than the earliest date prescribed for the giving of such notice, and in the
event of suspension of regular mail service or for any other reason it shall be
impracticable to give such notice to Holders of Notes by mail, then such
notification to Holders of Notes shall be made in the manner specified in
Section 1.05(b) and such notification shall constitute sufficient notification
for every purpose hereunder. In any case where notice to Holders of Notes is
given by mail, neither the failure to mail such notice, nor any defect in any
notice so mailed, to any particular Holder of a Note shall affect the
sufficiency of such notice with respect to other Holders of Notes or the
sufficiency of any notice by publication to Holders of Notes given as provided
in Section 1.05(b). In computing any time period for the mailing or giving of
notice of any event hereunder, the computation shall be made by counting back or
forward, as appropriate, from the date of the event in question, without
counting the date of such event but counting as a full day the ending date of
such period no matter when notice was mailed or given on such ending date.

                                       18
<Page>

          (b)     In case by reason of the suspension of regular mail service or
by reason of any other cause it shall be impracticable to give such notice by
mail, then such notification as shall be made with the approval of the Trustee
shall constitute a sufficient notification for every purpose hereunder.

          (c)     Where this Indenture provides for notice in any manner, such
notice may be waived in writing by the Person entitled to receive such notice,
either before or after the event, and such waiver shall be the equivalent of
such notice. Waivers of notice by Holders shall be filed with the Trustee, but
such filing shall not be a condition precedent to the validity of any action
taken in reliance upon such waiver.

          SECTION 1.06 CONFLICT WITH TRUST INDENTURE ACT. If any provision
hereof limits, qualifies or conflicts with (i) another provision hereof which is
required to be included in this Indenture by any of the provisions of the Trust
Indenture Act, or (ii) any provision of the Trust Indenture Act, such required
provision or such provision of the Trust Indenture Act, as the case may be,
shall control.

          SECTION 1.07 EFFECT OF HEADINGS AND TABLE OF CONTENTS. The Article and
Section headings herein and the Table of Contents are for convenience only and
shall not affect the construction hereof.

          SECTION 1.08 SUCCESSORS AND ASSIGNS. All covenants and agreements in
this Indenture by the Company shall bind its successors and assigns, whether so
expressed or not.

          SECTION 1.09 SEPARABILITY CLAUSE. In case any provision in this
Indenture or in the Notes shall be invalid, illegal or unenforceable, the
validity, legality and enforceability of the remaining provisions shall not in
any way be affected or impaired thereby.

          SECTION 1.10 BENEFITS OF INDENTURE. Nothing in this Indenture or in
the Notes, express or implied, shall give to any Person, other than the parties
hereto and their successors hereunder and the Holders, any benefit or any legal
or equitable right, remedy or claim under this Indenture.

          SECTION 1.11 GOVERNING LAW. This Indenture and the Notes shall be
governed by and construed in accordance with the laws of the State of New York,
without regard to the conflict of laws principles thereof.

          SECTION 1.12 LEGAL HOLIDAYS. In any case where any Interest Payment
Date, Redemption Date or Stated Maturity of any Note shall not be a Business Day
at any Place of Payment, then (notwithstanding any other provision of this
Indenture or of the Notes) payment of the principal of, premium, if any, or
interest, if any, on such Note need not be made at such Place of Payment on such
date, but may be made on the next succeeding Business Day at such Place of
Payment with the same force and effect as if made on the Interest Payment Date
or redemption date, or at the Stated Maturity, provided that no additional
interest shall accrue with respect to the payment due on such

                                       19
<Page>

date for the period from and after such Interest Payment Date, Redemption Date
or Stated Maturity, as the case may be.

          SECTION 1.13 APPOINTMENT OF AGENT FOR SERVICE. By the execution and
delivery of this Indenture, the Company hereby appoints CT Corporation System as
its agent upon which process may be served in any legal action or proceeding
which may be instituted in any Federal or State court in the Borough of
Manhattan, the City of New York, arising out of or relating to the Notes or this
Indenture, but for that purpose only. Service of process upon such agent at the
office of such agent at 1633 Broadway, New York, New York 10019, and written
notice of said service to the Company by the Person servicing the same addressed
as provided by Section 1.04, shall be deemed in every respect effective service
of process upon the Company in any such legal action or proceeding, and the
Company hereby submits to the nonexclusive jurisdiction of any such court in
which any such legal action or proceeding is so instituted. Such appointment
shall be irrevocable so long as the Holders of Notes shall have any rights
pursuant to the terms thereof or of this Indenture until the appointment of a
successor by the Company with the consent of the Trustee and such successor's
acceptance of such appointment. The Company further agrees to take any and all
actions, including the execution and filing of any and all such documents and
instruments, as may be necessary to continue such designation and appointment of
such agent or successor.

          SECTION 1.14 COUNTERPART ORIGINALS. The parties may sign any number of
copies of this Indenture. Each signed copy shall be an original, but all of them
together represent the same agreement.

                                   ARTICLE TWO

                                   NOTE FORMS

          SECTION 2.01 FORMS GENERALLY. The Notes and the Trustee's certificate
of authentication shall be in substantially the forms set forth in this Article,
with such appropriate insertions, omissions, substitutions and other variations
as are required or permitted by this Indenture and may have such letters,
numbers or other marks of identification and such legends or endorsements placed
thereon as may be required to comply with the rules of any securities exchange
or as may, consistently herewith, be determined by the officers executing such
Notes as evidenced by their execution of the Notes. Any such legend or
endorsement shall be delivered in writing to the Trustee by the Company.

          The definitive Notes shall be printed, lithographed or engraved on
steel engraved borders or may be produced in any other manner permitted by the
rules of any securities exchange on which the Notes may be listed, all as
determined by the officers executing such Notes, as evidenced by their execution
of such Notes.

          SECTION 2.02 FORM OF FACE OF NOTE.

                                 GRUPO TMM, S.A.

                                       20
<Page>

                            12% Senior Note Due 2004

CUSIP NO.
No.   $

          GRUPO TMM, S.A., a corporation duly organized and existing under
the laws of the United Mexican States (herein called the "Company", which
term includes any successor Person under the Indenture hereinafter referred
to), for value received, hereby promises to pay to _________, or registered
assigns, the principal sum of _________ Dollars on May 15, 2004, and to pay
interest thereon, from the date hereof, at the rate of 12% per annum, until
the principal hereof is paid or made available for payment. The interest so
payable, and punctually paid or duly provided for, on the Interest Payment
Date will, as provided in such Indenture, be paid to the Person entitled to
receipt of the principal amount in respect of such Note payment of the
principal of (and premium, if any), interest and Additional Amounts, if any,
on this Note will be made at the office or agency of the Company maintained
for that purpose in New York, New York, in such coin or currency of the
United States of America as at the time of payment is legal tender for
payment of public and private debts; provided, however, that at the option of
the Company payment of interest and Additional Amounts, if any, may be made
by check mailed to the address of the Person entitled thereto as such address
shall appear in the Note Register.

          Reference is hereby made to the further provisions of this Note set
forth on the reverse hereof, which further provisions shall for all purposes
have the same effect as if set forth at this place.

          Unless the certificate of authentication hereon has been executed by
the Trustee referred to on the reverse hereof by manual signature, this Note
shall not be entitled to any benefit under the Indenture or be valid or
obligatory for any purpose.

          IN WITNESS WHEREOF, the Company has caused this instrument to be duly
executed.

                                       21
<Page>

DATED:

                                                     GRUPO TMM, S..A.

                                                     By
                                                       -------------------------

ATTEST:

--------------------------

          SECTION 2.03 FORM OF REVERSE OF NOTE. This Note is one of a duly
authorized issue of Notes of the Company designated as its 12% Notes Due 2004
(herein called the "Notes"), limited in aggregate principal amount to $[-],
issued under an Indenture, dated as of May __, 2003 (herein called the
"Indenture"), by and between the Company and The Bank of New York, as Trustee
(herein called the "Trustee", which term includes any successor trustee under
the Indenture), to which Indenture and all indentures supplemental thereto
reference is hereby made for a statement of the respective rights, limitations
of rights, duties and immunities thereunder of the Company, the Trustee and the
Holders of the Notes and of the terms upon which the Notes are, and are to be,
authenticated and delivered.

          The Company hereby further agrees, subject to the limitations and
exceptions set forth below, that if any deduction or withholding for any present
or future taxes, assessments or other governmental charges of the United Mexican
States (or any political subdivision or taxing authority thereof or therein)
shall at any time be required by such jurisdiction (or any such political
subdivision or taxing authority) in respect of any amounts to be paid by the
Company under the Notes, then the Company will pay to the Holder of a Note as
additional interest such additional amounts ("Additional Amounts") as may be
necessary in order that the net amounts paid to the Holder of such Note who,
with respect to any such tax, assessment, or other governmental charge, is not
resident in such jurisdiction, after such deduction or withholding, shall be not
less than the amounts specified in such Note to which such Holder is entitled;
provided, however, that the Company shall not be required to make any payment of
Additional Amounts for or on account of:

          (a)     any tax, assessment or other governmental charge which would
not have been imposed but for (i) the existence of any present or former
connection between such Holder (or between a fiduciary, settlor, beneficiary,
member or shareholder of, or possessor of a power over, such Holder, if such
Holder is an estate, trust, partnership or corporation) and the taxing
jurisdiction or any political subdivision or territory or possession thereof or
area subject to its jurisdiction, including, without limitation, such Holder (or
such fiduciary, settlor, beneficiary, member, shareholder or possessor) being or
having been a citizen or resident thereof or being or having been present or
engaged in trade or business therein or having or having had a permanent
establishment therein or (ii) the presentation of a Note (where presentation is
required) for payment on a date

                                       22
<Page>

more than 30 days after the date on which such payment became due and payable or
the date on which payment thereof is duly provided for, whichever occurs later;

          (b)     any estate, inheritance, gift, sale, transfer, personal
property or similar tax, assessment or other governmental charge;

          (c)     any tax, assessment, or other governmental charge which is
payable otherwise than by withholding from payments of (or in respect of)
principal of or interest on the Notes;

          (d)     any tax, assessment or other governmental charge that is
imposed or withheld by reason of the failure to comply by the Holder or the
beneficial owner of a Note with a request of the Company addressed to the Holder
(i) to provide information, documents and other evidence concerning the
nationality, residence or identity of the Holder or such beneficial owner or
(ii) to make and deliver any declaration or other similar claim (other than a
claim for refund of a tax, assessment or other governmental charge withheld by
the Company) or satisfy any information or reporting requirement, which, in the
case of (i) or (ii), is required or imposed by a statute, treaty, regulation or
administrative practice of the taxing jurisdiction as a precondition to
exemption from all or part of such tax, assessment or other governmental charge;
or

          (e)     any combination of items (a), (b), (c) and (d);

nor shall Additional Amounts be paid with respect to any payment of the
principal of or interest on any Note to any Holder who is a fiduciary or
partnership or other than the sole beneficial owner of such payment to the
extent such payment would be required by the laws of the jurisdiction (or any
political subdivision or taxing authority thereof or therein) to be included in
the income for tax purposes of a beneficiary or settlor with respect to such
fiduciary or a member of such partnership or a beneficial owner who would not
have been entitled to such Additional Amounts had it been the Holder of the
Note.

          As of the Initial Issuance Date, the Company is obligated, as a result
of the Mexican withholding tax of 4.9%, to pay Additional Amounts to Holders of
Notes with respect to all interest payments to be made on the Notes.

          The Notes may be redeemed at the option of the Company in whole but
not in part at any time, upon not less than 30 days' not more than 60 days'
notice by mail, at a Redemption Price equal to the principal amount thereof plus
accrued interest to the date fixed for redemption if, as a result of any change
in or amendment to the laws or any regulations or rulings promulgated thereunder
of Mexico (or of any political subdivision or taxing authority thereof or
therein) or any change in the official application or interpretation of such
laws, regulations or rulings, or any change in the official application or
interpretation of, or any execution of or amendment to, any treaty or treaties
affecting taxation to which Mexico (or such political subdivision or taxing
authority) is a party, which becomes effective on or after the Initial Issuance
Date, the Company is or would be required on the next succeeding Interest
Payment Date to pay additional amounts with respect to the Notes in excess of
the Additional Amounts

                                       23
<Page>

required to be paid by the Company pursuant to the preceding paragraph, and the
payment of such Additional Amounts cannot be avoided by the use of any
reasonable measures available to the Company. The Company will also pay to the
Holders on the Redemption Date any Additional Amounts which would otherwise be
payable.

          The Notes are also subject to redemption upon not less than 30
days' nor more than 60 days' notice by mail, at the election of the Company,
in whole or in part, at any time within 60 days after receipt by the Company
or any of its Restricted Subsidiaries, directly or indirectly, of proceeds
from a Major Asset Sale in an aggregate principal amount equal to the amount
of such proceeds at a Redemption Price equal to 100% of the principal amount,
together in the case of any such redemption with accrued interest and
Additional Amounts, if any, to the Redemption Date. In the case of any
redemption pursuant to this paragraph, interest installments whose Stated
Maturity is on or prior to the applicable Redemption Date will be payable to
the Holders of such Notes, or one or more Predecessor Notes, of record at the
close of business on the relevant Record Dates referred to on the face
hereof, all as provided in the Indenture.

          In the event of redemption of this Note in part only, a new Note or
Notes for the unredeemed portion hereof will be issued in the name of the
Holder, or the Person designated by such Holder, hereof upon the cancellation
hereof.

          The Indenture provides that, in the event of a Change of Control (as
defined in the Indenture), the Company will be obligated to offer to purchase
all of the Notes then outstanding at a purchase price equal to 101% of the
principal amount thereof plus accrued interest and Additional Amounts, if any,
thereon to the purchase date.

          The Indenture provides that, subject to certain conditions, in the
event of certain asset sales, the Company will be obligated to offer to purchase
on a pro rata basis Notes at a purchase price equal to 100% of the principal
amount thereof plus accrued interest and Additional Amounts, if any, thereon to
the purchase date, with the excess net cash proceeds of such asset sale.

                                       24
<Page>

          If an Event of Default shall occur and be continuing, the principal of
all the Notes may be declared due and payable in the manner and with the effect
provided in the Indenture.

          As provided in the Indenture and subject to the conditions set forth
therein, the Company may terminate all of its obligations under the Notes,
except certain specified obligations, 91 days following the deposit with the
Trustee, in trust, of money and/or U.S. Government Obligations which through the
payment of interest and principal in respect thereof in compliance with their
terms will provide money in an amount sufficient to pay the principal of, and
premium, if any, and each installment of interest on the Outstanding Notes at
maturity or upon redemption.

          The Indenture permits, with certain exceptions as therein provided,
the amendment thereof and the modification of the rights and obligations of the
Company and the rights of the Holders of the Notes under the Indenture at any
time by the Company and the Trustee with the consent of the Holders of a
majority in aggregate principal amount of the Notes at the time Outstanding. The
Indenture also contains provisions permitting the Holders of specified
percentages in aggregate principal amount of the Notes at the time Outstanding,
on behalf of the Holders of all the Notes, to waive compliance by the Company
with certain provisions of the Indenture and certain past defaults under the
Indenture and their consequences. Any such consent or waiver by the Holder of
this Note shall be conclusive and binding upon such Holder and upon all future
Holders of this Note and of any Note issued upon the registration of transfer
hereof or in exchange herefor or in lieu hereof, whether or not notation of such
consent or waiver is made upon this Note.

          No reference herein to the Indenture and no provision of this Note or
of the Indenture shall alter or impair the obligations of the Company, which are
absolute and unconditional, to pay the principal of (and premium, if any) and
interest and Additional Amounts, if any, this Note at the times, place, and
rate, and in the coin or currency, herein prescribed.

          As provided in the Indenture and subject to certain limitations
therein set forth, the transfer of this Note is registrable in the Note
Register, upon surrender of this Note for registration of transfer at the office
or agency of the Company in New York, New York, duly endorsed by, or accompanied
by a written instrument of transfer in form satisfactory to the Company and the
Note Registrar duly executed by, the Holder hereof or his attorney duly
authorized in writing, and thereupon one or more new Notes, of authorized
denominations and for the same aggregate principal amount, will be issued to the
designated transferee or transferees.

          The Notes are issuable only in registered form without coupons in
denominations of $1,000 and any integral multiple thereof. As provided in the
Indenture and subject to certain limitations therein set forth, Notes are
exchangeable for a like aggregate principal amount of Notes of a different
authorized denomination, as requested by the Holder surrendering the same.

                                       25
<Page>

          No service charge shall be made for any such registration of transfer
or exchange, but the Company may require payment of a sum sufficient to cover
any tax or other governmental charge payable in connection therewith.

          The Company, the Trustee and any agent of the Company or the Trustee
may treat the Person in whose name this Note is registered as the owner hereof
for all purposes (subject to the provisions on the face hereof), whether or not
this Note be overdue, and neither the Company, the Trustee nor any such agent
shall be affected by notice to the contrary.

          All terms used in this Note which are defined in the Indenture shall
have the meanings assigned to them in the Indenture.

                                       26
<Page>

                                [ASSIGNMENT FORM]

If you the holder want to assign this Note, fill in the form below:

I or we assign and transfer this Note to

________________________________________________________________________________

________________________________________________________________________________

________________________________________________________________________________
(Print or type assignee's name, address and zip code and social security number
or tax ID number)

and irrevocably appoint

________________________________________________________________________________

agent to transfer this Note on the books of the Company. The agent may
substitute another to act for him.

________________________________________________________________________________

Date:                     Your signature:
     --------------------                ---------------------------------------
                                         (Sign exactly as your name appears on
                                         the other side of this Note)

Signature Guarantee:
                    ------------------------------------------------------------

                                       27
<Page>

                  [FORM OF OPTION OF HOLDER TO ELECT PURCHASE]

          If you wish to elect to have this Note purchased by the Company
pursuant to Section 5.16 (repurchase Offer upon a Change of Control) or 5.18
(Net Cash Proceeds Offer) of the Indenture, check the box:

                                                     / /

          If you wish to elect to have only part of this Note purchased by the
Company pursuant to Section 5.16 or 5.18 of the Indenture, state the amount:
$______________.

Date:                                     Your Signature:
     --------------------                 --------------------------------------
                                          (Sign exactly as your name appears on
                                          the other side of this Note)

Signature Guarantee:
                    ------------------------------------------------------------

          SECTION 2.04 FORM OF GUARANTEE. TMM HOLDINGS, S.A. DE C.V.
(hereinafter referred to as the "Guarantor," which term includes any
successors or assigns under the Indenture, dated as of May __, 2003, among
the Guarantor, the Company (defined below) and The Bank of New York, as
trustee (the "Indenture")), has irrevocably and unconditionally guaranteed on
a senior basis the Guarantee Obligations (as defined in Section 14.01 of the
Indenture), which include (i) the due and punctual payment of the principal
of, premium, if any, and interest on the 12% Senior Notes due 2004 (the
"Notes") of Grupo TMM, S.A., a company organized under the laws of the United
Mexican States (the "Company"), whether at maturity, by acceleration, call
for redemption, upon an Offer, upon a Net Cash Proceeds Offer or otherwise,
the due and punctual payment of interest on the overdue principal and
premium, if any, and (to the extent permitted by law) interest on any
interest on the Notes, and the due and punctual performance of all other
obligations of the Company, to the Holders or the Trustee all in accordance
with the terms set forth in Article Fourteen of the Indenture, and (ii) in
case of any extension of time of payment or renewal of any Notes or any such
other obligations, that the same will be promptly paid in full when due or
performed in accordance with the terms of the extension or renewal, whether
at stated maturity, by acceleration, call for redemption, upon an Offer, upon
a Net Cash Proceeds Offer or otherwise.

          The obligations of the Guarantor to the Holders and to the Trustee
pursuant to this Guarantee and the Indenture are expressly set forth in Article
Fourteen of the Indenture and reference is hereby made to such Indenture for the
precise terms of this Guarantee.

                                       28
<Page>

          No past, present or future director, officer, employee, incorporator
or stockholder (direct or indirect) of the Guarantor (or any such successor
entity), as such, shall have any liability for any obligations of the Guarantor
under this Guarantee or the Indenture or for any claim based on, in respect of,
or by reason of, such obligations or their creation.

          This is a continuing Guarantee and shall remain in full force and
effect and shall be binding upon the Guarantor and its successors and assigns
until full and final payment of all of the Company's obligations under the Notes
and Indenture or until released or until the Notes are legally defeased in
accordance with the Indenture, and shall inure to the benefit of the successors
and assigns of the Trustee and the Holders, and, in the event of any transfer or
assignment of rights by any Holder or the Trustee, the rights and privileges
herein conferred upon that party shall automatically extend to and be vested in
such transferee or assignee, all subject to the terms and conditions hereof.
This is a Guarantee of payment and not of collectability.

          This Guarantee shall not be valid or obligatory for any purpose until
the certificate of authentication on the Note upon which this Guarantee is noted
shall have been executed by the Trustee under the Indenture by the manual
signature of one of its authorized officers.

          The obligations of the Guarantor under this Guarantee shall be limited
to the extent necessary to insure that it does not constitute a fraudulent
conveyance under applicable law.

          THE TERMS OF ARTICLE FOURTEEN THE INDENTURE ARE INCORPORATED HEREIN BY
REFERENCE.

          Capitalized terms used herein have the same meanings given in the
Indenture unless otherwise indicated.

          IN WITNESS WHEREOF, the Guarantor has caused this instrument to be
duly executed.

DATED:

                                               TMM HOLDINGS, S.A. DE C.V.

                                               By
                                                 -------------------------------

ATTEST:

--------------------------

                                       29
<Page>

          SECTION 2.05 FORM OF TRUSTEE'S CERTIFICATE OF AUTHENTICATION. The
Trustee's certificate of authentication on all Notes shall be in substantially
the following form:

          This is one of the Notes referred to in the within-mentioned
Indenture.

                                           THE BANK OF NEW YORK,
                                           as Trustee

                                           By
                                             -----------------------------------
                                           Authorized Signatory

                                  ARTICLE THREE

                                    THE NOTES

          SECTION 3.01 TITLE AND TERMS. The aggregate principal amount of Notes
which may be authenticated and delivered from time to time under this Indenture
is limited to $376,875,000, except for Notes authenticated and delivered upon
registration of transfer of, or in exchange for, or in lieu of, other Notes
pursuant to Sections 3.04, 3.05, 3.06, 4.08, 5.16, 5.18 and 10.06.

          The Notes shall be known and designated as the "12% Notes Due 2004"
of the Company. Their Stated Maturity shall be May 15, 2004, and they shall
bear interest at the rate of 12% per annum, from May __, 2003, payable on
May 15, 2003.

          The principal of (and premium, if any), interest and Additional
Amounts, if any, on the Notes shall be payable at the office or agency of the
Company in New York, New York maintained for such purpose and at any other
office or agency maintained by the Company for such purpose; provided, however,
that at the option of the Company payment of interest and Additional Amounts, if
any, may be made by check mailed to the address of the Person entitled thereto
as such address shall appear in the Note Register.

          The Notes shall be redeemable as provided in Article Four.

          SECTION 3.02 DENOMINATIONS; PAYMENT CURRENCY. The Notes shall be
issuable only in fully registered form without coupons and only in denominations
of $1,000 and any integral multiple thereof. All payments in respect of
principal of and premium, if any, and interest on the Notes shall be in United
States Dollars.

          SECTION 3.03 EXECUTION, AUTHENTICATION, DELIVERY AND DATING. The Notes
shall be signed on behalf of the Company by its Chief Executive Officer, its

                                       30
<Page>

Director General, its Chief Operating Officer, or its Chief Financial Officer,
and by its Director of Administration, its Treasurer or any other duly
authorized officer. Such signatures may be manual or facsimile signatures of the
present or any future such authorized officers and may be imprinted or otherwise
reproduced on the Notes.

          Only such Notes as shall bear thereon a certificate of authentication
substantially in the form herein before recited, manually executed by the
Trustee, shall be entitled to the benefits of this Indenture or be valid or
obligatory for any purpose. Such certificate by the Trustee upon any Note
executed by the Company shall be conclusive evidence that the Note so
authenticated has been duly authenticated and delivered hereunder.

          Notes bearing the manual or facsimile signatures of individuals who
were at any time the proper officers of the Company and the Guarantor shall bind
the Company and the Guarantor, notwithstanding that such individuals or any of
them have ceased to hold such offices prior to the authentication and delivery
of such Notes or did not hold such offices at the date of such Notes.

          At any time and from time to time after the execution and delivery of
this Indenture, the Company may deliver Notes executed by the Company and the
Guarantor to the Trustee for authentication. The Trustee shall thereupon
authenticate and deliver such Notes to the Company or as directed by a Company
Order, without any further action by the Company or the Guarantor.

          Each Note shall be dated the date of its authentication.

          SECTION 3.04 TEMPORARY NOTES. Pending the preparation of definitive
Notes, the Company may execute, and upon compliance with Section 3.03 the
Trustee shall authenticate and deliver, temporary Notes substantially of the
tenor of the definitive Notes in lieu of which they are issued, which are
printed, lithographed, typewritten, mimeographed or otherwise produced, in any
authorized denomination, and with such appropriate insertions, omissions,
substitutions and other variations as the officers executing such Notes may
determine, as evidenced by their execution of such Notes.

          If temporary Notes are issued, the Company will cause definitive Notes
to be prepared without unreasonable delay. After the preparation of definitive
Notes, the temporary Notes shall be exchangeable for definitive Notes upon
surrender of the temporary Notes at the office of agency of the Company in a
Place of Payment. Upon surrender for cancellation of any one or more temporary
Notes, the Company shall execute and the Trustee shall authenticate and deliver
in exchange therefor a like principal amount of definitive Notes of authorized
denominations and of like tenor. Until so exchanged, the temporary Notes shall
in all respects be entitled to the same benefits under this Indenture as
definitive Notes.

          SECTION 3.05 REGISTRATION; REGISTRATION OF TRANSFER AND EXCHANGE. The
Company shall cause to be kept at one of the offices or agencies maintained in
accordance with Section 5.02 a register or registers herein sometimes
collectively

                                       31
<Page>

referred to as the "NOTE REGISTER" in which, subject to such reasonable
regulations as it may prescribe, the Company shall provide for the registration
of Notes and of transfers of Notes. Said office or agency is hereby appointed
"NOTE REGISTRAR" for the purpose of registering Notes and transfers of Notes as
herein provided.

          At the option of the Holder, Notes may be exchanged for other Notes of
any authorized denominations and of a like aggregate principal amount and Stated
Maturity, upon surrender of the Notes to be exchanged at such office or agency.
Whenever any Notes are so surrendered for exchange, the Company shall execute
and the Trustee shall authenticate and deliver, the Notes which the Holder
making the exchange is entitled to receive.

          All Notes issued upon any registration of transfer or exchange of
Notes shall be the valid obligations of the Company, evidencing the same debt,
and entitled to the same benefits under this Indenture, as the Notes surrendered
upon such registration of transfer or exchange.

          Every Note presented or surrendered for registration of transfer or
for exchange shall (if so required by the Company or the Trustee) be duly
endorsed, or be accompanied by a written instrument of transfer in form
satisfactory to the Company and the Note Registrar duly executed, by the Holder
thereof or his attorney duly authorized in writing.

          No service charge shall be made for any registration of transfer or
exchange of Notes, but the Company may require payment of a sum sufficient to
cover any tax or other governmental charge that may be imposed in connection
with any registration of transfer or exchange of Notes.

          Neither the Company nor the Trustee nor any agent of either shall be
required (i) to issue, authenticate, register the transfer of or exchange any
Note during a period beginning at the opening of business 15 days before the day
of the mailing of a notice of redemption hereunder and ending at the close of
business on the day of the mailing of a notice of redemption of Notes selected
for redemption, or (ii) to register the transfer of or exchange any Note so
selected for redemption in whole or in part, except the unredeemed portion of
any Note being redeemed in part.

          SECTION 3.06 MUTILATED, DESTROYED, LOST AND STOLEN NOTES. If any
mutilated Note is surrendered to the Trustee, the Company shall execute, and the
Trustee shall authenticate and deliver in exchange herefor a new Note of like
tenor, principal amount and Stated Maturity and bearing a number not
contemporaneously outstanding.

          If there shall be delivered to the Company and the Trustee (i)
evidence to their satisfaction of the destruction, loss or theft of any Note and
(ii) such security or indemnity as may be required by them to hold each of them
and any agent of either of them harmless, then, in the absence of notice to the
Company or the Trustee that such Note has been acquired by a bona fide
purchaser, the Company shall execute and upon its request the Trustee shall
authenticate and deliver, in lieu of any such destroyed, lost or

                                       32
<Page>

stolen Note, a new Note of like tenor, principal amount and Stated Maturity and
bearing a number not contemporaneously outstanding. If after the delivery of
such new Note, a bona fide purchaser of the original Note in lieu of which such
new Note was issued presents for payment such original Note, the Company and the
Trustee shall be entitled to recover such new Note from the person to whom it
was delivered or any transferee thereof, except a bona fide purchaser of such
new Note, and shall be entitled to recover upon the security or indemnity
provided herefor to the extent of any loss, damage, cost or expense incurred by
the Company or the Trustee in connection therewith.

          In case any such mutilated, destroyed, lost or stolen Note has become
or is about to become due and payable, the Company in its discretion may,
instead of issuing a new Note, pay such Note.

          Upon the issuance of any new Note under this Section, the Company may
require the payment of a sum sufficient to cover any tax or other governmental
charge that may be imposed in relation thereto and any other expenses (including
the fees and expenses of the Trustee) connected therewith.

          Except as provided above, every new Note issued pursuant to this
Section in lieu of any destroyed, lost or stolen Note shall constitute an
original additional contractual obligation of the Company, whether or not the
destroyed, lost or stolen Note shall be at any time enforceable by anyone, and
shall be entitled to all the benefits of this Indenture equally and
proportionately with any and all other Notes duly issued hereunder.

          The provisions of this Section are exclusive and shall preclude (to
the extent lawful) all other rights and remedies with respect to the replacement
or payment of mutilated, destroyed, lost or stolen Notes.

          SECTION 3.07 PAYMENT OF INTEREST; INTEREST RIGHTS PRESERVED. Interest
on any Note which is payable, and is punctually paid or duly provided for, on
any Interest Payment Date shall be paid to the Person in whose name that Note
(or one or more Predecessor Notes) is registered at the close of business on the
Regular Record Date for such interest.

          Any interest on any Note which is payable, but is not punctually paid
or duly provided for, on any Interest Payment Date (which, together with
interest on overdue installments of interest, to the extent legally enforceable
under applicable law, at the rate borne by such Note, is herein called
"DEFAULTED INTEREST") shall forthwith cease to be payable to the Holder on the
relevant Regular Record Date by virtue of having been such Holder, and such
Defaulted Interest may be paid by the Company, at its election in each case, as
provided in clause (1) or (2) below:

          (1)     The Company may elect to make payment of any Defaulted
Interest to the Persons in whose names the Notes (or their respective
Predecessor Notes) are registered at the close of business on a Special Record
Date for the payment of such Defaulted Interest, which shall be fixed in the
following manner. The Company shall notify the Trustee in writing of the amount
of Defaulted Interest proposed to be paid on

                                       33
<Page>

each Note and the date of the proposed payment, and at the same time the Company
shall deposit with the Trustee an amount of money equal to the aggregate amount
proposed to be paid in respect of such Defaulted Interest or shall make
arrangements satisfactory to the Trustee for such deposit prior to the date of
the proposed payment, such money when deposited to be held in trust for the
benefit of the Persons entitled to such Defaulted Interest as in this clause (1)
provided. Thereupon the Company shall fix a Special Record Date for the payment
of such Defaulted Interest which shall be not more than 15 days and not less
than 10 days prior to the date of the proposed payment and not less than 10 days
after the receipt by the Trustee of the notice of the proposed payment. The
Company shall promptly notify the Trustee in writing of such Special Record Date
and the Trustee, in the name and at the expense of the Company, shall cause
notice of the proposed payment of such Defaulted Interest and the Special Record
Date herefor to be mailed, first-class postage prepaid, to each Holder at his
address as it appears in the Note Register, not less than 10 days prior to such
Special Record Date. Notice of the proposed payment of such Defaulted Interest
and the Special Record Date herefor having been so mailed, such Defaulted
Interest shall be paid to the Persons in whose names the Notes (or their
respective Predecessor Notes) are registered at the close of business on such
Special Record Date and shall no longer be payable pursuant to the following
clause (2).

          (2)     The Company may make payment of any Defaulted Interest on the
Notes of any series in any other lawful manner not inconsistent with the
requirements of any securities exchange on which such Notes may be listed, and
upon such notice as may be required by such exchange, if, after notice given by
the Company to the Trustee of the proposed payment pursuant to this clause, such
manner of payment shall be deemed practicable by the Trustee.

          Subject to the foregoing provisions of this Section, each Note
delivered under this Indenture upon registration of transfer of or in exchange
for or in lieu of any other Note shall carry the rights to interest accrued and
unpaid, and to accrue, which were carried by such other Note.

          SECTION 3.08 PERSONS DEEMED OWNERS. Prior to due presentation of a
Note for registration of transfer, the Company, the Trustee and any agent of the
Company or the Trustee may treat the Person in whose name any Note is registered
as the owner of such Note for the purpose of receiving payment of principal of,
premium, if any, and (subject to Section 3.07) interest on such Note and for all
other purposes whatsoever, whether or not such Note be overdue, and neither the
Company, the Trustee nor any agent of the Company, or the Trustee shall be
affected by notice to the contrary.

          SECTION 3.09 CANCELLATION. All Notes surrendered for payment,
redemption, registration of transfer or exchange shall, if surrendered to any
Person other than the Trustee, be delivered to the Trustee and shall be promptly
canceled by it. The Company may at any time deliver to the Trustee for
cancellation any Notes previously authenticated and delivered hereunder which
the Company may have acquired in any manner whatsoever, and all Notes so
delivered shall be promptly canceled by the Trustee. No Notes shall be
authenticated in lieu of or in exchange for any Notes canceled as provided in
this Section, except as expressly permitted by this Indenture. All canceled

                                       34
<Page>

Notes held by the Trustee shall be destroyed by the Trustee and, upon written
request of the Company, the Trustee shall deliver to the Company a certificate
of destruction in respect thereof.

          SECTION 3.10 COMPUTATION OF INTEREST. Interest on the Notes shall be
computed on the basis of a 360-day year of twelve 30-day months.

                                  ARTICLE FOUR

                               REDEMPTION OF NOTES

          SECTION 4.01 RIGHT OF REDEMPTION.

   (a)    The Notes may be redeemed at the election of the Company, in whole
or in part, at any time within 60 days after receipt by the Company or any of
its Restricted Subsidiaries, directly or indirectly, of proceeds from a Major
Asset Sale, in an aggregate principal amount equal to the amount of such
proceeds at a Redemption Price equal to 100% of the principal amount thereof,
together with accrued interest and Additional Amounts, if any, to the
Redemption Date.

   (b)    The Notes may be redeemed at the election of the Company in whole but
not in part pursuant to Section 4.09.

          SECTION 4.02 APPLICABILITY OF ARTICLE. Redemption of Notes at the
election of the Company as permitted by any provision of this Indenture, shall
be made in accordance with such provision and this Article.

          SECTION 4.03 ELECTION TO REDEEM; NOTICE TO TRUSTEE. The election of
the Company to redeem any Notes pursuant to Section 4.01 shall be evidenced by a
Board Resolution. In case of any partial redemption at the election of the
Company, the Company shall, at least 60 days prior to the Redemption Date fixed
by the Company

                                       35
<Page>

(unless a shorter notice shall be satisfactory to the Trustee), notify the
Trustee by Company Order of such Redemption Date and of the principal amount of
Notes to be redeemed.

          SECTION 4.04 SELECTION BY TRUSTEE OF NOTES TO BE REDEEMED. If less
than all the Notes are to be redeemed, the particular Notes to be redeemed shall
be selected not more than 60 nor less than 30 days prior to the Redemption Date
by the Trustee, from the Outstanding Notes not previously called for redemption,
by such method as the Trustee shall deem fair and appropriate and which may
provide for the selection for redemption of portions (equal to $1,000 or any
integral multiple thereof) of the principal amount of Notes of a denomination
larger than $1,000.

          The Trustee shall promptly notify the Company and each Note Registrar
in writing of the Notes selected for redemption and, in the case of any Notes
selected for partial redemption, the principal amount thereof to be redeemed.

          For all purposes of this Indenture, unless the context otherwise
requires, all provisions relating to the redemption of Notes shall relate, in
the case of any Notes redeemed or to be redeemed only in part, to the portion of
the principal amount of such Notes which has been or is to be redeemed.

          SECTION 4.05 NOTICE OF REDEMPTION. Notice of redemption shall be given
by first-class mail, postage prepaid, mailed not less than 30 nor more than 60
days prior to the Redemption Date, to each Holder of Notes to be redeemed, at
his address appearing in the Note Register.

          All notices of redemption shall state:

          (1)     the Redemption Date,

          (2)     the Redemption Price and the amount of accrued interest and
Additional Amounts, if any, to the Redemption Date,

          (3)     if less than all of the Outstanding Notes are to be redeemed,
the identification (and, in the case of partial redemption, the principal
amounts to be redeemed) of the particular Notes to be redeemed,

          (4)     that on the Redemption Date the Redemption Price and accrued
interest and Additional Amounts, if any, will become due and payable upon each
such Note to be redeemed and that interest thereon will cease to accrue on and
after said date, and

          (5)     the place or places where such Notes are to be rendered for
payment of the Redemption Price and accrued interest and Additional Amounts, if
any.

          Notice of redemption of Notes to be redeemed at the election of the
Company shall be given by the Company or, at the Company's request, by the
Trustee in the name and at the expense of the Company.

                                       36
<Page>

          SECTION 4.06 DEPOSIT OF REDEMPTION PRICE. Prior to any Redemption
Date, the Company shall deposit with the Trustee or with a Paying Agent (or, if
the Company is acting as its own Paying Agent, segregate and hold in trust as
provided in Section 5.03) an amount of money in immediately available funds by
10:00 a.m., New York City time, on such Redemption Date sufficient to pay the
Redemption Price of, and (except if the Redemption Date shall be an Interest
Payment Date) accrued interest and Additional Amounts on, all the Notes which
are to be redeemed on that date.

          SECTION 4.07 NOTES PAYABLE ON REDEMPTION DATE. Notice of redemption
having been given as aforesaid, the Notes so to be redeemed shall on the
Redemption Date become due and payable at the Redemption Price therein
specified, and from and after such date (unless the Company shall default in the
payment of the Redemption Price and accrued interest and Additional Amounts)
such Notes shall cease to bear interest. Upon surrender of any such Note for
redemption in accordance with said notice, such Note shall be paid by the
Company at the Redemption Price, together with accrued interest, if any, and
Additional Amounts, if any, to the Redemption Date; provided, however, that
installments of interest whose Stated Maturity is on or prior to the Redemption
Date shall be payable to the Holders of such Notes, or one or more Predecessor
Notes, registered as such at the close of business on the relevant Record Dates
according to their terms and the provisions of Section 3.07.

          Notwithstanding the foregoing, the Trustee shall not redeem any Notes
or mail any notice of optional redemption during the continuance of a default in
payment of interest on the Notes or of any Event of Default.

          If any Note called for redemption shall not be so paid upon surrender
thereof for redemption, the principal (and premium, if any) shall, until paid,
bear interest from the Redemption Date at the rate borne by the Note.

          SECTION 4.08 NOTES REDEEMED IN PART. Any Note which is to be redeemed
only in part shall be surrendered at an office or agency of the Company
designated for that purpose pursuant to Section 5.02 (with, if the Company or
the Trustee so requires, due endorsement by, or a written instrument of transfer
in form satisfactory to the Company and the Trustee duly executed by, the Holder
thereof or his attorney duly authorized in writing), and the Company shall
execute, and the Trustee shall authenticate and deliver to the Holder of such
Note without service charge, a new Note or Notes, of any authorized denomination
as requested by such Holder, in aggregate principal amount equal to and in
exchange for the unredeemed portion of the principal of the Note so surrendered.

          SECTION 4.09 OPTIONAL REDEMPTION DUE TO CHANGES IN TAX TREATMENT. The
Notes may be redeemed at the option of the Company in whole but not in part at
any time at a Redemption Price equal to the principal amount thereof plus
accrued interest and Additional Amounts to the date fixed for redemption if, as
a result of any change in or amendment to the laws or any regulations or rulings
promulgated thereunder of the United Mexican States (or of any political
subdivision or taxing authority thereof or therein) or any change in the
official application or interpretation of such laws,

                                       37
<Page>

regulations or rulings, or any change in the official application or
interpretation of, or any execution of or amendment to, any treaty or treaties
affecting taxation to which the United Mexican States (or such political
subdivision or taxing authority) is a party, which change, execution or
amendment becomes effective after the Initial Issuance Date, the Company is or
would be required to pay additional amounts with respect to the Notes in excess
of the Additional Amounts payable on the Initial Issuance Date as described in
Section 2.03, and the payment of such additional amounts cannot be avoided by
the use of any reasonable measures available to the Company. Prior to the giving
of notice of redemption of such Notes pursuant to this Indenture, the Company
will deliver to the Trustee an Officers' Certificate, stating that the Company
is entitled to effect such redemption based on an Opinion of Counsel that the
Company has or will become obligated to pay such additional amounts as a result
of such change or amendment. Such notice, once delivered by the Company to the
Trustee, will be irrevocable.

                                  ARTICLE FIVE

                                    COVENANTS

          Each of the Company and, as applicable, the Guarantor covenants
that so long as any of the Notes shall remain Outstanding, and subject to
Section 5.26:

          SECTION 5.01 PAYMENTS OF PRINCIPAL, PREMIUM, IF ANY, AND INTEREST. The
Company will duly and punctually pay or cause to be paid the principal of,
premium, if any, interest and Additional Amounts on the Notes in accordance with
the terms of the Notes and this Indenture.

          SECTION 5.02 MAINTENANCE OF OFFICE OR AGENCY. The Company and the
Guarantor shall maintain in New York, New York an office or agency where Notes
may be presented or surrendered for payment, where Notes may be surrendered for
registration of transfer or exchange and where notices and demands to or upon
the Company and the Guarantor in respect of the Notes and this Indenture may be
served. The Company and the Guarantor shall give prompt written notice to the
Trustee of the location, and any change in the location, of any such office or
agency.

          The Company and the Guarantor may also from time to time designate one
or more other offices or agencies where the Notes may be presented or
surrendered for any or all such purposes, and may from time to time rescind such
designations; provided, however, that no such designation or rescission shall in
any manner relieve the Company and the Guarantor of their obligation to maintain
an office or agency in accordance with the requirements set forth above. The
Company and the Guarantor shall give prompt written notice to the Trustee of any
such designation or rescission and of any change in the location of any such
other office or agency.

          SECTION 5.03 MONEY FOR NOTE PAYMENTS TO BE HELD IN TRUST. If the
Company shall at any time act as its own Paying Agent, it will, on or before
each due date of the principal of (and premium, if any) or interest and
Additional Amounts on any of the Notes, segregate and hold in trust for the
benefit of the Persons entitled thereto a

                                       38
<Page>

sum sufficient to pay the principal (and premium, if any) or interest and
Additional Amounts so becoming due until such sums shall be paid to such Persons
or otherwise disposed of as herein provided and will promptly notify the Trustee
of its action or failure so to act.

          Whenever the Company shall have one or more Paying Agents, it will,
prior to each due date of the principal of (and premium, if any) or interest on
any Notes, deposit with a Paying Agent a sum sufficient to pay the principal
(and premium, if any) or interest so becoming due, such sum to be held in trust
for the benefit of the Persons entitled to such principal, premium or interest,
and (unless such Paying Agent is the Trustee) the Company will promptly notify
the Trustee of its action or failure so to act.

          The Company will cause each Paying Agent other than the Trustee to
execute and deliver to the Trustee an instrument in which such Paying Agent
shall agree with the Trustee, subject to the provisions of this Section, that
such Paying Agent will:

          (1)     hold all sums held by it for the payment of the principal of
(and premium, if any) or interest and Additional Amounts on Notes in trust for
the benefit of the Persons entitled thereto until such sums shall be paid to
such Persons or otherwise disposed of as herein provided;

          (2)     give the Trustee notice of any default by the Company (or any
other obligor upon the Notes) in the making of any payment of principal (and
premium, if any) or interest and Additional Amounts; and

          (3)     at any time during the continuance of any such default, upon
the written request of the Trustee, forthwith pay to the Trustee all sums so
held in trust by such Paying Agent.

          The Company may at any time, for the purpose of obtaining the
satisfaction and discharge of this Indenture or for any other purpose, pay, or
by Company Order direct any Paying Agent to pay, to the Trustee all sums held in
trust by the Company or such Paying Agent, such sums to be held by the Trustee
upon the same trusts as those upon which such sums were held by the Company or
such Paying Agent; and, upon such payment by any Paying Agent to the Trustee,
such Paying Agent shall be released from all further liability with respect to
such money.

          Any money deposited with the Trustee or any Paying Agent, or then held
by the Company, in trust for the payment of the principal of (and premium, if
any) or interest on any Note and remaining unclaimed for two years after such
principal (and premium, if any) or interest has become due and payable shall be
paid to the Company on Company Request, or (if then held by the Company) shall
be discharged from such trust; and the Holder of such Note shall thereafter, as
an unsecured general creditor, look only to the Company for payment thereof, and
all liability of the Trustee or such Paying Agent with respect to such trust
money, and all liability of the Company as trustee thereof, shall thereupon
cease; provided, however, that the Trustee or such Paying Agent, before being
required to make any such repayment, may at the expense of the Company cause to
be

                                       39
<Page>

published once, in a newspaper published in the English language, customarily
published on each Business Day and of general circulation in New York, New York,
notice that such money remains unclaimed and that, after a date specified
therein, which shall not be less than 30 days from the date of such publication,
any unclaimed balance of such money then remaining will be repaid to the
Company. The Company hereby appoints the Trustee as the initial Registrar and
Paying Agent for the Notes.

          SECTION 5.04 EXISTENCE. Subject to Article Eleven, the Company will do
or cause to be done all things necessary to preserve and keep in full force and
effect its existence, and the rights (charter and statutory) and franchises of
the Company and each of its Restricted Subsidiaries; provided, however, that the
Company shall not be required to preserve the existence of any of its Restricted
Subsidiaries (subject to Article Eleven) or any such right or franchise if the
Company shall determine that the preservation thereof is no longer desirable in
the conduct of the business of the Company and that the loss thereof is not
disadvantageous in any material respect to the Holders.

          SECTION 5.05 MAINTENANCE OF PROPERTIES; INSURANCE. The Company will
cause all properties used or useful in the conduct of its business or the
business of any of its Restricted Subsidiaries to be maintained and kept in good
condition, repair and working order and supplied with all necessary equipment
and will cause to be made all necessary repairs, renewals, replacements,
betterments and improvements thereof, all as in the judgment of the Company may
be necessary so that the business carried on in connection therewith may be
conducted in the ordinary course consistent with the Company's custom and
practice at all times; provided, however, that nothing in this Section shall
prevent the Company from discontinuing the operation or maintenance of any of
such properties if such discontinuance is, in the judgment of the Company,
desirable in the conduct of its business or the business of any Subsidiary.

          (b)     For so long as any vessel or property is deemed to be useful
to the conduct of the business of the Company or any of its Restricted
Subsidiaries, the Company will, or will cause its Restricted Subsidiaries to,
maintain appropriate insurance, in accordance with industry practice, on such
vessels and properties.

          SECTION 5.06 PAYMENT OF TAXES. The Company will pay or discharge or
cause to be paid or discharged, before the same shall become delinquent, all
taxes, assessments and governmental charges levied or imposed upon the Company
or any Subsidiary or upon the income, profits or property of the Company or any
Subsidiary; provided, however, that the Company shall not be required to pay or
discharge or cause to be paid or discharged any such tax, assessment or charge
whose amount, applicability or validity is being contested in good faith by
appropriate proceedings.

          SECTION 5.07 ANNUAL OFFICERS' CERTIFICATE TO TRUSTEE. The Company will
deliver to the Trustee prior to April 30 in each year an Officers' Certificate,
complying with Section 314(a)(4) of the Trust Indenture Act, from the principal
executive officer, principal financial officer or principal accounting officer
as to his or her knowledge of the Company's compliance with all conditions and
covenants under this Indenture. For the purposes of such certificate, such
compliance shall be determined

                                       40
<Page>

without regard to any period of grace or requirement of notice provided under
this Indenture.

          SECTION 5.08 REPORTS TO BE FURNISHED TO HOLDERS. For so long as any of
the Notes are outstanding, the Company will deliver to the Trustee:

          (i)     within 45 business days of the close of its fiscal year, or
such later time as is then permitted under Mexican law, an English translation
of the unaudited consolidated financial statements of the Company, together with
information sufficient to ascertain the financial condition and results of
operations of the Company and its Restricted Subsidiaries, accounting for Grupo
TFM and its consolidated subsidiaries under the equity method of accounting;

          (ii)    within 120 days of the close of its fiscal year, or such later
time as is then permitted under Mexican law, an English translation of the
audited consolidated financial statements of the Company, together with
information sufficient to ascertain the financial condition and results of
operations of the Company and its Restricted Subsidiaries, accounting for Grupo
TFM and its consolidated subsidiaries under the equity method of accounting;

          (iii)   within 180 days of the close of the fiscal year, an English
translation of the audited consolidated financial statements of the Company,
together with a reconciliation (in the form required by the Commission) to U.S.
generally accepted accounting principles, together with information sufficient
to ascertain the financial condition and results of operations of the Company
and its Restricted Subsidiaries, accounting for Grupo TFM and its consolidated
subsidiaries under the equity method of accounting;

          (iv)    within 30 business days of the close of the relevant quarter,
an English translation of the unaudited quarterly consolidated financial
statements of the Company, for each of the first three fiscal quarters, together
with information sufficient to ascertain the financial condition and results of
operations of the Company and its Restricted Subsidiaries, accounting for Grupo
TFM and its consolidated subsidiaries under the equity method of accounting;

          (v)     simultaneously with the delivery of each set of consolidated
financial statements referred to in clauses (ii), (iii) and (iv) above, an
Officers' Certificate stating whether any Event of Default exists on the date of
such certificate and, if any Event of Default then exists, setting forth the
details thereof and the action which the Company is taking or proposes to take
with respect thereto;

          (vi)    without duplication, copies of such other reports or notices
as may be filed by the Company with the Commission or the New York Stock
Exchange, or, if the Notes cease to be listed on the New York Stock Exchange, as
would be required to be so filed if the Notes had continued to be so listed; and

                                       41
<Page>

          (vii)   upon any officer of the Company becoming aware of the
existence of an Event of Default, an Officers' Certificate setting forth the
details thereof and the action which the Company is taking or proposes to take
with respect thereto.

          (b)     The Company will transmit or cause to be transmitted to the
Holders, as soon as practicable after the mailing of such material to its
stockholders, English translations of copies of all quarterly and annual
financial reports distributed to its stockholders generally. Reports pursuant to
this Section shall be transmitted by mail to all Holders of Notes, as the names
and addresses of such Holders appear upon the Note Register.

          SECTION 5.09 FURTHER ASSURANCES. From time to time whenever reasonably
demanded by the Trustee, the Company and the Guarantor will make, execute and
deliver or cause to be made, executed and delivered any and all such further and
other instruments and assurances as may be reasonably necessary or proper to
carry out the intention or facilitate the performance of the terms of this
Indenture.

          SECTION 5.10 COMPANY TO FURNISH TRUSTEE INFORMATION AS TO NAMES AND
ADDRESSES OF HOLDERS. The Company shall furnish or cause to be furnished to the
Trustee (a) not more than 15 days after each Regular Record Date, but in any
event not less frequently than semiannually, a list in such form as the Trustee
may reasonably require, containing all the information in the possession or
control of the Company or any of its Paying Agents other than the Trustee, as to
the names and addresses of the Holders of Notes to which such Regular Record
Date applies as of such Regular Record Date, and (b) at such other times as the
Trustee may request in writing, within 5 days after receipt by the Company of
any such request, a list of similar form and content as of a date not more than
15 days prior to the time such list is furnished, excluding from any such list
names and addresses received by the Trustee in its capacity as Note Registrar.

          SECTION 5.11 WAIVER OF STAY, EXTENSION OR USURY LAWS. The Company and
the Guarantor covenant (to the extent that they may lawfully do so) that they
will not at any time insist upon, or plead, or in any manner whatsoever claim or
take the benefit or advantage of, any stay or extension law or any usury law or
other law, which would prohibit or forgive the Company or the Guarantor from
paying all or any portion of the principal of, premium, if any, or interest on
the Notes or the Guarantee as contemplated herein, wherever enacted now or at
any time hereafter in force, or which may affect the covenants or the
performance of this Indenture; and (to the extent that it may lawfully do so)
the Company and the Guarantor each hereby expressly waives all benefit or
advantage of any such law, and covenants that it will not hinder, delay or
impede the execution of any power herein granted to the Trustee, but will suffer
and permit the execution of every such power as though no such law had been
enacted.

          SECTION 5.12 LIMITATION ON RESTRICTED PAYMENTS.

          (a)     The Company shall not, and shall cause its Restricted
Subsidiaries not to, directly or indirectly, (i) declare or pay any dividend on,
or make any distribution to the holders of, any Capital Stock of the Company,
other than dividends or distributions

                                       42
<Page>

payable in Capital Stock of the Company (other than Disqualified Stock); (ii)
repay, redeem or otherwise acquire or retire for value (other than through the
issuance of Capital Stock of the Company (excluding Disqualified Stock)) any
Capital Stock of the Company or any of its Restricted Subsidiaries, other than
any such repayment, redemption, acquisition or retirement of such Capital Stock
held by the Company or its Restricted Subsidiaries; (iii) prepay, repay, redeem,
defease or otherwise acquire or retire for value (other than through the
issuance of Capital Stock of the Company (excluding Disqualified Stock)), prior
to any scheduled maturity, scheduled repayment or scheduled sinking fund
payment, any Indebtedness of the Company or any of its Restricted Subsidiaries
that ranks junior in right of payment to the Notes, except as permitted pursuant
to Section 5.14(b)(vii); or (iv) make any Investment in any Affiliate of the
Company other than (A) an Investment by the Company or any of its Restricted
Subsidiaries in the Company or any such Restricted Subsidiaries or in TFM or any
other Affiliate that is bidding for or has obtained concessions or railroad
assets from the Mexican government with respect to the ownership or operation of
railroads in Mexico, or (B) an Investment by the Company or any Restricted
Subsidiary arising as a result of, or in connection with, a Qualifying
Disposition (the foregoing actions set forth in clauses (i) through (iv) being
referred to hereinafter as "RESTRICTED PAYMENTS") if at the time of any such
Restricted Payment, and after giving effect thereto on a pro forma basis, (1) a
Default or an Event of Default shall have occurred and be continuing, (2) the
Consolidated Net Worth of the Company and its Restricted Subsidiaries shall be
less than $250,000,000, (3) the Company could not incur at least $1.00 of
additional Indebtedness pursuant to Section 5.14(a), or (4) the aggregate amount
of all Restricted Payments declared or made after the Initial Issuance Date
including such Restricted Payment (the value of any such payment, if other than
cash, shall be the value determined in good faith by the Board of Directors and
evidenced by a Board Resolution) shall exceed the sum of:

          (A)     50% of the aggregate Consolidated Net Income (or, in the event
such aggregate Consolidated Net Income shall be a loss, minus 100% of such loss)
of the Company earned subsequent to January 1, 1993 to the end of the fiscal
quarter immediately preceding such Restricted Payment (treated as a single
accounting period), plus

          (B)     the aggregate net cash proceeds received by the Company from
the issuance or sale (other than to a Restricted Subsidiary of the Company)
subsequent to January 1, 1993 of Capital Stock of the Company (excluding
Disqualified Stock) including any such shares issued upon exercise of any
rights, options or warrants or upon the conversion of any Indebtedness of the
Company, plus

          (C)     $10,000,000.

          (b)     The provisions of this Section 5.12 will not prevent (i) the
payment of any dividend within 60 days after the date of its declaration if the
dividend would have been permitted on the date of declaration, (ii) the
purchase, redemption, acquisition or retirement of any shares of Capital Stock
of the Company solely out of the proceeds of the substantially concurrent sale
(other than to a Restricted Subsidiary of the Company) of shares of Capital
Stock (other than Disqualified Stock) or (iii) purchases by the

                                       43
<Page>

Company of shares of its Capital Stock pursuant to the terms of the Company's
share repurchase program as in effect on the Initial Issuance Date. For purposes
of calculating the aggregate amount of Restricted Payments made pursuant to
clause (4) of the first paragraph of Section 5.12(a), (A) payments made under
clauses (i) and (ii) of this Section 5.12(b) shall be included in such amount
and payments made under clause (iii) of this Section 5.12(b) shall be excluded,
provided that dividends paid within 60 days of the date of declaration shall be
deemed to be paid at the date of declaration and (B) any Restricted Payments
made by Grupo Servia prior to the effective date of the Merger shall be
excluded.

          (c)     Prior to making any Restricted Payment under this Section 5.12
(other than a permitted Restricted Payment described in Section 5.12(b)(iii)),
the Company shall deliver to the Trustee an Officers' Certificate setting forth
the computation by which the amount available for Restricted Payments was
determined. The Trustee shall have no duty or responsibility to determine the
accuracy or correctness of this computation and shall be fully protected in
relying on such Officers' Certificate.

          SECTION 5.13 LIMITATION ON TRANSACTIONS WITH AFFILIATES. The Company
shall not, and shall not permit any Restricted Subsidiary of the Company to,
directly or indirectly, sell, lease, transfer or otherwise dispose of any of its
properties or assets to, or purchase or lease any property or assets from, or
enter into any contract, agreement, understanding, loan, advance or guarantee
with, or make any loan, advance or capital contribution to, or for the benefit
of, an Affiliate of the Company or any direct or indirect holder of 10% or more
of the shares of Capital Stock of the Company outstanding or with an Affiliate
of any such holder (an "AFFILIATE TRANSACTION") unless (i) such transaction or
series of transactions is on terms that are no less favorable to the Company or
such Restricted Subsidiary, as the case may be, than would be available in a
comparable arm's length transaction with an unrelated Person, (ii) with respect
to a transaction or series of related transactions involving aggregate
consideration equal to or greater than $1 million, such transaction or series of
related transactions is approved by a majority of the Board of Directors,
including a majority of the disinterested directors and evidenced by a Board
Resolution and (iii) with respect to a transaction or series of related
transactions involving aggregate consideration greater than $10 million, an
opinion as to the fairness of such transaction or series of related transactions
to the Company or such Restricted Subsidiary from a financial point of view is
issued to the Company by an independent investment banking firm of national
standing. Notwithstanding the foregoing, Affiliate Transactions shall not
include (i) the payment of reasonable fees to directors or executive officers of
the Company or any Restricted Subsidiary of the Company; and (ii) any
transaction between or among the Company and any of its Restricted Subsidiaries
in the ordinary course of business and consistent with past practices of the
Company and its Restricted Subsidiaries.

          SECTION 5.14 LIMITATION ON INDEBTEDNESS.

          (a)     Subject to the other provisions of this Section 5.14, the
Company shall not, and shall not permit any Restricted Subsidiary of the Company
to, directly or indirectly, create, incur, issue, suffer to exist, assume,
guarantee or otherwise become

                                       44
<Page>

directly or indirectly liable with respect to, any Indebtedness (collectively,
an "INCURRENCE"), provided that the Company or any of its Restricted
Subsidiaries may incur additional Indebtedness if, at the time of the original
incurrence of such Indebtedness and after giving effect thereto on a pro forma
basis, the Consolidated Debt Service Coverage Ratio for the Company for the four
fiscal quarters immediately preceding such incurrence for which quarterly
financial statements are available in accordance with Section 5.08, taken as one
period, is greater than 2.0 to 1.0.

          (b)     Notwithstanding the foregoing, Indebtedness may be incurred as
follows:

          (i)     Indebtedness of the Company and its Restricted Subsidiaries
existing on the Initial Issuance Date;

          (ii)    Indebtedness of the Company evidenced by the Notes and the
Indenture;

          (iii)   Indebtedness of the Company or a Restricted Subsidiary owing
to a Restricted Subsidiary or the Company, provided that any such Indebtedness
owing by the Company to a Restricted Subsidiary shall rank junior in right of
payment to the Notes;

          (iv)    Acquired Indebtedness of the Company or any Restricted
Subsidiary of the Company, provided that such Indebtedness if incurred by the
Company would be in compliance with paragraph (a) of this Section 5.14;

          (v)     (A) Indebtedness of a Restricted Subsidiary of the Company
under guarantees of Indebtedness otherwise permitted to be incurred pursuant to
this Section 5.14 and (B) Indebtedness of the Company under guarantees of
Indebtedness otherwise permitted to be incurred pursuant to this Section 5.14;

          (vi)    Indebtedness of the Company or a Restricted Subsidiary of the
Company in respect of letters of credit for the benefit of trade vendors issued
in the ordinary course of business in an aggregate amount not exceeding $20
million at any one time outstanding;

          (vii)   Indebtedness issued in exchange for, or the proceeds of which
are used to repay or refund or refinance or discharge or otherwise retire for
value, Indebtedness of the Company or any of its Restricted Subsidiaries
permitted under clauses (i), (ii), (iv), (vii), (viii), (ix) and (x) of this
paragraph (b) or under paragraph (a) above ("REFINANCING INDEBTEDNESS") in a
principal amount (or if such Refinancing Indebtedness provides for an amount
less than the principal amount thereof to be due and payable upon a declaration
of acceleration thereof, with an original issue amount not to exceed such
principal amount), not to exceed the principal amount of the Indebtedness so
refinanced (or, if the Indebtedness being refinanced was issued with original
issue discount, the original issue amount) plus customary fees, expenses and
costs related to the incurrence of such Refinancing Indebtedness; provided that
(A) Refinancing Indebtedness of any Restricted Subsidiary of the Company shall
not be used to refund or refinance outstanding Indebtedness of the Company, and
(B) with respect to any

                                       45
<Page>

Refinancing Indebtedness which refinances Indebtedness which ranks junior in
right of payment to the Notes, (x) such Refinancing Indebtedness is subordinated
in right of payment at least to the same extent as the Indebtedness to be
refunded or refinanced if such Indebtedness had remained outstanding and (y) the
Refinancing Indebtedness has an Average Life and Stated Maturity which is equal
to or greater than the Indebtedness to be repaid or refunded or refinanced or
discharged or otherwise retired for value at the time of such incurrence,
provided further that, for the purpose of determining the amount of Indebtedness
that has been incurred pursuant to any of foregoing enumerated clauses, there
shall be included in each such clause the principal amount then outstanding of
any Indebtedness originally incurred pursuant to such clause and thereafter
refinanced pursuant to this clause (vii) and any subsequent refinancings
thereof.

          (viii)  Indebtedness of the Company or any of its Restricted
Subsidiaries incurred to finance the cost of acquisition, construction,
refurbishing, modification to or alteration of vessels used or to be used in the
business of the Company or its Restricted Subsidiaries;

          (ix)    Indebtedness of the Company or any of its Restricted
Subsidiaries under Currency Agreements and Interest Rate Agreements; provided
that the obligations under such agreements are related to payment obligations
incurred in compliance with this Indenture and that such agreements (a) are
designed solely to protect the Company or its Restricted Subsidiaries against
fluctuations in foreign currency exchange rates or interest rates and (b) do not
increase the Indebtedness of the obligor outstanding at any time other than as a
result of fluctuations in foreign currency exchange rates or interest rates or
by reason of fees, indemnities and compensation payable thereunder;

          (x)     Indebtedness of the Company or any of its Restricted
Subsidiaries in an amount that, when added to the amount of all other
Indebtedness previously incurred and outstanding pursuant to this clause (x),
does not exceed 15% of the Company's Consolidated Net Tangible Assets at the
time such new Indebtedness is incurred; and

          (xi)    Indebtedness, to the extent the net proceeds thereof are
promptly applied to defease any of the Notes as described below under Section
12.1 and to pay fees, expenses, premiums and other payment obligations related
to such defeasance.

          SECTION 5.15 LIMITATION ON DIVIDEND AND OTHER PAYMENT RESTRICTIONS
AFFECTING RESTRICTED SUBSIDIARIES. The Company shall not, and shall not permit
any of its Restricted Subsidiaries to, directly or indirectly, create or
otherwise cause or suffer to exist or become effective any consensual
encumbrance or restriction on the ability of such Restricted Subsidiary to (a)
pay dividends or make any other distributions on its Capital Stock or any other
interest or participation in, or measured by, its profits, owned by, or pay any
Indebtedness owed to, the Company or its Restricted Subsidiaries, (b) make loans
or advances to the Company or its Restricted Subsidiaries, (c) transfer any of
its properties or assets to the Company or its Restricted Subsidiaries or (d)
guarantee any Indebtedness of the Company, except for such encumbrances or
restrictions existing under or by reason of: (i) applicable law; (ii) any
instrument governing Acquired

                                       46
<Page>

Indebtedness permitted to be incurred under Section 5.14, which encumbrances or
restrictions are not applicable to any Person or the properties or assets of any
Person, other than the Person so acquired, or the property or assets of the
Person so acquired or its consolidated Subsidiaries; (iii) any restrictions
existing under agreements in effect on the date of this Indenture; (iv) any
restrictions with respect to a Restricted Subsidiary imposed pursuant to an
agreement which has been entered into for the sale or disposition of all or
substantially all the Capital Stock or assets of such Restricted Subsidiary; (v)
any agreement governing Indebtedness restricting the sale or other disposition
of property securing such Indebtedness if such agreement does not expressly
restrict the ability of a Restricted Subsidiary to pay dividends or to make
distributions, loans or advances; (vi) customary restrictions in leases relating
to property covered thereby; or (vii) this Indenture.

          SECTION 5.16 CHANGE OF CONTROL OR RECEIPT OF VAT PROCEEDS. If (a)
(i) any person or group within the meaning of Section 13(d)(3) of the
Exchange Act (a "GROUP") together with any Affiliates and Associates of any
thereof, other than (A) the Serrano Segovia family, its Affiliates and
Associates, and (B) the CPO Trustee and any successor to the CPO Trustee,
shall beneficially own (within the meaning of Rule 13d-3 under the Exchange
Act) at least 35% of the total voting power of all classes of capital stock
of the Company entitled to vote generally in the election of directors of the
Company; provided that, in the event 100% of the total voting power of all
classes of the Company's Capital Stock entitled to vote generally in the
election of directors of the Company is held by any other Person, a Change of
Control shall be determined with respect to the Company as if the Company was
such other Person; or (ii) the Company is liquidated or dissolved or the
stockholders of the Company adopt a plan for the liquidation or dissolution
of the Company (each a "CHANGE OF CONTROL"); or, (b) TFM (or any successor
entity to TFM) receives (i) prior to the TFM Sale, any amounts in respect of
the currently pending VAT dispute and the Company or any of its Restricted
Subsidiaries receives, directly or indirectly, any cash proceeds from TFM
(whether by way of dividends, advances or the purchase of capital stock or
otherwise), or (ii) at the time of or after the TFM Sale, the additional
amounts payable by KCS upon the receipt by TFM of the VAT payment (each a
"VAT EVENT"), then the Company shall make an offer (an "OFFER") to holders of
the Notes then outstanding, as to clause (a) of this paragraph, to purchase
all of the Notes then outstanding on a date 60 days after a change of control
(the "CHANGE OF CONTROL REPURCHASE DATE") at a purchase price equal to 100%
of their principal amount plus accrued and unpaid interest through the Change
of Control Repurchase Date and additional amounts, if any, and, as to clause
(b) of this paragraph, to apply the net cash VAT Proceeds so received by the
Company or its Restricted Subsidiaries, net of any taxes payable on receipt
of such amounts (but not in excess of the Company's pro rata share of the
amount of the VAT Proceeds received by TFM) to purchase all or any part of
the Notes on a date 60 days after such receipt (the "VAT REPURCHASE DATE") at
100% of the principal amount thereof plus accrued and unpaid interest through
the VAT Repurchase Date and additional amounts, if any. In the event that the
funds available for an Offer pursuant to this paragraph are less than would
be required to redeem all Notes tendered in that Offer, selection for
redemption of Notes that are tendered will be made on a PRO RATA basis or on
as nearly a PRO RATA basis as is practicable (subject to the procedures of
DTC), unless that method is otherwise prohibited by law or the requirements
of the principal national securities exchange, if any, on which the Notes are
then listed, in which case selection shall be by lot or by any other method
as the Trustee shall deem fair and appropriate. No Notes of a principal
amount of $1,000 or less shall be redeemed in part and Notes of a principal
amount in excess of $1,000 may be redeemed in part in multiples of $1,000
only.

          (a)     The Company shall provide the Trustee with notice of an Offer
and with all information required to accompany such notice, not more than ten
days after a Change of Control or VAT Event.

          (b)     Notice of an Offer shall be mailed by the Trustee (at the
Company's expense) not more than ten Business Days after receipt by the
Trustee of the notice in accordance with 5.16(a) to all Holders of the Notes
at their last registered addresses appearing in the Notes Register. The Offer
shall remain open from the time of the mailing until the Change of Control
Repurchase Date or the VAT Repurchase Date, as the case may be. The notice
shall be accompanied by the most recently filed annual report (including
audited consolidated financial statements) of the Company and the most recent
subsequently filed quarterly report of the Company (or in the event the
Company is not required to prepare any of the foregoing reports, the
comparable information required pursuant to Section 5.08). The Company shall
provide the Trustee with copies of all materials to be delivered with such
notice. The notice shall contain all instructions and materials necessary to
enable such Holders to tender Notes pursuant to the Offer. The notice shall
state:

                                       47
<Page>

          (1)     that the Offer is being made pursuant to this Section 5.16,
the reason for the Offer and the amount of Notes tendered that will be
accepted for payment;

          (2)     the material circumstances and relevant material facts
regarding the reasons for the Offer;

          (3)     the purchase price and the Change of Control Repurchase
Date or VAT Repurchase Date, as the case may be;

          (4)     the name and address of the Paying Agent and the Trustee and
that Notes must be surrendered to the Paying Agent to collect the purchase
price;

          (5)     that any Note not tendered or accepted for payment will
continue to accrue interest;

          (6)     that any Note accepted for payment pursuant to the Offer shall
cease to accrue interest after the Repurchase Date;

          (7)     that each Holder electing to have a Note purchased pursuant to
an Offer will be required to surrender the Note, with the form entitled "Option
of Holder to Elect Purchase" on the reverse of the Note completed, to the Paying
Agent at the address specified in the notice prior to the close of business on
the Repurchase Date;

          (8)     that Holders will be entitled to withdraw their election if
the Paying Agent receives, not later than the close of business on the Business
Day immediately preceding the Repurchase Date, a telegram, telex, facsimile
transmission or letter setting forth the name of the Holder, the principal
amount of Notes the Holder delivered for purchase, the certificate number of
Notes the Holder delivered and a statement that such Holder is withdrawing its
election to have such Notes purchased;

          (9)     that Holders will be issued new Notes equal in principal
amount to the unpurchased portion of the Notes surrendered if such Holders only
desire part of such Notes to be purchased; and

          (10)    any other information required by applicable law, rules and
regulations.

          To the extent that any of the procedures relating to the making and
accepting of an Offer conflict with the provisions of the Exchange Act, other
applicable federal or state law, or the regulations which may be promulgated
thereunder, such provisions of the Exchange Act, other applicable federal or
state law, or the regulations which may be promulgated thereunder shall govern
such Offer in lieu of, and only to the extent of, such conflicting procedures.

          (c)     On the Change of Control Repurchase Date or VAT Repurchase
Date, as the case may be, the Company shall (i) accept for payment Notes or
portions thereof surrendered pursuant to the Offer, (ii) deposit with the
Paying Agent money sufficient to pay the purchase price of all Notes or
portions thereof so accepted, and that the Paying Agent will have funds
available to promptly mail or deliver such payments in accordance with the
following sentence, and (iii) deliver to the Trustee

                                       48
<Page>

Notes so accepted together with an Officers' Certificate stating the Notes or
portions thereof accepted for payment by the Company. The Paying Agent shall
promptly mail or deliver to Holders of Notes so accepted payment in an amount
equal to the purchase price, and the Company shall execute and the Trustee shall
promptly authenticate and mail or deliver to such Holders a new Note equal in
principal amount to any unpurchased portion of the Note surrendered if such
Holders only desire portions of their Notes to be purchased. The Company will
publicly announce the results of the Offer on or as soon as practicable after
the Repurchase Date. For purposes of this Section 5.16, the Trustee shall act as
the Paying Agent.

          SECTION 5.17 LIMITATION ON LIENS. The Company shall not, and shall not
permit any Restricted Subsidiary to, create, incur, assume or suffer to exist
any Lien upon any of its property or assets (including assets acquired after the
Initial Issuance Date and Capital Stock of any Restricted Subsidiary of the
Company), except for (i) Liens securing Indebtedness of the Company that ranks
pari passu in right of payment to the Notes, if the Notes are secured equally
and ratably with such Indebtedness; (ii) scheduled Liens outstanding on the
Initial Issuance Date; (iii) Liens for taxes not yet delinquent or which are
being contested in good faith by appropriate proceedings; provided, that
adequate reserves with respect thereto are maintained on the books of the
Company or its Restricted Subsidiaries, as the case may be, in conformity with
IAS; (iv) statutory Liens of landlords and Liens of carriers, warehousemen,
mechanics, materialmen, repairmen or other like Liens arising in the ordinary
course of business and not discharged for a period of not more than 90 days
after notice thereof or which are being contested in good faith by appropriate
proceedings; (v) pledges or deposits in connection with workers' compensation,
unemployment insurance and other social security legislation; (vi) easements,
rights-of-way, restrictions, minor defects or irregularities in title and other
similar encumbrances incurred in the ordinary course of business which, in the
aggregate, are not substantial in amount and which do not in any case materially
detract from the value of the property subject thereto or materially interfere
with the ordinary conduct of the business of the Company or such Restricted
Subsidiary; (vii) any attachment or judgment Lien, unless the judgment it
secures shall not, within 60 days after the entry thereof, have been discharged
or execution thereof stayed pending appeal, or shall not have been discharged
within 60 days after the expiration of any such stay; (viii) Liens securing
Acquired Indebtedness, provided that such Liens attach solely to the assets of
the acquired entity and do not extend to or cover any other assets of the
Company or any of its Restricted Subsidiaries; (ix) Liens to secure all or any
part of the purchase price of property acquired or constructed (including
construction of improvements or additions to improvements on existing property),
or to secure debt incurred solely to finance the acquisition or construction
(including construction of improvements or additions to improvements on existing
property) of such property ("PURCHASE MONEY LIENS"), by the Company or any of
its Restricted Subsidiaries, provided that such Purchase Money Liens (A) attach
solely to the property which is the subject of the transaction giving rise to
such obligation and does not extend to or cover any other property and (B)
attach within 180 days of the date of the acquisition or completion of
construction of such property; (x) pledges by the Company of receivables
relating to property which is the subject of a permitted Purchase Money Lien, in
an aggregate amount not to exceed $50 million at any one time outstanding; (xi)
any interest or title of a lessor pursuant to a lease constituting a

                                       49
<Page>

Capitalized Lease Obligation; (xii) Liens on any assets acquired by the Company
or any of its Restricted Subsidiaries after the Initial Issuance Date, which
Liens were in existence on or prior to the acquisition of such assets (to the
extent that such Liens were not created in contemplation of such acquisition),
provided that such Liens are limited to the asset so acquired and the proceeds
thereof; (xiii) Liens securing Indebtedness owed to the Company by any of its
Restricted Subsidiaries; (xiv) additional Liens ("ADDITIONAL LIENS") securing
Indebtedness outstanding from time to time not greater than the difference
between the amount of outstanding Indebtedness on the Initial Issuance Date
secured by Liens under clause (ii) above ("EXISTING LIENS") and the amount of
outstanding Indebtedness secured by Existing Liens at the time of the creation,
incurrence or assumption of the Additional Lien, provided that the Additional
Lien shall not extend to assets other than those covered by Existing Liens,
except as otherwise permitted hereunder; (xv) restrictions on the disposition of
securities imposed by applicable law or by contract with respect to securities
received in connection with any Qualifying Disposition or interests arising in
connection with any joint venture agreement; and (xvi) any renewal of or
substitution for any Lien permitted by any of the preceding clauses, provided
that the Indebtedness secured is not increased nor the Lien extended to any
additional assets. This Section 5.17 does not authorize the incurrence of any
Indebtedness not otherwise permitted by Section 5.14.

          SECTION 5.18 RESTRICTION ON ASSET DISPOSITIONS.

          (a)     The Company shall not, and shall not permit any of its
Restricted Subsidiaries to, make any Asset Disposition unless (i) the
consideration received from such Asset Disposition is equal to or greater than
the fair market value of the assets or stock sold (as determined in good faith
by the Board of Directors and evidenced by a Board Resolution) and (ii) at least
80% of the consideration received from such Asset Disposition is in the form of
cash; PROVIDED that (A) the amount of (x) any liabilities (as shown on the
Company's or such Restricted Subsidiary's most recent balance sheet or in the
notes thereto) of the Company or such Restricted Subsidiary which are assumed by
the transferee of such assets, including any Indebtedness of a Restricted
Subsidiary whose stock is purchased by the transferee, and (y) any notes or
other obligations received by the Company or any such Restricted Subsidiary from
such transferee that are immediately converted by the Company or such Restricted
Subsidiary into cash (to the extent of the cash received) shall be deemed to be
cash for purposes of this Section 5.18(a) and (B) this clause (ii) shall not
apply in the case of any Qualifying Disposition.

          (b)     The Company may apply, or cause its Restricted Subsidiaries
to apply 100% of such Net Cash Proceeds as follows: (a) other than in the
case of a Major Asset Sale, within 180 days of receipt of Net Cash Proceeds
from such Asset Disposition to (i) the prepayment or repurchase of the Notes
or the prepayment, repayment or repurchase of any other Indebtedness of the
Company and its Restricted Subsidiaries which ranks pari passu with the
Notes; or (ii) the purchase of assets or businesses in the shipping,
transportation and distribution services industry; and (b) in the case of a
Major Asset Sale, within 60 days of the receipt of such Net Cash Proceeds to
the redemption of the Notes in accordance with Article 4 hereof. Any Net Cash
Proceeds which are not applied as permitted by the immediately preceding
sentence shall constitute "Excess Proceeds." If at any time the aggregate
amount of Excess Proceeds exceeds

                                       50
<Page>

5% of the original aggregate principal amount outstanding of the Notes, the
Company shall offer to purchase (a "NET CASH PROCEEDS OFFER") from all
Holders of Notes on a date not later than 60 days after the date on which (x)
in the case of clause (a) above, Excess Proceeds first exceed 5% of the
original aggregate principal amount outstanding of the Notes, and (y) in the
case of clause (b) above, the receipt of cash proceeds from the Major Asset
Sales (the "NET CASH PROCEEDS PURCHASE DATE"), pursuant to the procedures set
forth in Section 5.18(d), the maximum principal amount of Notes that may be
purchased with such Excess Proceeds at a purchase price in cash equal to 100%
of the principal amount thereof plus accrued interest and Additional Amounts,
if any, to the Net Cash Proceeds Purchase Date. Notwithstanding the
foregoing, we may use up to $15 million from the Port Sale for working
capital and payment of expenses relating to the Exchange Offers, the Port
Sale and the TFM sale. To the extent that the aggregate amount of Notes
tendered pursuant to such offer is less than the amount of Excess Proceeds,
the Company shall use such portion of the Excess Proceeds that is not used to
purchase Notes so tendered (i) to reduce Indebtedness of the Company or any
Restricted Subsidiary, (ii) to acquire assets or businesses engaged in the
shipping, transportation and distribution services industry, or (iii) for
general corporate purposes and to pay expenses relating to the Exchange
Offers, the Port Sale and the TFM Sale. Until such time as the Net Cash
Proceeds from any Asset Disposition are applied in accordance with this
Section 5.18(b), such Net Cash Proceeds shall be segregated from the other
assets of the Company and its Restricted Subsidiaries and invested in Cash
Equivalents. For purposes of this Section 5.18, the principal amount of Notes
for which a Net Cash Proceeds Offer shall be made is referred to as the "NET
CASH PROCEEDS OFFER AMOUNT."

          (c)     The Company may credit against its obligation to make a Net
Cash Proceeds Offer pursuant to Section 5.18(b), 100% of the principal amount of
Notes which have been acquired by the Company and surrendered for cancellation
after the making of the Net Cash Proceeds Offer and which have not been used as
a credit against or acquired pursuant to any prior obligation to make an offer
to purchase Notes pursuant to Section 5.16 or this Section 5.18. The Company
shall provide the Trustee with notice of a Net Cash Proceeds Offer and with all
information required to accompany such notice at least 45 days before such Net
Cash Proceeds Purchase Date.

          (d)     Notice of a Net Cash Proceeds Offer shall be mailed by the
Trustee (at the Company's expense) not less than 30 days nor more than 45 days
before the Net Cash Proceeds Purchase Date to the Holders of the Notes at their
last registered addresses appearing in the Note Register. The Net Cash Proceeds
Offer shall remain open from the time of mailing until the Net Cash Proceeds
Purchase Date. The notice shall be accompanied by the most recently filed annual
report (including audited consolidated financial statements) of the Company and
the most recent subsequently filed quarterly report of the Company (or in the
event the Company is not required to prepare any of the foregoing reports, the
comparable information required pursuant to Section 5.08). The Company shall
provide the Trustee with copies of all materials to be delivered with such
notice. The notice shall contain all instructions and materials necessary to
enable such Holders to tender Notes pursuant to the Net Cash Proceeds Offer. The
notice shall state:

          (1)     that the Net Cash Proceeds Offer is being made pursuant to
this Section 5.18 and the reason for the Net Cash Proceeds Offer;

          (2)     the purchase price, the Net Cash Proceeds Offer Amount and the
Net Cash Proceeds Purchase Date;

                                       51
<Page>

          (3)     the name and address of the Paying Agent and the Trustee and
that Notes must be surrendered to the Paying Agent to collect the purchase
price;

          (4)     that any Note not tendered or accepted for payment will
continue to accrue interest;

          (5)     that any Note accepted for payment pursuant to the Net Cash
Proceeds Offer shall cease to accrue interest after Net Cash Proceeds Purchase
Date;

          (6)     that each Holder electing to have a Note purchased pursuant to
a Net Cash Proceeds Offer will be required to surrender the Note, with the form
entitled "Option of Holder to Elect Purchase" on the reverse of the Note
completed, to the Paying Agent at the address specified in the notice prior to
the close of business on the Net Cash Proceeds Purchase Date;

          (7)     that Holders will be entitled to withdraw their election if
the Paying Agent receives, not later than the close of business on the Business
Day immediately preceding the Net Cash Proceeds Purchase Date, a telegram,
telex, facsimile transmission or letter setting forth the name of the Holder,
the principal amount of Notes the Holder delivered for purchase, the certificate
number of the Notes the Holder delivered and a statement that such Holder is
withdrawing its election to have such Notes purchased;

          (8)     that if Notes in a principal amount in excess of the Net Cash
Proceeds Offer Amount are surrendered pursuant to the Net Cash Proceeds Offer,
the Company shall purchase Notes on a pro rata basis (with such adjustments as
may be deemed appropriate by the Company so that only Notes in denominations of
$1,000 or integral multiples of $1,000 shall be acquired);

          (9)     that Holders whose Notes are purchased only in part will be
issued new Notes equal in principal amount to the unpurchased portion of the
Notes surrendered; and

          (10)    any other information required by applicable law, rules and
regulations.

          To the extent that any of the procedures relating to the making and
accepting of a Net Cash Proceeds Offer conflict with the provisions of the
Exchange Act, other applicable federal or state law, or the regulations which
may be promulgated thereunder, such provisions of the Exchange Act, other
applicable federal or state law, or the regulations which may be promulgated
thereunder shall govern such Net Cash Proceeds Offer in lieu of, and only to the
extent of, such conflicting procedures.

          (e)     On the Net Cash Proceeds Purchase Date, the Company shall (i)
accept for payment Notes or portions thereof surrendered pursuant to the Net
Cash Proceeds Offer (on a pro rata basis if required pursuant to paragraph
(d)(8) above), (ii) deposit with the Paying Agent money sufficient to pay the
purchase price of all Notes or portions thereof so accepted, and that the Paying
Agent will have funds available to

                                       52
<Page>

promptly mail or deliver such payments in accordance with the following
sentence, and (iii) deliver to the Trustee Notes so accepted together with an
Officers' Certificate stating the Notes or portions thereof accepted for payment
by the Company. The Paying Agent shall promptly mail to the Holders of Notes so
accepted payment in an amount equal to the purchase price, and the Company shall
execute and the Trustee shall promptly authenticate and mail or deliver to such
Holders a new Note equal in principal amount to any unpurchased portion of the
Note surrendered. Any Notes not so accepted shall be promptly mailed or
delivered by the Company to the Holders thereof. The Company will publicly
announce the results of the Net Cash Proceeds Offer on or as soon as practicable
after the Net Cash Proceeds Purchase Date. For purposes of this Section 5.18,
the Trustee shall act as the Paying Agent.

          SECTION 5.19 LIMITATION ON SALE AND LEASEBACK TRANSACTIONS. The
Company shall not, and shall not permit any Restricted Subsidiary to, enter into
any sale and leaseback transaction unless (i) the Company or such Restricted
Subsidiary could have incurred Indebtedness and secured a Lien on Indebtedness
in an amount equal to the Attributable Debt relating to such sale and leaseback
transaction pursuant to the provisions of Sections 5.14 and 5.17 or (ii) the
proceeds of such sale and leaseback transaction are at least equal to the fair
value (as determined in good faith by the Board of Directors and evidenced by a
Board Resolution) of the property and the Company or such Restricted Subsidiary
applies or causes to be applied an amount in cash equal to the net proceeds from
such sale to (A) purchase Notes or Indebtedness ranking pari passu with the
Notes or (B) purchase assets or businesses in the shipping, transportation and
distribution services industry, in each case within 180 days of the effective
date of any such sale.

          SECTION 5.20 LIMITATION ON ISSUANCE OF SUBORDINATED INDEBTEDNESS. The
Company shall not, directly or indirectly, incur, create or assume any
Indebtedness of the Company (other than Indebtedness of the Company which is
convertible into Capital Stock (other than Disqualified Stock) of the Company)
which (i) is subordinate or junior in right of payment of principal, premium, if
any, or interest to the Notes and (ii) requires any principal payment,
redemption payment or sinking fund payment thereon, or purchase thereof, in
whole or in part, to be made prior to the final Stated Maturity of the Notes;
provided that this Section 5.20 shall not prohibit the incurrence of
Indebtedness owing by the Company to any Restricted Subsidiary.

          SECTION 5.21 LIMITATION ON INVESTMENTS. The Company shall not, and
shall not permit any of its Restricted Subsidiaries to, make any Investment in
any Person except: (i) any Investment in any Cash Equivalent; (ii) any
Investment in an amount not in excess of the amount of Restricted Payments that
the Company would be permitted to make under Section 5.12 immediately prior to
the making of such Investment; (iii) Investments in any Person engaged in the
same or a similar line of business as the Company and its consolidated
Subsidiaries or made for the purpose of maintaining, enhancing the productivity
of or expanding the capabilities of the Company and its consolidated
Subsidiaries in the worldwide transportation, shipping and distribution services
industry, including Investments that are part of, or directly related to, a
Qualifying PEMEX Securitization Transaction; (iv) Investments, not to exceed

                                       53
<Page>

$15 million at any one time outstanding, in the publicly traded equity
securities of any other companies; (v) Investments arising as a result of a
Qualifying Disposition; or (vi) scheduled Investments existing on the Initial
Issuance Date.

          SECTION 5.22 [Intentionally omitted.]

                                       54
<Page>

          SECTION 5.23 LIMITATION ON BUSINESS ACTIVITIES. The Company shall not,
and shall not permit any of the Restricted Subsidiaries to, engage in any type
of business other than the businesses the Company and its consolidated
Subsidiaries are engaged in on the date of the Indenture, other business
activities within the worldwide transportation, shipping and distribution
services industry, and other business activities complementary, incidental or
reasonably related thereto.

          SECTION 5.24 ADDITIONAL COVENANTS APPLICABLE TO THE COMPANY, THE
GUARANTOR AND TMM MULTIMODAL.

          (a)     The Company shall not assign, transfer, sell or otherwise
divest of any of its ownership interest in the Guarantor while the Guarantee is
in effect.

                                       55
<Page>

          (b)     The Company shall cause the Guarantor and TMM Multimodal not
to, and the Company and the Guarantor shall not and shall cause TMM Multimodal
not to:

                  (i)     directly or indirectly, create, incur, issue, suffer
     to exist, assume, guarantee or otherwise become directly or indirectly
     liable with respect to, any Indebtedness, except for, in the case of the
     Guarantor, the Guarantee;

                  (ii)    create, incur, assume or suffer to exist any Lien upon
     any of its property or assets (including assets acquired after the date of
     this Indenture), except for Liens for taxes, assessments or other
     governmental charges not yet delinquent;

                  (iii)   except in accordance with Section 5.22 or in a
     Qualifying Disposition, sell, assign, lease, transfer or hedge, directly or
     indirectly, any shares of common stock of TMM Multimodal, in the case of
     the Guarantor, or any shares of common stock of Grupo TFM, in the case of
     TMM Multimodal, held on or after the date of this Indenture; provided that
     such shares may be sold for cash so long as any Net Cash Proceeds from such
     sale are promptly and irrevocably deposited with the Trustee under the
     terms of an irrevocable trust agreement in form and substance satisfactory
     to the Trustee, as trust funds in trust solely for the benefit of the
     Holders for the purpose of payment of principal and interest on the
     Outstanding Notes, in the form of money or U.S. Government Obligations, and
     the Trustee shall have been irrevocably instructed to apply such trust
     funds to the payment of principal and interest on the Outstanding Notes; or

                  (iv)    engage in any business activity except as required or
     contemplated under this Indenture.

          SECTION 5.25 PAYMENTS FOR CONSENT. None of the Company, any of its
consolidated Subsidiaries or any of their respective Affiliates shall, directly
or indirectly, pay or cause to be paid any consideration, whether by way of
interest, fee or otherwise, to any Holder of any Notes for or as an inducement
to any consent, waiver or amendment of any of the terms or provisions of this
Indenture or the Notes unless such consideration is offered to be paid or agreed
to be paid to all Holders of the Notes which so consent, waive or agree to amend
in the time frame set forth in the solicitation documents relating to such
consent, waiver or agreement.

          SECTION 5.26 COVENANT SUSPENSION.

     (a)  During any Suspension Period, the Company and its Restricted
Subsidiaries shall not be subject to, and no Event of Default shall occur based
on any breach by the Company or a Restricted Subsidiary of, the provisions of
Sections 5.12, 5.14, 5.16, 5.18, 5.20, 5.21 and 5.23, and paragraphs (3) and (4)
of Section 11.01. Subject to the preceding sentence, (i) for purposes of Section
5.12, (A) any Restricted Payments made on or after a Reversion Date shall be
calculated as if such covenant had been in

                                       56
<Page>

effect during the entire period of time from the Initial Issuance Date, and (B)
such covenant shall not prohibit any payments in respect of any Indebtedness
incurred during any Suspension Period that ranks junior in right of payment to
the Notes (provided that any such payments shall be taken into account for
purposes of calculating the ability of the Company to make other Restricted
Payments hereunder); (ii) for purposes of Section 5.14, on the Reversion Date,
all Indebtedness incurred during the applicable Suspension Period shall be
deemed to have been incurred (A) pursuant to Section 5.14(a) or an applicable
provision of Section 5.14(b), as determined by the Company (to the extent that
such Indebtedness would be permitted to be incurred under any such provision as
of the Reversion Date and after giving effect to any Indebtedness incurred
during the Suspension Period and outstanding on the Reversion Date), and (B) to
the extent not permitted by clause (A), shall be deemed to be Indebtedness
existing on the Initial Issuance Date; and (iii) for purposes of compliance with
Section 5.23, any activities engaged in by the Company and its Restricted
Subsidiaries on the Reversion Date shall be deemed to have been engaged in by
the Company and its Restricted Subsidiaries on the date of this Indenture.

     (b)  On and after the first Suspension Date, if any, to occur, the
Guarantor shall no longer be subject to, and no Event of Default shall occur
based on any breach by the Guarantor of, Sections 5.02, 5.09, 5.11, 5.22 and
5.24.

                                   ARTICLE SIX

                                    REMEDIES

          SECTION 6.01 EVENTS OF DEFAULT. "EVENT OF DEFAULT," wherever used
herein, means any one of the following events:

          (1)     default in the payment of any interest or Additional Amount
upon any Note when it becomes due and payable, and continuance of such default
for a period of 30 days; or

          (2)     default in the payment of the principal of (or premium, if
any, on) any Note when due or at its maturity; or

          (3)     default in the observance or performance by the Company of its
obligations under Section 5.04 or Article Eleven; or

          (4)     default in the performance, or breach, of any other covenant
or warranty of the Company or the Guarantor in this Indenture (other than a
covenant or warranty a default in whose performance or whose breach is elsewhere
in this Section specifically dealt with), and continuance of such default or
breach for a period of 30 days after there has been given, by registered or
certified mail, to the Company by the Trustee or to the Company and the Trustee
by the Holders of at least 25% in principal amount of the Outstanding Notes a
written notice specifying such default or breach and requiring it to be remedied
and stating that such notice is a "Notice of Default" hereunder; or

                                       57
<Page>

          (5)     a default under any bond, debenture, note or other evidence
of indebtedness for money borrowed by the Company other than under untendered
9 1/2% Notes due 2003 or any Restricted Subsidiary or under any mortgage,
indenture or instrument under which there may be issued or by which there may
be secured or evidenced indebtedness for money borrowed, individually or in
the aggregate, in excess of $10,000,000, whether such indebtedness now exists
or shall hereafter be created, which default shall constitute a failure to
pay any portion of the principal of such indebtedness when due and payable or
shall have resulted in such indebtedness becoming or being declared due and
payable prior to the date on which it would otherwise have become due and
payable; or

          (6)     the failure of the Guarantor to continue to hold unencumbered
the common stock of TMM Multimodal held by it on the date of this Indenture (or
such other securities as may be held by the Guarantor in lieu of such common
stock following a Qualifying Disposition), or the failure of TMM Multimodal to
continue to hold unencumbered the common stock of Grupo TFM held by it on the
date of this Indenture (or such other securities as may be held by TMM
Multimodal in lieu of such common stock following a Qualifying Disposition);

          (7)     the entry by a court having jurisdiction in the premises of
(A) a decree or order for relief in respect of the Company or any Restricted
Subsidiary in an involuntary case or proceeding under any applicable Federal or
State bankruptcy, insolvency, reorganization or other similar law (each, a
"BANKRUPTCY LAW") or (B) a decree or order adjudging the Company or any
Restricted Subsidiary a bankrupt or insolvent, or approving as properly filed a
petition seeking reorganization, arrangement, adjustment or composition of or in
respect of the Company or any Restricted Subsidiary under any Bankruptcy Law, or
appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or
other similar official of the Company or any Restricted Subsidiary or of any
substantial part of its property, or ordering the winding up or liquidation of
its affairs, and the continuance of any such decree or order for relief or any
such other decree or order unstayed and in effect for a period of 90 consecutive
days;

          (8)     the commencement by the Company or any Restricted Subsidiary
of a voluntary case or proceeding under any applicable Federal or State
bankruptcy, insolvency, reorganization or other similar law or of any other case
or proceeding to be adjudicated a bankrupt or insolvent, or the consent by the
Company or any Restricted Subsidiary to the entry of a decree or order for
relief in respect of the Company or such Restricted Subsidiary in an involuntary
case or proceeding under any Bankruptcy Law (each, a "BANKRUPTCY LAW") or to the
commencement of any bankruptcy or insolvency case or proceeding against it, or
the filing by it of a petition or answer or consent seeking reorganization or
relief under any applicable Bankruptcy Law, or the consent by it to the filing
of such petition or to the appointment of or taking possession by a custodian,
receiver, liquidator, assignee, trustee, sequestrator or similar official of the
Company or such Restricted Subsidiary or of any substantial part of its
property, or the making by it of an assignment for the benefit of creditors, or
the admission by it in writing of its inability to pay its debts generally as
they become due, or the taking of corporate action by the Company or such
Restricted Subsidiary in furtherance of any such action; or

                                       58
<Page>

          (9)     a final judgment or final judgments for the payment of money
are entered by a court of competent jurisdiction against the Company or any
Restricted Subsidiary and either (A) an enforcement proceeding shall have been
commenced by any creditor upon such judgment or (B) such judgment remains
unsettled, undischarged or unstayed for a period (during which execution shall
not be effectively stayed) of 60 consecutive days after such judgment becomes
final, provided that the aggregate of all such judgments exceeds $10,000,000.

          SECTION 6.02 ACCELERATION OF MATURITY; RESCISSION AND ANNULMENT. If an
Event of Default occurs and is continuing, then and in every such case the
Trustee or the Holders of not less than 25% in principal amount of the
Outstanding Notes may declare the principal of all the Notes to be due and
payable immediately, by a notice in writing to the Company (and to the Trustee
if given by Holders), and upon any such declaration such principal shall become
immediately due and payable.

          At any time after such a declaration of acceleration has been made and
before a judgment or decree for payment of the money due has been obtained by
the Trustee as hereinafter in this Article provided, the Holders of a majority
in principal amount of the Outstanding Notes, by written notice to the Company
and the Trustee, may rescind and annul such declaration and its consequences if:

          (1)     the Company has paid or deposited with the Trustee a sum
sufficient to pay

          (A)     all overdue interest and Additional Amounts, if any, on all
Notes,

          (B)     the principal of (and premium, if any, on) any Notes which
have become due otherwise than by such declaration of acceleration and interest
thereon at the rate borne by the Notes,

          (C)     to the extent that payment of such interest is lawful,
interest upon overdue interest and Additional Amounts, if any, at the rate borne
by the Notes, and

          (D)     all sums paid or advanced by the Trustee hereunder and the
reasonable compensation, expenses, disbursements and advances of the Trustee,
its agents and counsel; and

          (2)     all Events of Default, other than the non-payment of the
principal of Notes which have become due solely by such declaration of
acceleration, have been cured or waived as provided in Section 6.12.

          No such rescission shall affect any subsequent default or impair any
right consequent thereon.

          SECTION 6.03 COLLECTION OF INDEBTEDNESS BY TRUSTEE; TRUSTEE MAY PROVE
DEBT. The Company covenants that:

                                       59
<Page>

          (1)     in case default shall be made in the payment of any
installment of interest or Additional Amounts on any of the Notes, as and when
the same shall become due and payable, and such default shall have continued for
a period of 30 days, or

          (2)     in case default shall be made in the payment of the principal
of or premium, if any, on any of the Notes when and as the same shall have
become due and payable, whether upon maturity of the Notes or upon redemption or
upon declaration or otherwise,

then, upon demand of the Trustee, the Company will pay to the Trustee, for the
benefit of the Holders of such Notes, the whole amount that then shall have
become due and payable on such Notes for principal and premium, if any, interest
and Additional Amounts with interest upon the overdue principal and premium, if
any, of each such Note and (to the extent legally enforceable under applicable
law) upon any installments of interest and Additional Amounts, at the rate borne
by the Notes; and, in addition thereto, such further amount as shall be
sufficient to cover the costs and expenses of collection, including a reasonable
compensation to the Trustee, its agents, attorneys and counsel, and any expenses
or liabilities incurred by the Trustee hereunder.

          In addition to the rights and powers set forth in Section 317(a) of
the Trust Indenture Act, the Trustee shall be entitled to file such other papers
or documents as may be necessary or advisable in order to have the claims of the
Trustee and of the Holders of the Notes allowed in any judicial proceeding
relative to the Company, the Guarantor or other obligor upon the Notes, its
creditors, or its property, and to collect and receive any moneys or other
property payable or deliverable on any such claims, and to distribute the same
after the deduction of its charges and expenses; and any receiver, assignee or
trustee in bankruptcy or reorganization is hereby authorized by each of the
Holders to make such payments to the Trustee, and, in the event that the Trustee
shall consent to the making of such payments directly to the Holders, to pay to
the Trustee any amount due it for compensation and expenses, including counsel
fees incurred by it up to the date of such distribution.

          If an Event of Default occurs and is continuing, the Trustee may in
its discretion proceed to protect and enforce its rights and the rights of the
Holders by such appropriate judicial proceedings as the Trustee shall deem most
effectual to protect and enforce such rights, whether for the specific
enforcement of any covenant or agreement in this Indenture or in aid of the
exercise of any power granted herein, or to enforce any other proper remedy.

          SECTION 6.04 TRUSTEE MAY FILE PROOFS OF CLAIM. In case of the pendency
of any receivership, insolvency, liquidation, bankruptcy, reorganization,
arrangement, adjustment, composition or other judicial proceeding relative to
the Company, the Guarantor or any other obligor upon the Notes or the property
of the Company, the Guarantor or of such other obligor or their creditors, the
Trustee (irrespective of whether the principal of the Notes shall then be due
and payable as therein expressed or by declaration or otherwise and irrespective
of whether the Trustee shall have made any demand on the Company for the payment
of overdue principal or

                                       60
<Page>

interest) shall be entitled and empowered, by intervention in such proceeding or
otherwise,

          (i)     to file and prove a claim for the whole amount of principal
(and premium, if any) and interest owing and unpaid in respect of the Notes and
to file such other papers or documents as may be necessary or advisable in order
to have the claims of the Trustee and any predecessor trustee (including any
claim for the reasonable compensation, expenses, disbursements and advances of
the Trustee and any predecessor trustee, their agents and counsel) and of the
Holder allowed in such judicial proceeding, and

          (ii)    to collect and receive any moneys or other property payable or
deliverable on any such claims and to distribute the same; and any custodian,
receiver, assignee, trustee, liquidator, sequestrator or other similar official
in any such judicial proceeding is hereby authorized by each Holder to make such
payments to the Trustee and, in the event that the Trustee shall consent to the
making of such payments directly to the Holders, to pay to the Trustee any
amount due it for the reasonable compensation, expenses, disbursements and
advances of the Trustee and any predecessor trustee, their agents and counsel,
and any other amounts due the Trustee and any predecessor trustee under
Section 7.06.

          Nothing herein contained shall be deemed to authorize the Trustee to
authorize or consent to or accept or adopt on behalf of any Holder any plan of
reorganization, arrangement, adjustment or composition affecting the Notes or
the rights of any Holder thereof or to authorize the Trustee to vote in respect
of the claim of any Holder in any such proceeding.

          SECTION 6.05 TRUSTEE MAY ENFORCE CLAIMS WITHOUT POSSESSION OF NOTES.
All rights of action and claims under this Indenture or the Notes (including the
Guarantee) may be prosecuted and enforced by the Trustee without the possession
of any of the Notes or the production thereof in any proceeding relating
thereto, and any such proceeding instituted by the Trustee shall be brought in
its own name as trustee of an express trust, and any recovery of judgment shall,
after provision for the payment of the reasonable compensation, expenses,
disbursements and advances of the Trustee, its agents and counsel, be for the
ratable benefit of the Holders of the Notes in respect of which such judgment
has been recovered.

          SECTION 6.06 APPLICATION OF MONEY OR PROPERTY COLLECTED. Subject to
Article Thirteen, any money or property collected by the Trustee pursuant to
this Article shall be applied in the following order, at the date or dates fixed
by the Trustee and, in case of the distribution of such money or property on
account of principal (or premium, if any), interest or Additional Amounts, upon
presentation of the Notes and the notation thereon of the payment if only
partially paid and upon surrender thereof if fully paid:

          FIRST: To the payment of all amounts due the Trustee and any
predecessor trustee under Section 7.06; and

                                       61
<Page>

          SECOND: To the payment of the amounts then due and unpaid for
principal of (and premium, if any), interest and Additional Amounts on the Notes
in respect of which or for the benefit of which such money or property has been
collected, ratably, without preference or priority of any kind, according to the
amounts due and payable on such Notes for principal (and premium, if any) and
interest and Additional Amounts, respectively.

          SECTION 6.07 LIMITATION ON SUITS. No Holder of any Note shall have any
right to institute any proceeding, judicial or otherwise, with respect to this
Indenture, or for the appointment of a receiver or trustee, or for any other
remedy hereunder, unless

          (1)     such Holder has previously given written notice to the Trustee
of a continuing Event of Default;

          (2)     the Holders of not less than 25% in aggregate principal amount
of the Outstanding Notes shall have made written request to the Trustee to
institute proceedings in respect of such Event of Default in its own name as
Trustee hereunder;

          (3)     such Holder or Holders have offered to the Trustee reasonable
indemnity against the costs, expenses and liabilities to be incurred in
compliance with such request;

          (4)     the Trustee for 60 days after its receipt of such notice,
request and offer of indemnity has failed to institute any such proceeding; and

          (5)     no direction inconsistent with such written request has been
given to the Trustee during such 60-day period by the Holders of a majority in
aggregate principal amount of the Outstanding Notes;

          it being understood and intended that no one or more Holders shall
have any right in any manner whatever by virtue of, or by availing of, any
provision of this Indenture to affect, disturb or prejudice the rights of any
other Holders, or to obtain or to seek to obtain priority or preference over any
other Holders or to enforce any right under this Indenture, except in the manner
herein provided and for the equal and ratable benefit of all the Holders.

          SECTION 6.08 RESTORATION OF RIGHTS AND REMEDIES. If the Trustee or any
Holder has instituted any proceeding to enforce any right or remedy under this
Indenture and such proceeding has been discontinued or abandoned for any reason,
or has been determined adversely to the Trustee or to such Holder, then and in
every such case, subject to any determination in such proceeding, the Company,
the Trustee and the Holders shall be restored severally and respectively to
their former positions hereunder and thereafter all rights and remedies of the
Trustee and the Holders shall continue as though no such proceeding had been
instituted.

          SECTION 6.09 RIGHTS AND REMEDIES CUMULATIVE. Except as otherwise
provided with respect to the replacement or payment of mutilated, destroyed,
lost or stolen Notes in the last paragraph of Section 3.06, no right or remedy
herein conferred

                                       62
<Page>

upon or reserved to the Trustee or to the Holders is intended to be exclusive of
any other right or remedy, and every right and remedy shall, to the extent
permitted by law, be cumulative and in addition to every other right and remedy
given hereunder or now or hereafter existing at law or in equity or otherwise.
The assertion or employment of any right or remedy hereunder, or otherwise,
shall not prevent the concurrent assertion or employment of any other
appropriate right or remedy.

          SECTION 6.10 DELAY OR OMISSION NOT WAIVER. No delay or omission of the
Trustee or of any Holder of any Note to exercise any right or remedy accruing
upon any Event of Default shall impair any such right or remedy or constitute a
waiver of any such Event of Default or an acquiescence therein. Every right and
remedy given by this Article or by law to the Trustee or to the Holders may be
exercised from time to time, and as often as may be deemed expedient, by the
Trustee or by the Holders, as the case may be.

          SECTION 6.11 CONTROL BY HOLDERS. The Holders of a majority in
principal amount of the Outstanding Notes shall have the right to direct the
time, method and place of conducting any proceeding for any remedy available to
the Trustee or exercising any trust or power conferred on the Trustee, provided
that

          (1)     direction shall not be in conflict with any rule of law or
with this Indenture,

          (2)     the Trustee may take any other action deemed proper by the
Trustee which is not inconsistent with such direction, and

          (3)     the Trustee may decline to follow any such direction if the
Trustee in good faith by its board of directors or executive committee of
directors or Responsible Officers of the Trustee shall determine that the action
or proceeding so directed would involve it in personal liability, or if the
Trustee in good faith shall determine that the actions or forbearances specified
in or pursuant to such direction would be unduly prejudicial to the interests of
Holders not joining in the giving of such direction, it being understood that
the Trustee shall have no duty to ascertain whether or not such actions or
forbearances are unduly prejudicial to such Holders.

          SECTION 6.12 WAIVER OF PAST DEFAULTS. The Holders of not less than a
majority in aggregate principal amount of the Outstanding Notes may on behalf of
the Holders of all the Notes waive any past default hereunder and its
consequences, except a default

          (1)     in the payment of the principal of (or premium, if any),
interest or Additional Amounts on any Note, or

          (2)     in respect of a covenant or provision hereof which under
Article Ten cannot be modified or amended without the consent of the Holder of
each Outstanding Note affected.

                                       63
<Page>

          Upon any such waiver, such default shall cease to exist, and any Event
of Default arising therefrom shall be deemed to have been cured, for every
purpose of this Indenture; but no such waiver shall extend to any subsequent or
other default or impair any right consequent thereon.

                                  ARTICLE SEVEN

                             CONCERNING THE TRUSTEE

          SECTION 7.01 DUTIES OF TRUSTEE.

          (a)     If an Event of Default has occurred and is continuing, the
Trustee shall exercise such of the rights and powers vested in it by this
Indenture and use the same degree of care and skill in their exercise as a
prudent person would exercise or use under the circumstances in the conduct of
its own affairs.

          (b)     Except during the continuance of an Event of Default:

          (1)     The Trustee need perform only those duties that are
specifically set forth in this Indenture and no others.

          (2)     In the absence of bad faith on its part, the Trustee may
conclusively rely, as to the truth of the statements and the correctness of the
opinions expressed therein, upon certificates or opinions furnished to the
Trustee and conforming to the requirements of this Indenture, but in the case of
any certificate or opinion which by any provision hereof is specifically
required to be furnished to the Trustee or which the Trustee relies on, the
Trustee shall examine the certificates and opinions submitted to determine
whether or not they conform to the requirements of this Indenture.

          (c)     The Trustee may not be relieved from liability for its
negligent actions, its negligent failure to act or its willful misconduct,
except that:

          (1)     This paragraph does not limit the effect of paragraph (b) of
this Section 7.01;

          (2)     The Trustee shall not be liable for any error of judgment made
in good faith by a Responsible Officer, unless it is proved that the Trustee was
negligent in ascertaining the pertinent facts;

          (3)     The Trustee shall not be liable with respect to any action it
takes or omits to take in good faith in accordance with a direction received by
it pursuant to Section 6.11; and

          (4)     No provision of this Indenture shall require the Trustee to
expend or risk its own funds or otherwise incur any financial liability in the
performance of any of its duties hereunder or in the exercise of any of its
rights or powers if it shall have reasonable grounds for believing that
repayment of such funds or adequate indemnity against such risk or liability is
not reasonably assured to it.

                                       64
<Page>

          (d)     Every provision of this Indenture that in any way relates to
the Trustee is subject to paragraphs (a), (b) and (c) of this Section 7.01.

          (e)     The Trustee may refuse to perform any duty or exercise any
right or power unless it receives indemnity satisfactory to it against any loss,
cost, liability or expense.

          (f)     The Trustee shall not be liable for interest on any money
received by it.

          (g)     Money held in trust by the Trustee need not be segregated from
other funds except to the extent required by law.

          (h)     The Trustee shall make payments pursuant to Sections 5.01,
5.16 and 5.18 to the Holders as soon as practicable after receipt from the
Company of the funds.

          SECTION 7.02 CERTAIN RIGHTS OF TRUSTEE. Except as otherwise provided
in Section 315 of the Trust Indenture Act:

          (a)     The Trustee may rely and shall be protected in acting, or
refraining from acting, upon any resolution, certificate, statement, instrument,
opinion, report, notice, request, consent, order, bond, debenture or other paper
or document believed by it to be genuine and to have been signed or presented by
the proper party or parties;

          (b)     Any request, direction, order or demand of the Company
mentioned herein shall be sufficiently evidenced by an instrument signed in the
name of the Company by the (i) Chairman of the Board of Directors, a Vice
Chairman of the Board of Directors, its President or any Vice President and (ii)
its Secretary or an Assistant Secretary or its Treasurer or an Assistant
Treasurer (unless other evidence in respect thereof be herein specifically
prescribed); and any resolution of the Board of Directors may be evidenced to
the Trustee by a copy thereof certified by the Secretary or an Assistant
Secretary of the Company;

          (c)     Before it acts or refrains from acting, the Trustee may
consult with counsel and the advice of counsel or any Opinion of Counsel shall
be full and complete authorization and protection in respect of any action
taken, suffered or omitted by it hereunder in good faith and in reliance
thereon;

          (d)     The Trustee shall be under no obligation to exercise any of
the rights or powers vested in it by this Indenture at the request, order or
direction of any of the Holders, pursuant to the provisions of this Indenture,
unless such Holders shall have offered to the Trustee reasonable security or
indemnity against the costs, expenses and liabilities which may be incurred
therein or thereby;

          (e)     The Trustee shall not be liable for any action taken, suffered
or omitted by it in good faith and believed by it to be authorized or within the
discretion or rights or powers conferred upon it by this Indenture;

                                       65
<Page>

          (f)     Prior to the occurrence of an Event of Default hereunder and
after the curing or waiving of all Events of Default the Trustee shall not be
bound to make any investigation into the facts or matters stated in any
resolution, certificate, statement, instrument, opinion, report, notice,
request, consent, order, approval, appraisal, bond, debenture or other paper or
document with respect to the Notes unless requested in writing so to do by the
Holders of not less than a majority in aggregate principal amount of the Notes
then Outstanding; provided, however, that (i) if the Trustee shall determine to
make such further inquiry or investigation, it shall be entitled to examine,
during normal business hours and upon reasonable notice, the books, records and
premises relevant to such inquiry or investigation, either personally or by
agent or attorney; and (ii) if the payment within a reasonable time to the
Trustee of the costs, expenses or liabilities likely to be incurred by it in the
making of such investigation is, in the opinion of the Trustee, not reasonably
assured to the Trustee by the security afforded to it by the terms of this
Indenture, the Trustee may require reasonable indemnity against such expenses or
liabilities as a condition to so proceeding. The reasonable expense of every
such investigation shall be paid by the Company or, if paid by the Trustee,
shall be repaid by the Company upon demand;

          (g)     The Trustee may execute any of the trusts or powers hereunder
or perform any duties hereunder either directly or by or through agents or
attorneys, and the Trustee shall not be responsible for any misconduct or
negligence on the part of any agent or attorney appointed with due care by it
hereunder;

          (h)     The Trustee shall not be deemed to have knowledge of a default
or Event of Default until a Responsible Officer has received written notice
thereof; and

          (i)     The Trustee shall not have any duty, express or implied, to
monitor the financial condition of the Company.

          SECTION 7.03 TRUSTEE NOT RESPONSIBLE FOR RECITALS, ETC. The recitals
contained herein and in the Notes and the Guarantee, except the Trustee's
certificate and the representation as to the power of the Trustee to enter into
this Indenture and accept and execute the trusts hereby created, shall be taken
as the statements of the Company and the Guarantor, and the Trustee assumes no
responsibility for the correctness of the same. The Trustee makes no
representations as to the validity or sufficiency of this Indenture or of the
Notes. The Trustee shall not be (i) accountable for the use or application by
the Company of any of the Notes or of the proceeds of such Notes, (ii)
accountable for any money paid to the Company, or upon the Company's direction,
if made under and in accordance with any provision of this Indenture, or (iii)
responsible for the use or application of any money received by any Paying Agent
other than itself.

          SECTION 7.04 TRUSTEE AND OTHERS MAY HOLD NOTES. The Trustee or any
Paying Agent or Note Registrar or any other agent of the Company or the Trustee,
in its individual or any other capacity, may become the owner or pledgee of
Notes and may otherwise deal with the Company or any other obligor on the Notes
with the same rights it would have if it were not Trustee, Paying Agent, Note
Registrar or such other agent.

                                       66
<Page>

          SECTION 7.05 MONEYS HELD BY TRUSTEE OR PAYING AGENT. Subject to
Sections 12.02 and 12.03, all moneys received by the Trustee or any Paying Agent
shall, until used or applied as herein provided, be held in trust for the
purposes for which they were received, but need not be segregated from other
funds except to the extent required by law. Neither the Trustee nor any Paying
Agent shall be under any liability for interest on any moneys received by it
hereunder except such as it may agree with the Company to pay thereon. So long
as no Event of Default other than an Event of Default under subparagraph (3) of
Section 6.01 shall have occurred and be continuing, all interest allowed on any
such moneys shall be paid from time to time upon a Company Order. The provisions
of this Section 7.05 shall not apply to the Company acting as its own Paying
Agent pursuant to Section 5.03.

          SECTION 7.06 COMPENSATION OF TRUSTEE AND ITS LIEN. The Company
covenants and agrees to pay to the Trustee from time to time, and the Trustee
shall be entitled to, reasonable compensation for all services rendered by it
hereunder (which shall be agreed to from time to time by the Company and the
Trustee and which shall not be limited by any provision of law in regard to the
compensation of a trustee of an express trust), and, except as herein otherwise
expressly provided, the Company will pay or reimburse the Trustee upon its
request for all reasonable expenses, disbursements and advances incurred or made
by the Trustee in accordance with any of the provisions of this Indenture
(including the reasonable compensation and the expenses and disbursements of its
counsel and of all persons not regularly in its employ) except any such expense,
disbursement or advance as may arise from its negligence or bad faith. If any
property other than cash shall at any time be subject to the lien of this
Indenture, the Trustee, if and to the extent authorized by a receivership or
bankruptcy court of competent jurisdiction or by the supplemental instrument
subjecting such property to such lien, shall be entitled to make advances for
the purpose of preserving such property or of discharging tax liens or other
prior liens or encumbrances thereon.

          Subject to the further provisions of this paragraph, the Company also
covenants and agrees to indemnify the Trustee for, and to hold it harmless
against, any loss, liability, claim, damage or expense incurred without
negligence or bad faith on the part of the Trustee, arising out of or in
connection with the acceptance or administration of the trust or trusts
hereunder, including liability which the Trustee may incur as a result of
failure to withhold, pay or report taxes arising out of the transactions
contemplated by this Indenture (other than taxes based on the Trustee's income)
and including the costs and expenses of defending itself against any claim or
liability in the premises. The Trustee shall notify the Company promptly of any
claim for which it may seek indemnity. The Company shall defend the claim, and
the Trustee shall cooperate in the defense. The Trustee may have separate
counsel, and the Company shall pay the reasonable fees and expenses of such
counsel. The Company shall have no obligation to pay for any settlement of any
such claim made without its consent.

          The obligations of the Company under this Section shall constitute
additional indebtedness hereunder. Such additional indebtedness shall be secured
by a lien prior to that of the Notes upon all property and funds held or
collected by the Trustee as such, except funds held in trust for the benefit of
the Holders of particular Notes.

                                       67
<Page>

          When the Trustee incurs expenses or renders services after an Event of
Default specified in Section 6.01(7) or (8) occurs, the expenses and the
compensation for the services are intended to constitute expenses of
administration under any Bankruptcy Law.

          SECTION 7.07 RIGHT OF TRUSTEE TO RELY ON CERTIFICATE OF CERTAIN
OFFICERS. Except as otherwise provided in Section 315 of the Trust Indenture
Act, whenever in the administration of the provisions of this Indenture the
Trustee shall deem it necessary or desirable that a matter be proved or
established prior to taking or suffering any action hereunder, such matter
(unless other evidence in respect thereof be herein specifically prescribed)
may, in the absence of negligence or bad faith on the part of the Trustee, be
deemed to be conclusively proved and established by an Officers' Certificate
delivered to the Trustee and such certificate, in the absence of negligence or
bad faith on the part of the Trustee, shall be full warrant to the Trustee for
any action taken, suffered or omitted by it under the provisions of this
Indenture upon the faith thereof.

          SECTION 7.08 PERSONS ELIGIBLE FOR APPOINTMENT AS TRUSTEE. The Trustee
hereunder shall at all times be a corporation which complies with the
requirements of the Trust Indenture Act, having a combined capital and surplus
of at least $50,000,000. If such corporation publishes reports of condition at
least annually, pursuant to law or to the requirements of the supervising or
examining authority to which it is subject, then for the purposes of this
Section, the combined capital and surplus of such corporation shall be deemed to
be its combined capital and surplus as set forth in its most recent report of
condition so published. In case at any time the Trustee shall cease to be
eligible in accordance with this Section, the Trustee shall resign immediately
in the manner and with the effect specified in Section 7.09.

          SECTION 7.09 RESIGNATION AND REMOVAL OF TRUSTEE; APPOINTMENT OF
SUCCESSOR. (a) The Trustee, or any trustee or trustees hereafter appointed, may
at any time resign by giving written notice to the Company and by giving notice
of such resignation to the Holders of Notes in the manner provided in Section
1.05. Upon receiving such notice of resignation, the Company shall promptly
appoint a successor trustee by written instrument executed by order of the Board
of Directors, one copy of which instrument shall be delivered to the resigning
trustee and one copy to the successor trustee. If no successor trustee shall
have been so appointed and have accepted appointment within 30 days after the
mailing of such notice of resignation, the resigning trustee may petition any
court of competent jurisdiction for the appointment of a successor trustee, or
any Holder who has been a bona fide Holder of a Note or Notes for at least six
months may, subject to the requirements of Section 315(e) of the Trust Indenture
Act, on behalf of such Holder and all others similarly situated, petition any
such court for the appointment of a successor trustee. Such court may thereupon
after such notice, if any, as it may deem proper and prescribe, appoint a
successor trustee.

          (b)     In case at any time any of the following shall occur:

          (1)     the Trustee shall cease to be eligible under Section 7.08 and
shall fail to resign after written request herefor by the Company or by any such
Holder, or

                                       68
<Page>

          (2)     the Trustee shall become incapable of acting, or shall be
adjudged bankrupt or insolvent, or a receiver of the Trustee or of its property
shall be appointed, or any public officer shall take charge or control of the
Trustee or of its property or affairs for the purpose of rehabilitation,
conservation or liquidation;

then, in any such case, the Company may remove the Trustee, and appoint a
successor trustee by written instrument, in duplicate, executed by order of the
Board of Directors of the Company, one copy of which instrument shall be
delivered to the trustee so removed and one copy to the successor trustee, or,
subject to the requirements of Section 315(e) of the Trust Indenture Act, any
Holder who has been a bona fide Holder of a Note or Notes for at least six
months may, on behalf of such Holder and all others similarly situated, petition
any court of competent jurisdiction for the removal of the Trustee and the
appointment of a successor trustee. Such court may thereupon after such notice,
if any, as it may deem proper and prescribe, remove the Trustee and appoint a
successor trustee.

          (c)     The Holders of a majority in aggregate principal amount of the
Notes at the time Outstanding may at any time remove the Trustee and appoint a
successor trustee by delivering to the trustee so removed, to the successor
trustee so appointed and to the Company, the evidence provided for in Section
8.01 of the action taken by the Holders.

          (d)     Any resignation or removal of the Trustee and any appointment
of a successor trustee pursuant to this Section shall become effective only upon
acceptance of appointment by the successor trustee as provided in Section 7.10.

          SECTION 7.10 ACCEPTANCE OF APPOINTMENT BY SUCCESSOR TRUSTEE. Any
successor trustee appointed under Section 7.09 shall execute, acknowledge and
deliver to the Company and to its predecessor trustee an instrument accepting
such appointment hereunder, and thereupon the resignation or removal of the
predecessor trustee shall become effective and such successor trustee, without
any further act, deed or conveyance, shall become vested with all the rights,
powers, trusts, duties and obligations of its predecessor hereunder, with like
effect as if originally named as Trustee herein; but, nevertheless, on the
written request of the Company or of the successor trustee, the Trustee ceasing
to act shall, upon payment of any such amounts then due it pursuant to the
provisions of Section 7.06, execute and deliver an instrument transferring to
such successor trustee all the rights, powers and trusts of the Trustee so
ceasing to act. Upon request of any such successor trustee, the Company shall
execute any and all instruments in writing for more fully and certainly vesting
in and confirming to such successor trustee all such rights and powers. Any
Trustee ceasing to act shall, nevertheless, retain a lien upon all property or
funds held or collected by such Trustee to secure any amounts then due it
pursuant to Section 7.06.

          No successor trustee with respect to the Notes shall accept
appointment as provided in this Section unless at the time of such acceptance
such successor trustee shall with respect to the Notes be qualified under the
Trust Indenture Act and eligible under Section 7.08.

                                       69
<Page>

          Upon acceptance of appointment by a successor trustee, the Company
shall give notice of the succession of such trustee hereunder to the Holders of
Notes in the manner provided in Section 1.05. If the Company fails to give such
notice within 10 days after acceptance of appointment by the successor trustee,
the successor trustee shall cause such notice to be given at the expense of the
Company.

          SECTION 7.11 MERGER, CONVERSION OR CONSOLIDATION OF TRUSTEE. Any
corporation into which the Trustee may be merged or converted or with which it
may be consolidated, or any corporation resulting from any merger, conversion or
consolidation to which the Trustee shall be a party, or any corporation
succeeding to all or substantially all the corporate trust business of the
Trustee, shall be the successor of the Trustee hereunder without the execution
or filing of any paper or any further act on the part of any of the parties
hereto, provided that such successor trustee shall be qualified under the Trust
Indenture Act and eligible under the provisions of Section 7.08 hereof and
Section 310(a) of the Trust Indenture Act.

          SECTION 7.12 AUTHENTICATING AGENTS. There may be an Authenticating
Agent appointed by the Trustee from time to time with power to act on its behalf
and subject to its direction in connection with the authentication and delivery
of Notes issued upon exchange, transfer or redemption thereof as fully to all
intents and purposes as though such Authenticating Agent (the "AUTHENTICATING
AGENT") had been expressly authorized to authenticate and deliver Notes, and
Notes so authenticated shall be entitled to the benefits of this Indenture and
shall be valid and obligatory for all purposes as though authenticated by the
Trustee hereunder. For all purposes of this Indenture (except in the case of
original issuance of Notes and the issuance of Notes in replacement of lost,
stolen, mutilated or destroyed Notes), the authentication and delivery of Notes
by an Authenticating Agent appointed pursuant to the provisions of this Section
shall be deemed to be the authentication and delivery of such Notes "by the
Trustee," and whenever this Indenture provides (except in the case of original
issuance of the Notes and the issuance of Notes in replacement of lost, stolen,
mutilated or destroyed Notes) that "the Trustee shall authenticate and deliver"
Notes, such authentication and delivery by any Authenticating Agent shall be
deemed to be authentication and delivery by the Trustee. Any such Authenticating
Agent shall at all times be a corporation organized and doing business under the
laws of the United States of America or any State or the District of Columbia,
with a combined capital and surplus of at least $25,000,000 and authorized under
such laws to act as an authenticating agent, duly registered to act as such, if
and to the extent required by applicable law and subject to supervision or
examination by Federal, State or District of Columbia authority. If such
corporation publishes reports of its condition at least annually, pursuant to
law or the requirements of such authority, then for the purposes of this Section
7.12 the combined capital and surplus of such corporation shall be deemed to be
its combined capital and surplus as set forth in its most recent report of
condition so published. If at any time an Authenticating Agent shall cease to be
eligible to act as such in accordance with the provisions of this Section 7.12,
it shall resign immediately in the manner and with the effect herein specified
in this Section 7.12.

          Any corporation into which any Authenticating Agent may be merged or
converted or with which it may be consolidated, or any corporation resulting
from any

                                       70
<Page>

merger, conversion or consolidation to which any Authenticating Agent shall be a
party, or any corporation succeeding to the corporate agency business of any
Authenticating Agent, shall be the successor of the Authenticating Agent
hereunder, if such successor corporation is otherwise eligible to act as such in
accordance with the provisions of this Section 7.12, without the execution or
filing of any paper or any further act on the part of the Trustee or the
Authenticating Agent or such successor corporation.

          Any Authenticating Agent may at any time resign by giving written
notice of resignation to the Trustee and to the Company. The Trustee may at any
time terminate the agency of any Authenticating Agent by giving written notice
of termination to such Authenticating Agent and to the Company. Upon receiving
such a notice or resignation or upon a termination, or in case at any time any
Authenticating Agent shall cease to be eligible to act as such in accordance
with the provisions of this Section 7.12, the Trustee may appoint a successor
authenticating agent. Upon the appointment, at any time after the original
issuance of any of the Notes, of any successor, additional or new authenticating
agent, the Trustee shall give written notice of such appointment to the Company
and shall at the expense of the Company give notice of such appointment to all
Holders of Notes in the manner provided in Section 1.05. Any successor
authenticating agent upon acceptance of its appointment pursuant to the
provisions of this Section shall become vested with all the rights, powers,
duties and obligations of its predecessor hereunder, with like effect as if
initially named as an Authenticating Agent herein. No successor authenticating
agent shall be appointed unless eligible to act as such in accordance with the
provisions of this Section 7.12.

          Any Authenticating Agent by the acceptance of its appointment shall be
deemed to have represented to the Trustee that it is eligible for appointment as
Authenticating Agent under this Section and to have agreed with the Trustee
that: it will perform and carry out the duties of an Authenticating Agent as
herein set forth, including, among other things, the duties to authenticate and
deliver Notes when presented to it in connection with exchanges, registrations
of transfer or redemptions thereof; it will keep and maintain, and furnish to
the Trustee from time to time as requested by the Trustee, appropriate records
of all transactions carried out by it as Authenticating Agent and will furnish
the Trustee such other information and reports as the Trustee may reasonably
require; and it will notify the Trustee promptly if it shall cease to be
eligible to act as Authenticating Agent in accordance with the provisions of
this Section 7.12. Any Authenticating Agent by the acceptance of its appointment
shall be deemed to have agreed with the Trustee to indemnify the Trustee against
any loss, liability or expense incurred by the Trustee and to defend any claim
asserted against the Trustee by reason of any acts or failures to act of such
Authenticating Agent, but such Authenticating Agent shall have no liability for
any action taken by it in accordance with the specific written direction of the
Trustee.

          The Trustee agrees to pay to each Authenticating Agent from time to
time reasonable compensation and expenses for its services (to the extent such
compensation is not paid by the Company), and the Trustee shall be entitled to
be reimbursed for such payments subject to the provisions of Section 7.06.

                                       71
<Page>

          The provisions of Sections 7.03, 7.04 and 7.07 shall inure to the
benefit of each Authenticating Agent to the same extent that they inure to the
benefit of the Trustee.

          If an appointment is made pursuant to this Section, the Notes may have
endorsed thereon, in addition to the Trustee's certificate of authentication, an
alternate certificate of authentication in substantially the following form:

          This is one of the Notes referred to in the within-mentioned
Indenture.

                                    THE BANK OF NEW YORK,
                                    As Trustee

                                    By
                                      -------------------------------
                                    As Authenticating Agent

                                    By
                                      -------------------------------
                                    Authorized Signatory

          SECTION 7.13 REPORTS BY TRUSTEE. On or before March 1, in every year,
so long as any Notes are outstanding hereunder, the Trustee shall transmit to
the Holders a brief report, dated as of the preceding February 1, and as
otherwise required by Section 313 of the Trust Indenture Act in accordance with
the procedures set forth in said Section.

          SECTION 7.14 TRUSTEE RISK. None of the provisions contained in this
Indenture shall require the Trustee to expend or risk its own funds or otherwise
incur personal financial liability in the performance of any of its duties or in
the exercise of any of its rights or powers, if there is reasonable ground for
believing that the repayment of such funds or liability is not reasonably
assured to it. Whether or not therein expressly so provided, every provision of
this Indenture relating to the conduct or affecting the liability of or
affording protection to the Trustee shall be subject to the requirements of the
Trust Indenture Act.

                                  ARTICLE EIGHT

                             CONCERNING THE HOLDERS

          SECTION 8.01 EVIDENCE OF ACTION TAKEN BY HOLDERS. Whenever in this
Indenture it is provided that the Holders of a specified percentage or a
majority in aggregate principal amount of the Notes may take any action
(including the making of any demand or request, the giving of any notice,
consent or waiver or the taking of any other action), such action may be taken
by (i) any instrument or any number of instruments of similar tenor executed in
person or by agent or proxy appointed in writing, (ii) vote of the Holders of
Notes at a meeting duly called and held in accordance with the provisions of
Article Nine, or (iii) a combination of such instrument or instruments and such
vote, and the fact that at the time of taking any such action the Holders of
such

                                       72
<Page>

specified percentage or majority have joined therein may be evidenced by (a)
such instrument or instruments (b) the record of such vote, or (c) a combination
of such instrument or instruments and any such record, and except as herein
otherwise expressly provided, such action shall become effective when such
instrument or instruments and/or such record are delivered to the Trustee, and
where expressly required, to the Company.

          SECTION 8.02 PROOF OF EXECUTION OF INSTRUMENTS AND OF HOLDING OF
NOTES. Subject to the provisions of Sections 7.01, 7.02 and 9.05 hereof and
Section 315 of the Trust Indenture Act, proof of the execution of any instrument
by a Holder or his agent or proxy and proof of the holding by any person of any
of the Notes shall be sufficient if made in the following manner:

          The fact and date of the execution by any such person of any
instrument may be proved by the certificate of any notary public or other
officer authorized to take acknowledgments of deeds to be recorded in any State
within the United States, that the person executing such instrument acknowledged
to him the execution thereof, or by an affidavit of a witness to such execution
sworn to before any such notary or other such officer. Where such execution is
by an officer of a corporation or association or a member of a partnership on
behalf of such corporation, association or partnership, such certificate or
affidavit shall also constitute sufficient proof of his authority. The fact and
date of the execution of any such instrument may also be proved in any other
manner which the Trustee may deem sufficient.

          The ownership of Notes may be proved by the Note Registrar or by a
certificate of the Note Registrar.

          If the Company shall solicit from the Holders of Notes any request,
demand, authorization, direction, notice, consent, waiver or other act, the
Company may, at its option, by Board Resolution, fix in advance a record date
for the determination of Holders of Notes entitled to give such request, demand,
authorization, direction, notice, consent, waiver or other act, but the Company
shall have no obligation to do so. Any such record date shall be fixed at the
Company's discretion in accordance with Section 316(c) of the Trust Indenture
Act. If such a record date is fixed, such request, demand, authorization,
direction, notice, consent and waiver or other act may be sought or given before
or after the record date, but only the Holders of Notes of record at the close
of business on such record date shall be deemed to be the Holders of Notes for
the purpose of determining whether Holders of the requisite proportion of Notes
Outstanding have authorized or agreed or consented to such request, demand,
authorization, direction, notice, consent, waiver or other act, and for that
purpose the Notes Outstanding shall be computed as of such record date.

          The Trustee may require such additional proof, if any, of any matter
referred to in this Section 8.02 as it shall deem necessary.

          The record of any Holders' meeting shall be proved as provided in
Section 9.06.

                                       73
<Page>

          SECTION 8.03 RIGHT OF REVOCATION OF ACTION TAKEN. At any time prior to
(but not after) the earlier of (a) the evidencing to the Trustee, as provided in
Section 8.01, of the taking of any action by the Holders of the percentage in
aggregate principal amount of the Notes specified in this Indenture in
connection with such action, and (b) such earlier date as shall be established
by the Company and notice of which shall have been provided to the Holders, any
Holder of a Note the serial number of which is shown by the evidence to be
included in the Notes the Holders of which have consented to such action may, by
filing written notice with the Trustee at its principal office and upon proof of
holding as provided in Section 8.02, revoke such action so far as concerns such
Note. Except as aforesaid, any such action taken by the Holder of any Note shall
be conclusive and binding upon such Holder and upon all future holders and
owners of such Note, and of any Note issued in exchange herefor or in place
thereof, irrespective of whether or not any notation in regard thereto is made
upon such Note or any Note issued in exchange herefor or in place thereof. Any
action taken by the Holders of the percentage in aggregate principal amount of
the Notes specified in this Indenture in connection with such action shall be
conclusively binding upon the Company, the Trustee and the Holders of all the
Notes.

                                  ARTICLE NINE

                                HOLDERS' MEETINGS

          SECTION 9.01 PURPOSES FOR WHICH HOLDERS' MEETINGS MAY BE CALLED. A
meeting of Holders may be called at any time and from time to time pursuant to
this Article Nine for any of the following purposes:

          (a)     to give any notice to the Company or to the Trustee, or to
give any directions to the Trustee, or to waive or to consent to the waiving of
any default hereunder and its consequences, or to take any other action
authorized to be taken by Holders pursuant to Article Six;

          (b)     to remove the Trustee and appoint a successor trustee pursuant
to Article Seven;

          (c)     to consent to the execution of an indenture or indentures
supplemental hereto pursuant to Section 10.02; or

          (d)     to take any other action authorized to be taken by or on
behalf of the Holders of any specified aggregate principal amount of the Notes
under any other provision of this Indenture or under applicable law.

          SECTION 9.02 CALL OF MEETINGS BY TRUSTEE. The Trustee may at any time
call a meeting of Holders to be held at such time and at such place in The City
of New York as the Trustee shall determine. Notice of every meeting of Holders,
setting forth the time and the place of such meeting and in general terms the
action proposed to be taken at such meeting, shall be given by the Trustee, in
the manner provided in Section 1.05,

                                       74
<Page>

not less than 20 nor more than 180 days prior to the date fixed for the meeting,
to the Holders of the Notes.

          SECTION 9.03 COMPANY AND HOLDERS MAY CALL MEETING. In case the
Company, pursuant to a resolution of its Board of Directors, or the Holders of
at least 10% in aggregate principal amount of the Notes then Outstanding, shall
have requested the Trustee to call a meeting of Holders, by written request
setting forth in general terms the action proposed to be taken at the meeting,
and the Trustee shall not have made the mailing of the notice of such meeting
within 20 days after receipt of such request, then the Company or the Holders of
such Notes in the amount above specified may determine the time and the place in
The City of New York for such meeting and may call such meeting to take any
action authorized in Section 9.01, by giving notice thereof as provided in
Section 9.02.

          SECTION 9.04 PERSONS ENTITLED TO VOTE AT MEETING. To be entitled to
vote at any meeting of Holders a person shall, as of the opening of business on
the date of such meeting, be (a) a Holder of one or more Notes or (b) a person
appointed by an instrument in writing as proxy for the Holder or Holders of such
Notes by a Holder of one or more such Notes. The only persons who shall be
entitled to be present or to speak at any meeting of Holders shall be the
persons entitled to vote at such meeting and their counsel and any
representatives of the Trustee and its counsel and any representatives of the
Company and its counsel.

          SECTION 9.05 DETERMINATION OF VOTING RIGHTS; CONDUCT AND ADJOURNMENT
OF MEETING. Notwithstanding any other provisions of this Indenture, the Trustee
may make such reasonable regulations as it may deem advisable for any meeting of
Holders, in regard to proof of the holding of Notes and of the appointment of
proxies, and in regard to the appointment and duties of inspectors of votes, the
submission and examination of proxies, certificates and other evidence of the
right to vote, and such other matters concerning the conduct of the meting as it
shall think fit. Such regulations may provide that written instruments
appointing proxies, regular on their face, may be presumed valid and genuine
without the proof specified in Section 8.02 or other proof. Except as otherwise
permitted or required by any such regulations, the holding of Notes shall be
proved in the manner specified in Section 8.02 and the appointment of any proxy
shall be proved in the manner specified in said Section 8.02 or by having the
signature of the person executing the proxy witnessed or guaranteed by any bank,
banker, trust company or firm satisfactory to the Trustee.

          The Trustee shall, by an instrument in writing, appoint a temporary
chairman of the meeting, unless the meeting shall have been called by the
Company or by Holders as provided in Section 9.03, in which case the Company or
the Holders calling the meeting, as the case may be, shall in like manner
appoint a temporary chairman. A permanent chairman and a permanent secretary of
the meeting shall be elected by vote of the Holders of a majority in principal
amount of the Notes represented at the meeting and entitled to vote.

                                       75
<Page>

          At any meeting each Holder of a Note or proxy shall be entitled to one
vote for each $1 principal amount of Notes held or represented by such Holder;
provided, however, that no vote shall be cast or counted at any meeting in
respect of any Note challenged as not Outstanding and ruled by the chairman of
the meeting to be not Outstanding. The chairman of the meeting shall have no
right to vote other than by virtue of Notes held by such chairman or instruments
in writing as aforesaid duly designating such chairman as the person to vote on
behalf of other Holders. Any meeting of Holders duly called pursuant to Section
9.02 or 9.03 may be adjourned from time to time, and the meeting may be held as
so adjourned without further notice.

          At any meeting, the presence of persons holding or representing Notes
in an aggregate principal amount sufficient to take action upon the business for
the transaction of which such meeting was called shall be necessary to
constitute a quorum; but, if less than a quorum be present, the persons holding
or representing a majority of the Notes represented at the meeting may adjourn
such meeting with the same effect, for all intents and purposes, as though a
quorum had been present.

          SECTION 9.06 COUNTING VOTES AND RECORDING ACTION OF MEETING. The vote
upon any resolution submitted to any meeting of Holders shall be by written
ballots on which shall be subscribed the signatures of the Holders of Notes or
of their representatives by proxy and the serial numbers and principal amounts
of the Notes held or represented by them. The permanent chairman of the meeting
shall appoint two inspectors of votes who shall count all votes cast at the
meeting for or against any resolution and who shall make and file with the
secretary of the meeting their verified written reports in duplicate of all
votes cast at the meeting. A record in duplicate of the proceedings of each
meeting of Holders shall be prepared by the secretary of the meeting and there
shall be attached to said record the original reports of the inspectors of votes
on any vote by ballot taken thereat and affidavits by one or more persons having
knowledge of the facts setting forth a copy of the notice of the meeting and
showing that said notice was given as provided in Section 9.02. The record shall
show the serial numbers of the Notes voting in favor of or against each
resolution. The record shall be signed and verified by the affidavits of the
permanent chairman and secretary of the meeting and one of the duplicates shall
be delivered to the Company and the other to the Trustee to be preserved by the
Trustee, the latter to have attached thereto the ballots voted at the meeting.

          Any record so signed and verified shall, absent manifest error, be
conclusive evidence of the matters therein stated.

                                   ARTICLE TEN

                             SUPPLEMENTAL INDENTURES

          SECTION 10.01 SUPPLEMENTAL INDENTURES WITHOUT CONSENT OF HOLDERS.
Without the consent of any Holders, the Company, when authorized by a Board
Resolution, and the Trustee, at any time and from time to time, may enter into
one or

                                       76
<Page>

more indentures supplemental hereto, in form satisfactory to the Trustee, for
any of the following purposes:

          (1)     to evidence the succession of another Person to the Company or
the Guarantor, and the assumption by any such successor of the covenants of the
Company or the Guarantor herein and in the Notes; or

          (2)     to add to the covenants of the Company or the Guarantor for
the benefit of the Holders, or to surrender any right or power herein conferred
upon the Company or the Guarantor; or

          (3)     to cure any ambiguity, to correct or supplement any provision
herein which may be inconsistent with any other provision herein, or to make any
other provisions with respect to matters or questions arising under this
Indenture, provided such action pursuant to this clause (3) shall not adversely
affect the interests of the Holders.

          SECTION 10.02 SUPPLEMENTAL INDENTURES WITH CONSENT OF HOLDERS. With
the consent of the Holders of not less than a majority in aggregate principal
amount of the Outstanding Notes, by act of said Holders delivered to the Company
and the Trustee, the Company, when authorized by a Board Resolution, and the
Trustee may enter into an indenture or indentures supplemental hereto for the
purpose of adding any provisions to or changing in any manner or eliminating any
of the provisions of this Indenture or of modifying in any manner the rights of
the Holders under this Indenture; provided, however, that no such supplemental
indenture shall, without the consent of the Holder of each Outstanding Note
affected thereby,

          (1)     change the Stated Maturity of the principal of, or any
installment of interest or Additional Amounts on, any Note, or reduce the
principal amount thereof or the rate of interest thereon or any premium payable
upon the redemption thereof, or change the place of payment where, or the coin
or currency in which, any Note or any premium or the interest or Additional
Amounts thereon is payable, impair the right to institute suit for the
enforcement of any such payment on or after the Stated Maturity thereof (or, in
the case of redemption, on or after the redemption date), or release, or amend
in a manner adverse to the holders of the new notes, the obligation of the
Guarantor under Sections 14.01 and 14.02 to make payments under the Guarantee,
or

          (2)     reduce the percentage in principal amount of the Outstanding
Notes, the consent of whose Holders is required for any such supplemental
indenture, or the consent of whose Holders is required for any waiver (of
compliance with certain provisions of this Indenture or certain defaults
hereunder and their consequences) provided for in this Indenture, or

          (3)     modify any of the provisions of this Section or Section 6.12,
except to increase any such percentage or to provide that certain other
provisions of this Indenture cannot be modified or waived without the consent of
the Holder of each Outstanding Note affected thereby.

                                       77
<Page>

          It shall not be necessary for any act of Holders under this Section to
approve the particular form of any proposed supplemental indenture, but it shall
be sufficient if such act shall approve the substance thereof.

          SECTION 10.03 EXECUTION OF SUPPLEMENTAL INDENTURES. In executing, or
accepting the additional trusts created by, any supplemental indenture permitted
by this Article or the modifications thereby of the trusts created by this
Indenture, the Trustee shall be entitled to receive, and (subject to Section
7.01) shall be fully protected in relying upon, an Opinion of Counsel stating
that the execution of such supplemental indenture is authorized or permitted by
this Indenture. The Trustee may, but shall not be obligated to, enter into any
such supplemental indenture which affects the Trustee's own rights, duties or
immunities under this Indenture or otherwise.

          SECTION 10.04 EFFECT OF SUPPLEMENTAL INDENTURES. Upon the execution of
any supplemental indenture under this Article, this Indenture shall be modified
in accordance therewith, and such supplemental indenture shall form a part of
this Indenture for all purposes, and every Holder of Notes theretofore or
thereafter authenticated and delivered hereunder shall be bound thereby.

          SECTION 10.05 CONFORMITY WITH TRUST INDENTURE ACT. Every supplemental
indenture executed pursuant to this Article shall conform to the requirements of
the Trust Indenture Act as then in effect.

          SECTION 10.06 REFERENCE IN NOTES TO SUPPLEMENTAL INDENTURES. Notes
authenticated and delivered after the execution of any supplemental indenture
pursuant to this Article may, and shall if required by the Trustee, bear a
notation in form approved by the Trustee and the Company as to any matter
provided for in such supplemental indenture. If the Company shall so determine,
new Notes so modified as to conform, in the opinion of the Trustee and the
Company, to any such supplemental indenture may be prepared and executed by the
Company and authenticated and delivered by the Trustee in exchange for
Outstanding Notes.

                                 ARTICLE ELEVEN

                              SUCCESSOR CORPORATION

          SECTION 11.01 WHEN COMPANY MAY MERGE, ETC. The Company shall not
consolidate with, merge with or into, or transfer, directly or indirectly by
lease, assignment, sale or otherwise, including, without limitation, as a result
of the merger or consolidation of a Restricted Subsidiary with any other Person
(collectively, a "TRANSFER"), all or substantially all of its assets in one
transaction or a series of related transactions to, any Person or group of
affiliated Persons or permit any of its Restricted Subsidiaries to enter into
any such transaction or transactions if such transaction or transactions in the
aggregate would result in a transfer of all or substantially all of the assets
of the Company and its Restricted Subsidiaries on a consolidated basis, unless:

                                       78
<Page>

          (1)     either the Company shall be the continuing Person, or the
Person formed by such consolidation or into which the Company is merged or to
which all or substantially all of the properties and assets of the Company are
transferred or to which all or substantially all of the assets of the Company
and its Restricted Subsidiaries are transferred (the "SURVIVING ENTITY") shall
be a Person organized and existing under the laws of the United States of
America, any State thereof or the District of Columbia or Mexico and shall
expressly assume, by an indenture supplemental hereto, executed and delivered to
the Trustee, in form satisfactory to the Trustee, all the obligations of the
Company under the Notes and this Indenture; provided that a corporation at all
times shall be a co-obligor together with the continuing Person or transferee if
the continuing Person or transferee is itself not a corporation;

          (2)     immediately before and immediately after giving effect to such
transaction no Default or Event of Default exists;

          (3)     immediately after giving effect to such transaction, the
Consolidated Net Worth of the Company and its Restricted Subsidiaries or the
surviving entity is equal to or greater than the Consolidated Net Worth of the
Company and its Restricted Subsidiaries immediately prior to the transaction;

          (4)     immediately after giving effect to such transaction, the
Company or the surviving entity could incur at least $1.00 of additional
Indebtedness under Section 5.14(a) hereof; and

          (5)     the Company has delivered to the Trustee an Officers'
Certificate (attaching, except during the pendency of a Suspension Period, the
arithmetic computations to demonstrate compliance with paragraphs (3) and (4))
and an Opinion of Counsel, each stating that such consolidation, merger, sale,
assignment, transfer or lease and such supplemental indenture comply with this
Section 11.01(a) and that all conditions precedent herein provided for relating
to such transactions have been complied with.

          Notwithstanding anything in this Section 11.01, this Article Eleven
shall not apply to any transfer that is a Qualifying Disposition. SECTION

          11.02 SUCCESSOR CORPORATION. Upon any consolidation or merger or any
transfer of all or substantially all of the assets of the Company in accordance
with Section 11.01, except as otherwise provided herein, the successor
corporation formed by such consolidation or into which the Company is merged or
to which such transfer is made, shall succeed to, and be substituted for, and
may exercise every right and power of, the Company under this Indenture with the
same effect as if such successor corporation had been named as the Company
herein.

                                       79
<Page>

                                 ARTICLE TWELVE

            SATISFACTION AND DISCHARGE OF INDENTURE; UNCLAIMED MONEYS

          SECTION 12.01 TERMINATION OF COMPANY'S OBLIGATIONS. The Company may
terminate all of its obligations under the Notes and this Indenture, except
those obligations referred to below, if:

          (a)     all Notes previously authenticated and delivered (other than
destroyed, lost or stolen Notes which have been replaced or paid) have been
delivered to the Trustee for cancellation and the Company has paid all sums
payable by it hereunder; or

          (b)     either (i) the Notes mature within one year or all of them are
to be called for redemption within one year under arrangements reasonably
satisfactory to the Trustee for giving the notice of redemption or (ii) if the
Notes do not mature or are not to be called for redemption in accordance with
clause (i) hereof, the Company shall have delivered to the Trustee either (A) a
ruling directed to the Trustee received from the Internal Revenue Service to the
effect that the Holders of the Notes will not recognize income, gain or loss for
Federal income tax purposes as a result of the Company's exercise of its option
under this Section 12.01(b)(ii) and will be subject to Federal income tax on the
same amount and in the same manner and at the same times as would have been the
case if such option had not been exercised or (B) an Opinion of Counsel from
nationally recognized United States counsel, to the same effect as the ruling
described in clause (A) above with no material qualifications and, in the case
of either clause (i) or (ii):

          (1)     subject to applicable stock exchange requirements, if any, the
Company irrevocably deposits with the Trustee under the terms of an irrevocable
trust agreement in form and substance satisfactory to the Trustee, as trust
funds in trust solely for the benefit of the Holders for that purpose, money or
U.S. Government Obligations, maturing as to principal and interest in such
amounts and at such times as are sufficient (in the opinion of a nationally
recognized firm of independent certified public accountants expressed in a
written certification thereof delivered to the Trustee), without consideration
of any reinvestment of such interest on such U.S. Government Obligations, to pay
principal of and interest on the Outstanding Notes to maturity or redemption, as
the case may be, and to pay all other sums payable by it hereunder, provided
that the Trustee shall have been irrevocably instructed to apply such trust
funds to the payment of principal and interest on the Outstanding Notes;

          (2)     no Default or Event of Default with respect to this Indenture
or the Notes shall have occurred and be continuing on the date of such deposit
or shall occur as a result of such deposit or shall occur on or before 90 days
after the date of such deposit and such deposit will not result in a breach or
violation of, or constitute a default under, any other agreement or instrument
to which the Company is a party or by which it is bound;

                                       80
<Page>

          (3)     the Company shall have paid or caused to be paid all sums then
payable by the Company hereunder and under the Notes;

          (4)     such deposit shall not cause the Trustee to have a conflicting
interest as defined in and for purposes of the Trust Indenture Act;

          (5)     the Company has delivered to the Trustee an Opinion of Counsel
from nationally recognized United States counsel, with no material
qualifications, stating that (A) the deposit shall not result in the Company,
the Trustee or the trust becoming or being deemed to be an investment company"
under the Investment Company Act of 1940, as amended, and (B) upon making the
deposit, a valid trust is created at the time of such deposit and the Holders of
the Notes will have the sole beneficial ownership interest under applicable law
in the money or U.S. Government Obligations so deposited in such trust, except
that the Opinion of Counsel referred to in this clause (B) may contain a
qualification that in the event that a court of competent jurisdiction were to
determine that the trust funds remained property of the Company after such
deposit, the Holders of the Notes will have a nonavoidable first priority
perfected security interest under applicable law in the money or U.S. Government
Obligations so deposited, which security interest will not be subject to any
prior rights of holders of any other Indebtedness; and

          (6)     the Company shall take any and all acts necessary to create
and perfect, in favor of the Holders of the Notes, a first priority security
interest in the money or U.S. Government Obligations so deposited and shall take
any other action and execute and deliver any other documents that may reasonably
be requested by the Trustee to effectuate such security interest, and shall do
all of the above at such appropriate time so that such security interest shall
attach to the deposit at the time such deposit is made;

and in either case of (a) or (b) the Company has delivered to the Trustee an
Officers' Certificate and an Opinion of Counsel each stating that all conditions
precedent provided for herein relating to the satisfaction and discharge of this
Indenture have been complied with.

          It is the intention of the parties hereto that a valid trust for the
benefit of the Holders of the Notes be created at the time that the Company
makes the deposit pursuant to Section 12.0l(b)(l). The security interest in such
deposit that is granted herein to the Holders of the Notes is intended solely as
protection for the Holders of the Notes in the event that a court of competent
jurisdiction were to determine either that (i) such trust had not been validly
created or (ii) such trust is not enforceable.

          Notwithstanding the foregoing clause (b), prior to the end of the
90-day period referred to in clause (b)(2) above none of the Company's
obligations under this Indenture shall be discharged, and subsequent to the end
of such 90-day period the Company's obligations in Sections 3.01, 3.02, 3.03,
3.04, 3.05, 3.06, 5.01, 5.02, 5.04, 5.11, 7.06, 7.09, 12.02, 12.03 and 12.04
shall survive until the Notes are no longer outstanding. Thereafter, only the
Company's obligations in Sections 7.06, 12.03 and 12.04 shall survive. If and
when a ruling from the Internal Revenue Service or Opinion of Counsel referred
to in clause (b)(ii) above is able to be provided specifically without

                                       81
<Page>

regard to, and not in reliance upon, the continuance of the Company's
obligations under the Notes and Section 5.01, then the Company's obligations
under the Notes and Sections 5.01 and 5.02 shall cease upon delivery to the
Trustee of such ruling or opinion and compliance with the other conditions
precedent provided for herein relating to the satisfaction and discharge of this
Indenture.

          After a deposit and delivery of an Officers' Certificate and an
Opinion of Counsel and compliance with the other conditions precedent provided
for herein relating to the satisfaction and discharge of this Indenture, the
Trustee upon request shall acknowledge in writing the satisfaction and discharge
of the Company's obligations under this Indenture except for those surviving
obligations specified above.

          "U.S. GOVERNMENT OBLIGATIONS" means non-callable, direct obligations
of the United States of America for the payment of which the full faith and
credit of the United States of America is pledged.

          SECTION 12.02 APPLICATION OF TRUST MONEY. The Trustee shall hold
in trust money or U.S. Government Obligations deposited with it pursuant to
Section 12.01. It shall apply the deposited money and the money from U.S.
Government Obligations through the Paying Agent and in accordance with this
Indenture to the payment of principal of and interest on the Notes.

          SECTION 12.03 REPAYMENT TO COMPANY. Subject to Section 12.02 the
Trustee and the Paying Agent shall promptly pay to the Company upon written
request any excess money or Notes held by them at any time and they shall
thereupon be relieved from all liability with respect to such money.

          The Trustee and the Paying Agent shall pay to the Company upon written
request any money held by them for the payment of principal or interest that
remains unclaimed for two years; provided that the Company shall have first
caused notice of such payment to be mailed to each Holder entitled thereto no
less than 30 days prior to such repayment. After payment to the Company, Holders
entitled to the money must look to the Company for payment as general creditors
unless an applicable abandoned property law designates another Person, and all
liability of the Trustee and the Paying Agent with respect to such money shall
cease.

          SECTION 12.04 REINSTATEMENT. If the Trustee or the Paying Agent is
unable to apply any money in accordance with Section 12.02 by reason of any
legal proceeding or by reason of any order or judgment of any court or
governmental authority enjoining, restraining or otherwise prohibiting such
application, the Company's obligations under this Indenture and the Notes shall
be revived and reinstated as though no deposit had occurred pursuant to Section
12.01 until such time as the Trustee or the Paying Agent is permitted to apply
all such money in accordance with Section 12.02; provided that if the Company
has made any payment of interest on or principal of any Note because of the
reinstatement of its obligations, the Company shall be subrogated to the rights
of the Holders of such Notes to receive such payment from the money held by the
Trustee or the Paying Agent.

                                       82
<Page>

                                ARTICLE THIRTEEN

         IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS

          SECTION 13.01 PERSONAL IMMUNITY FROM LIABILITY OF INCORPORATORS,
STOCKHOLDERS, ETC. No recourse under or upon any obligation, covenant or
agreement of this Indenture or any indenture supplemental hereto, or of any
Note, or for any claim based thereon or otherwise in respect thereof, shall be
had against any incorporator or against any past, present or future stockholder,
officer, director, employee or agent, as such, of the Company or the Trustee or
any Paying Agent or Authenticating Agent or of any successor thereto, either
directly or through the Company or the Trustee or any Paying Agent or
Authenticating Agent or any successor thereto, whether by virtue of any
constitution, statute or rule of law, or by the enforcement of any assessment or
penalty or otherwise, all such liability and any and all such claims being
hereby expressly waived and released as a condition of, and as a consideration
for, the execution of this Indenture and issue of the Notes.

                                ARTICLE FOURTEEN

                                    GUARANTEE

          SECTION 14.01 GUARANTEE. By its execution hereof, the Guarantor
acknowledges and agrees that it receives substantial benefits from the
Company and that it is providing its Guarantee for good and valuable
consideration, including, without limitation, such substantial benefits and
services. Accordingly, subject to the provisions of this Article Fourteen,
the Guarantor hereby unconditionally guarantees on a senior basis to each
Holder of a Note authenticated and delivered by the Trustee and its
successors and assigns that: (i) the principal of, and premium and interest
on the Notes shall be duly and punctually paid in full when due, whether at
maturity, by acceleration, call for redemption, upon an Offer, upon a Net
Cash Proceeds Offer or otherwise, and interest on overdue principal, and
premium, if any, and (to the extent permitted by law) interest on any
interest, if any, on the Notes and all other obligations of the Company to
the Holders or the Trustee hereunder or under the Notes (including fees,
expenses or other) shall be promptly paid in full or performed, all in
accordance with the terms hereof; and (ii) in case of any extension of time
of payment or renewal of any Notes or any of such other obligations, the same
shall be promptly paid in full when due or performed in accordance with the
terms of the extension or renewal, whether at stated maturity, by
acceleration, call for redemption, upon a Change of Control, upon a Net Cash
Proceeds Offer or otherwise, subject, however, in the case of clauses (i) and
(ii) above, to the limitations set forth in Section 14.05 (collectively, the
"GUARANTEE OBLIGATIONS"). An Event of Default under this Indenture or the
Notes shall constitute an event of default under this Guarantee, and shall
entitle the Trustee or the Holders of Notes to accelerate the obligations of
the Guarantor hereunder in the same manner and to the same extent as the
Guarantee Obligations of the Company.

                                       83
<Page>

          Subject to the provisions of this Article Fourteen, the Guarantor
hereby agrees that its Guarantee hereunder shall be unconditional, irrespective
of the validity, regularity or enforceability of the Notes or this Indenture,
the absence of any action to enforce the same, any waiver or consent by any
Holder of the Notes with respect to any thereof, the entry of any judgment
against the Company, any action to enforce the same or any other circumstance
which might otherwise constitute a legal or equitable discharge or defense of a
Guarantor. The Guarantor hereby waives and relinquishes: (a) any right to
require the Trustee, the Holders or the Company (each, a "BENEFITED PARTY") to
proceed against the Company or any other Person or to proceed against or exhaust
any security held by a Benefited Party at any time or to pursue any other remedy
in any secured party's power before proceeding against the Guarantor; (b) any
defense that may arise by reason of the incapacity, lack of authority, death or
disability of any other Person or Persons or the failure of a Benefited Party to
file or enforce a claim against the estate (in administration, bankruptcy or any
other proceeding) of any other Person or Persons; (c) demand, protest and notice
of any kind (except as expressly required by this Indenture), including but not
limited to notice of the existence, creation or incurring of any new or
additional Indebtedness or obligation or of any action or non-action on the part
of the Guarantor, the Company, any Benefited Party, any creditor of the
Guarantor or the Company or on the part of any other Person whomsoever in
connection with any obligations the performance of which are hereby guaranteed;
(d) any defense based upon an election of remedies by a Benefited Party,
including but not limited to an election to proceed against the Guarantor for
reimbursement; and (e) any defense based upon any statute or rule of law which
provides that the obligation of a surety must be neither larger in amount nor in
other respects more burdensome than that of the principal. The Guarantee shall
be discharged upon the earlier of: (i) the first Suspension Date and (ii) the
payment in full of all Guarantee Obligations, including the principal, premium,
if any, and interest on the Notes and all other costs provided for under this
Indenture or as provided in Article Fourteen, and after such termination is not
reinstated except as set forth in the immediately succeeding paragraph.

          If any Holder or the Trustee is required by any court or otherwise to
return to either the Company or the Guarantor, or any trustee or similar
official acting in relation to either the Company or the Guarantor, any amount
paid by the Company or the Guarantor to the Trustee or such Holder, the
Guarantee, to the extent theretofore discharged, shall be reinstated in full
force and effect. The Guarantor agrees that it shall not be entitled to any
right of subrogation in relation to the Holders in respect of any Guarantee
Obligations hereby until payment in full of all such obligations guaranteed
hereby. The Guarantor agrees that, as between it, on the one hand, and the
Holders of Notes and the Trustee, on the other hand, (x) the maturity of the
obligations guaranteed hereby may be accelerated as provided in Article Six
hereof for the purposes hereof, notwithstanding any stay, injunction or other
prohibition preventing such acceleration in respect of the Guarantee
Obligations, and (y) in the event of any acceleration of such obligations as
provided in Article Six hereof, such Guarantee Obligations (whether or not due
and payable) shall forthwith become due and payable by the Guarantor for the
purpose of the Guarantee.

                                       84
<Page>

          SECTION 14.02 EXECUTION AND DELIVERY OF GUARANTEE. To evidence the
Guarantee set forth in Section 14.01 hereof, the Guarantor agrees that a
notation of the Guarantee substantially in the form included in Section 2.04
shall be endorsed on each Note authenticated and delivered by the Trustee and
that this Indenture shall be executed on behalf of the Guarantor by an officer
of the Guarantor.

          The Guarantor agrees that the Guarantee set forth in this Article
Fourteen shall remain in full force and effect and apply to all the Notes
notwithstanding any failure to endorse on each Note a notation of the
Guarantees.

          If an officer whose facsimile signature is on a Note or a notation of
Guarantee no longer holds that office at the time the Trustee authenticates the
Note on which the Guarantee is endorsed, the Guarantee shall be valid
nevertheless.

          The delivery of any Note by the Trustee, after the authentication
thereof hereunder, shall constitute due delivery of the Guarantee set forth in
this Indenture on behalf of the Guarantor.

          SECTION 14.03 WHEN THE GUARANTOR AND TMM MULTIMODAL MAY MERGE, ETC.

          (a)     The Guarantor shall not consolidate with or merge with or into
any Person or group of affiliated Persons.

          (b)     TMM Multimodal shall not consolidate with or merge with or
into any Person or group of affiliated Persons, unless (i) such merger or
consolidation is a Qualifying Disposition and (ii) all of the following
conditions are satisfied:

          (A)     either TMM Multimodal shall be the continuing Person, or the
Person formed by such consolidation or into which TMM Multimodal is consolidated
or merged (the "surviving entity") shall be a corporation organized and existing
under the laws of the United States of America, any state thereof or the
District of Columbia or Mexico;

          (B)     both immediately before and immediately after giving effect to
such consolidation or merger, no Default or Event of Default has occurred and is
continuing; and

          (C)     the Company has delivered to the Trustee an Officers'
Certificate and an Opinion of Counsel, each stating that such consolidation or
merger complies with this Section 14.03 and that all conditions precedent herein
provided for relating to such merger or consolidation have been complied with.

          SECTION 14.04 APPLICATION OF CERTAIN TERMS AND PROVISIONS TO THE
GUARANTOR.

          (a)     For purposes of any provision of this Indenture that provides
for the delivery by the Guarantor of an Officers' Certificate and/or an Opinion
of Counsel,

                                       85
<Page>

the definitions of such terms in Section 1.01 shall apply to the Guarantor as if
references therein to the Company were references to the Guarantor.

          (b)     Any request, direction, order or demand that by any provision
of this Indenture is to be made by the Guarantor, shall be sufficient if
evidenced as described in Section 1.04 as if references therein to the Company
were references to the Guarantor.

          (c)     Any notice or demand that by any provision of this Indenture
is required or permitted to be given or served by the Trustee or by the holders
of Notes to or on the Guarantor may be given or served as described in
Section 1.04 as if references therein to the Company were references to the
Guarantor.

          (d)     Upon any demand, request or application by the Guarantor to
the Trustee to take any action under this Indenture, the Guarantor shall furnish
to the Trustee such certificates and opinions as are required in Section 1.02
hereof as if all references therein to the Company were references to the
Guarantor.

                                       86
<Page>

          IN WITNESS WHEREOF, the parties hereto have caused this Indenture to
be duly executed as of the day and year first above written.

                                       GRUPO TMM, S.A.,
                                         as Issuer

                                       By:
                                          -------------------------------------

                                       Name: Jacinto Marina
                                       Title: Chief Financial Officer

                                       TMM HOLDINGS, S.A. DE C.V.,
                                         as Guarantor

                                       By:
                                          -------------------------------------

                                       Name:
                                       Title:

                                       THE BANK OF NEW YORK,
                                         as Trustee

                                       By:
                                          -------------------------------------
                                       Name:
                                       Title:

                                       87

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00051-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00051-of-00352.parquet"}]]